Mapping the actions of prolactin in the brain: sexual dimorphism, steroid regulation and the neuroendocrinology of maternal behaviour by Salais López, Hugo
  
i 
 
 
MAPPING THE ACTIONS OF 
PROLACTIN IN THE MOUSE BRAIN 
Sexual Dimorphism, Steroid Regulation 
and the Neuroendocrinology of  
Maternal Behaviour 
 
Tesis Doctoral en Neurociencias 
Hugo Salais López 
Dirigida por 
Fernando Martínez García   Carmen Agustín Pavón 
Burjassot y Castellón, 2017 
ii 
 
 
Fernando Martínez García, Catedràtic de Fisiologia de la Unitat 
Predepartamental de Medicina de la Universitat Jaume I (UJI) de Castelló, i 
Carmen Agustín Pavón, Professora Ajudant Doctora del Departament de 
Biol·logia Cel·lular, Biol·logia Funcional y Antropologia Fìsica de la Universitat 
de València 
Certifique 
Que en Hugo Salais López, Màster en Neurociències per la Universitat de 
València, ha realitzat sota la nostra direcció el treball titulat 
“Mapping the Action of Prolactin in the Brain. Sexual Dimorphism, 
Steroid Regulation and the Neuroendocrinology of Maternal Behaviour”  
per a l’obtención del grau de Doctor en Neurociències Bàsiques i Aplicades.  
 
La qual cosa signem a Burjassot, el dia 18 de maig de 2017  
 
 
Fernando Martínez-García, PhD   Carmen Agustín-Pavón, PhD 
  
iii 
 
 
Fernando Martinez-Garcia, Professor of Physiology of the Predepartmental 
Unit of Medicine at the Universitat Jaume I (UJI), and Carmen Agustín Pavón, 
Lecturer of the Department of Cell Biology, Functional Biology and 
Antropology at the Universitat de València (UV)  
Hereby certify 
That Mr. Hugo Salais López, MSc in Neuroscience at the University of 
València, has performed, under our supervision the work entitled:  
“Mapping the Action of Prolactin in the Brain. Sexual Dimorphism, 
Steroid Regulation and the Neuroendocrinology of Maternal Behaviour”  
to obtain the PhD in Basic and Applied Neurosciences.  
 
What we sign as required in Burjassot, on May the 18th, 2017  
 
 
Fernando Martínez-García, PhD   Carmen Agustín-Pavón, PhD 
 
iv 
 
 
  
  
v 
 
Durante la realización de esta tesis, el autor ha sido beneficiario de una beca del Programa de 
Formación de Profesorado Universitario del Ministerio de Educación (FPU 12/05472).  
Este trabajo se ha enmarcado en los proyectos financiados por:  
 Ministerio de Economía y Competitividad-FEDER. Señales vomeronasales y control 
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R red nucleus 
RCh retrochiasmatic area 
Re reuniens thalamic nucleus 
RMg raphe magnus nucleus 
Rob raphe obscurus nucleus 
rs rubrospinal tract 
Rt reticular thalamic nucleus 
s5 sensory root of the trigeminal nerve 
SCh suprachiasmatic nucleus 
SCO subcommissural organ 
scp superior cerebellar peduncle 
SFi septofimbrial nucleus 
SFO subfornical organ 
SG suprageniculate thalamic nucleus 
SHi septohippocampal nucleus 
SI substantia innominata 
SLEA sublenticular extended amygdala 
sm stria medullaris of the thalamus 
SN substantia nigra 
SNC substantia nigra, pars compacta 
SNR substantia nigra, reticular part 
SO supraoptic nucleus 
sol solitary tract 
Sol nucleus of the solitary tract 
SolC nucleus of the solitary tract, 
commissural part 
SolDL nucleus of the solitary tract, 
dorsolateral part 
SolG nucleus of the solitary tract, gelatinous 
part 
SolM nucleus of the solitary tract, medial 
part 
SolV nucleus of the solitary tract, ventral 
part 
Sp5 spinal trigeminal nucleus 
Spa subparaventricular zone of the 
hypothalamus 
SPFPC subparafascicular thalamic nucleus, 
parvicellular part 
SPO superior paraolivary nucleus 
st stria terminalis 
STh subthalamic nucleus 
str superior thalamic radiation 
SubB subbrachial nucleus 
SubCD subcoeruleus nucleus, dorsal part 
SubCV subcoeruleus nucleus, ventral part 
SubG subgeniculate nucleus 
SubI subincertal nucleus 
SuMM supramammillary nucleus, medial part 
TC tuber cinereum 
Te terete hypothalamic nucleus 
Tu olfactory tubercle 
VEn ventral endopiriform nucleus 
VLG ventral lateral geniculate nucleus 
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VLGMC ventral lateral geniculate nucleus, 
magnocellular part 
VLGPC ventral lateral geniculate nucleus, 
parvicellular part 
VLPAG ventrolateral periaqueductal grey 
VLPO ventrolateral preoptic nucleus 
VMH ventromedial hypothalamic nucleus 
VMHc ventromedial hypothalamic nucleus, 
central part 
VMHdm ventromedial hypothalamic nucleus, 
dorsomedial part 
VMHvl ventromedial hypothalamic nucleus, 
ventrolateral part 
VMPO ventromedial preoptic nucleus 
VOLT vascular organ of the lamina terminalis 
VP ventral pallidum  
VRe ventral reuniens thalamic nucleus 
vsc ventral spinocerebellar tract 
VTA ventral tegmental area 
ZI zona incerta 
ZID zona incerta, dorsal part 
ZIV zona incerta, ventral part 
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The correct function of the body involves the coordinated action of its two main 
regulatory systems: the nervous and endocrine systems. For a successful 
neuroendocrine regulation, both systems have to communicate and interact 
reciprocally. In this regard, the brain is the main director of endocrine signals in the body 
(acting through the hypothalamus and pituitary gland), but hormones do also target the 
brain to regulate central functions and behaviour. Endocrine regulation of the brain is 
commonly carried out by steroid hormones which, given their lipoid nature (as 
cholesterol derivatives), can readily access the brain by passively diffusing through the 
blood-brain barrier (BBB). Conversely, peptide hormones (at least proteins with 
considerable size) lack the capacity of crossing the BBB and, consequently, have their 
actions generally restricted to the systemic level, being unable to directly influence 
behaviour. 
Prolactin (PRL) is a remarkable exception to this scenario. Despite its peptide nature, this 
hormone can be transported into the brain by means of at least one active transport 
mechanism (Walsh et al. 1987; Mangurian et al. 1992). Furthermore, the PRL receptor 
(PRLR) is widely expressed by neurons in many  brain nuclei (Bakowska and Morrell 
1997). As a result, PRL is an important endocrine regulator of the brain, currently known 
to intervene in multiple processes related to homeostasis, reproduction and behaviour 
(Freeman et al. 2000), in the female and also in the male brain. Perhaps the most 
eminent feature of PRL is its key role in maternal physiology. Discovered and best-
known for its role in mammary gland development and milk production during lactation 
in mammals (Riddle et al. 1933a), PRL exerts a complex and coordinated regulation of 
the brain during motherhood, adjusting physiology for the particular demands of this 
period and promoting the expression of maternal behaviours to properly manage the 
offspring.  
This work is aimed at better characterizing the central actions of PRL in the mouse brain, 
focusing on its interaction with other important neuroendocrine regulators and its 
multifaceted role in the neuroendocrinology of reproduction and motherhood. We will 
initiate this introduction by characterising the main molecular and endocrine features of 
PRL and its signalling mechanisms, including the PRL receptor (PRLR), PRL-associated 
signal transduction pathways and the regulation of PRL signalling in the brain, with 
special attention to its interaction with gonadal steroids. Then, we will give some 
insights on the functional identity of PRL, focusing on its paramount role integrating 
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neurological, physiological and behavioural adaptations to the maternal period. Finally, 
we will focus on the lactogenic regulation of maternal behaviour. 
 
Figure I.1 Prolactin: molecular and phylogenetical features 
(A) 3D structural model of Prolactin (PRL). PRL is a polypeptide hormone synthesized and 
secreted by the lactoroph cells of the adenohypohpysis. The PRL molecule has a molecular 
weight of 23 kDa and is arranged in a single amino acid chain, folded due to three intramolecular 
disulphide bonds. The structure of PRL is subject to substantial heterogeneity due to differing 
glycosylation, phosphorylation and sulfation processes.  
(B) PRL has multiple structural homologues in the body, including growth hormone and 
placental lactogens. PRL, growth hormone and placental lactogens all belong to the group I of 
the helix-bundle protein hormone/cytokine family. Genes encoding these molecules diverged 
from a common ancestral gene by gene duplication 400 million years ago (Freeman et al. 2000). 
Modified and adapted and from Soares et al. (2004). 
 
 PROLACTIN – GENERAL FEATURES 
Prolactin is a polypeptide hormone (Fig I.1A) belonging to the type I helix-bundle protein 
(cytokine) family (Rand-Weaver et al. 1991), which includes also growth hormone (GH) 
and other lactogenic molecules such as placental lactogens (Horseman and Yu-Lee 
1994). The protein is encoded by a single gene in humans and other primates and by 
several paralogue genes in rats, mice and other mammals (Soares 2004). The main form 
of the molecule consists of 197 to 199 amino acids (depending on the species) with a 
molecular mass of 23 kDa (Shome and Parlow 1977; Kohmoto et al. 1984), but several 
structural variants exist, generated by alternative splicing, proteolytic cleavage and 
other posttranslational modifications (Freeman et al. 2000). 
I. General Introduction 
5 
 
Despite the major involvement of PRL in mammalian reproduction and lactation, the 
evolutionary origin of PRL precedes ostensibly the appearance of mammals (Fig I.1B). 
The PRL gene seems to have originated in teleost fish (Rand-Weaver et al. 1991; Breves 
et al. 2014) or even in chondrichthyans (Yamaguchi et al. 2015) by duplication of the 
ancestral GH gene (Kawauchi and Sower 2006). The primitive function of PRL, however, 
remains poorly understood. In chondrichthyan and teleost fish, PRL exerts 
osmorregulatory functions aimed at maintaining plasma homeostasis in response to 
environmental osmolarity variations (Breves et al. 2014). Alternatively, it is hypothesized 
that PRL originated to regulate different aspects of the post-mating phase of 
reproduction, several of them closely related to integumentary and osmolar regulation 
(Horseman and Gregerson 2013). Thus, somehow, in mammals PRL eventually assumed 
the role of regulating integumentary glandular development and secretion of milk 
(Horseman and Gregerson 2013). 
In mammals, the major site of PRL synthesis are the lactotrophs , a heterogeneous 
population of specialized secretory cells located in the ventrolateral portion of the 
adenohypophysis (Nakane 1970). In addition, PRL and other structural homologues with 
lactogenic properties are produced in a wide range of tissues and organs. These include 
the placenta, amnion and decidua (synthesizing the so-called placental lactogens, Soares 
2004), the non-pregnant uterus (Walters et al. 1983), male reproductive organs (Marano 
and Ben-Jonathan 2014), the mammary gland (where PRL is released into milk itself, 
Grosvenor et al. 1993), lymphocytes and other immuno-competent cells (Gala and 
Shevach 1994) and, importantly, the brain. In the brain, PRL-producing neuron 
populations have been localized to date within the hypothalamus of the rat, namely in 
the paraventricular and supraoptic nuclei (Mejía et al. 1997), whereas in situ 
hybridisation performed in sheep brain tissue identified PRL expression in the 
paraventricular and periventricular nuclei, medial preoptic area and bed nucleus of the 
stria terminalis (Roselli et al. 2008). Conversely, PRL-immunoreactive nerve fibers have 
been characterised in a variety of mammals within several hypothalamic and 
extrahypothalamic sites (including the cerebral cortex, hippocampus, amygdala, septum, 
caudate putamen, cerebellum, brainstem and circumventricular organs, Freeman et al. 
2000). Still, little is known so far about the signalling dynamics and functionality of 
centrally-produced PRL. 
Consistent with its functional complexity, PRL has a great number of target tissues. In 
addition to the mammary gland, PRL binding sites have been detected in the 
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reproductive system of male and female, hypophysis, heart, lungs, kidney, liver, 
pancreas, muscle or skin, among others (Freeman et al. 2000). Perhaps, the most 
important target for PRL action, and the one that will focus the present work, is the 
brain. In addition to locally-produced PRL, systemic PRL can also be granted access to 
the brain, bypassing the blood-brain barrier through an active transport mechanism 
mediated by the choroid plexus (Walsh et al. 1987; Mangurian et al. 1992). Furthermore, 
PRL might gain access to the SNC through circumventricular organs, specialized regions 
lacking conventional blood-brain barrier (Ganong 2000). 
 
Figure I.2 The prolactin receptor: structural variants and signalling pathways 
Prolactin binds to the PRL receptor (PRLR), a single membrane-bound protein of the class 1 
cytokine receptor superfamily. The structural variants of the PRLR are highly variable between 
species and are generally classified as short- or long isoforms, according to the length of their 
intracellular domain. Modified and adapted from Freeman et al. (2000). 
(A) The main signalling pathway associated to the activation of the long form of the PRLR 
(PRLRl) is the Jak/STAT pathway. After PRL binding and heterodimerization of the PRLRl, the 
Janus kinase (JaK) docks to the intracellular domain of the PRLRl heterodimer and initiates a 
chain of transphosphorylation of several STAT (Signal Transducer and Activator of 
Transcription) proteins. The final step of this pathway involves phosphorylation of STAT5 to 
pSTAT5 and translocation to the cell nucleus, where it binds to GAS motifs to mediate the 
biological effects of PRL signalling. The PRLRl is known to trigger alternative signalling 
pathways, too, such as the MAP kinase pathway. 
(B) The short form of the PRLR (PRLRs) is considered to be non-functional, unable to initiate 
the Jak/STAT and other pathways. 
(C) Signalling of the PRLR is subject to a negative feedback control mediated mainly by CIS and 
SOCS proteins. 
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 PROLACTIN RECEPTOR AND SIGNALLING 
Prolactin exerts its action through its binding to the PRL receptor (PRLR). The PRLR is a 
single membrane-bound protein belonging to the class 1 cytokine receptor superfamily 
(Bazan 1990), with a single extracellular domain plus a transmembrane and an 
intracellular domain (Freeman et al. 2000). Several PRLR isoforms have been identified 
to date, generated by different transcription initiation sites and by alternative splicing 
(Hu and Dufau 1991). Variants of the PRLR have identical extracellular and 
transmembrane domains, differing only in the composition and length of the 
intracellular domain (Bole-feysot et al. 1998). These isoforms also occur with high 
interspecies variability. Rats, for instance, have three total isoforms (with a short, 
intermediate and long intracellular domain, respectively), whereas mice express one 
long and three different short isoforms of the PRLR (Bole-feysot et al. 1998). The long 
forms are considered fully functional, able to initiate the conventional signalling 
pathways associated to the PRLR, whereas short isoforms of the PRLR are deemed non-
functional (Berlanga et al. 1997).  
Figure I.2 illustrates the structural variability of the PRLR, as well as the major signalling 
pathways associated to each PRLR variant. Successful initiation of PRLR signalling 
involves the binding of PRL to the PRLR and the subsequent dimerization of a second 
functional PRLR to the hormone-receptor complex (Goffin et al. 1996). Then, signal 
transduction is initiated by the phosphorylation of intracellular domain-associated Janus 
kinase 2 (Jak2, Lebrun et al. 1995), which in turn transphosphorylates several docking 
sites of the intracellular domain of the PRLR (Rui et al. 1992). Upon this event, several 
signalling cascades can be triggered. The main pathway associated to the PRLR involves 
the STAT protein family (Signal Transducers and Activators of Transcription) and is 
termed the Jak/STAT pathway (Ihle et al. 1994). In this pathway, several different 
members of the STAT family interact with the PRLR after Jak2 phosphorylation, leading 
ultimately to the phosphorylation of STAT5 (Bole-feysot et al. 1998). Then, pSTAT5 
dimerizes and translocates to the nucleus to bind to specific DNA domains, where it acts 
as a transcription factor, leading to genomic and biological responses of the cell (Bole-
feysot et al. 1998). Although Jak/STAT is the major pathway associated to the PRLR, 
especially in the brain and other sites (Freeman et al. 2000), evidence indicates that 
alternative signalling events might be triggered by PRLR activation, too. These include 
activation of the mitogen-activated protein (MAP) kinase pathway (Buckley et al. 1994) 
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or other kinases (Berlanga et al. 1995; al-Sakkaf et al. 1997) or changes in K+ 
(Prevarskaya et al. 1995) or Ca2+ (Ratovondrahona et al. 1998) concentrations. 
 
Figure I.3 Feedback regulation of hypophyseal prolactin secretion 
The main source of systemic PRL are the lactotrophs of the adenohypophysis. Lactotrophic 
synthesis and secretion of PRL is regulated by a short-loop negative feedback mechanism 
dependent on the tuberoinfundibular dopaminergic (TIDA) neurons. Systemically released PRL 
enters the CNS through the choroid plexi and circumventricular organs and activates the TIDA 
neurons in the Arcuate nucleus of the hypothalamus. Then, TIDA neurons, the axons of which 
run through the Median Eminence, release Dopamine into the hypophyseal portal blood system. 
Dopamine then inhibits PRL secretion of the hypophyseal lactotrophs acting through D2 
receptors. Modified and adapted from Grattan et al. (2002). 
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 REGULATION OF CENTRAL PROLACTIN SIGNALLING 
The multiple and pleiotropic roles of PRL on the central control of brain function, 
physiology and behaviour require a complex and fine-tuned regulation of PRL signalling 
within the brain. Mechanisms integrating this regulatory system can be roughly divided 
into five categories. The first milestone of central regulation of PRL signalling is the 
secretion of PRL itself. As stated above, major sources of PRL interacting with brain 
tissue in normal conditions are systemic PRL (Freeman et al. 2000) and brain PRL. 
Although there is growing evidence of PRL being produced within the boundaries of the 
brain (DeVito et al. 1987; Paut-Pagano et al. 1993; Marano and Ben-Jonathan 2014), 
knowledge on the actual dynamics and functional role of this lactogenic element is still 
scarce. Conversely, the mechanisms underlying feedback regulation of hypophyseal 
lactotroph cells have been thoroughly characterized. Lactotroph cells have a high degree 
of spontaneous secretory activity, and are mainly under a tonic inhibitory control 
mediated by a short-loop negative feedback mechanism carried out by the 
hypothalamus (Freeman et al. 2000). The main inhibitor of lactotroph function is 
dopamine (Ben-Jonathan and Hnasko 2001a), which is released to the hypothalamo-
hypohyseal portal vascular system by tuberoinfundibular dopaminergic (TIDA) and 
periventricular-hypophyseal dopaminergic (PHDA) neurons (Goudreau et al. 1992). 
Dopamine then inhibits secretory function of hypohyseal lactotroph cells acting through 
D2 receptors (Caron et al. 1978). The short-loop negative feedback regulation 
mentioned above is established by the reciprocal activation of TIDA and PHDA neuron 
activity by PRL (DeMaria et al. 1999; Lyons et al. 2012), mediating PRL inhibition of its 
own secretion. Figure I.3 illustrates the main features of this regulatory mechanism, 
focusing on TIDA neurons. Activation of PRL secretion is achieved, in turn, by 
disinhibition, i.e., inhibition of this negative feedback mechanism. The disinhibition of 
PRL secretion might occur under special physiological situations, for instance during the 
period of lactation (Andrews et al. 2001b; Anderson et al. 2006). 
The second level of central PRL signalling regulation is the access of systemic PRL into 
the brain. Although PRL is apparently unfit to diffuse through the blood-brain barrier, an 
active mechanism in the choroid plexus transports it into the brain (Walsh et al. 1987; 
Mangurian et al. 1992). This active transport was proposed to depend on PRLR, but 
recent evidence suggests additional mechanisms independent of PRLR (Brown et al. 
2015). Assuming the existence of a PRLR-mediated import of PRL into the brain, the 
regulation of PRLR expression (Mangurian et al. 1992) or of its affinity to PRL (Tabata et 
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al. 2012) represents additional mechanisms to regulate PRL access to the brain and thus 
central PRL signalling. 
The third level of regulation of PRL signalling pertains to the expression of its receptors 
in the brain. A comprehensive mapping of the sites of expression of the PRLR is currently 
available for the female rat brain (Bakowska and Morrell 1997; Bakowska and Morrell 
2003). However, there is extensive evidence in the literature indicating a local or global 
regulation of the expression of PRLR under certain physiological conditions or stimuli, 
namely the period of lactation (Pi and Grattan 1999), suckling somatosensory 
stimulation (Pi and Voogt 2001), parturition or even just the presence of pups (Ma et al. 
2005a), chronic stress (Faron-Górecka et al. 2014) or the circulating levels of PRL 
(Muccioli and Di Carlo 1994).  
In this context, special attention should be paid to gonadal steroids, which stand among 
the best-documented modulators of PRLR expression and PRL signalling (Furigo et al. 
2014b) in the brain. Thus, for example, in the rat estradiol (and to a lesser extent 
progesterone) are responsible for the upregulation of PRLR expression (long form) in the 
female rat during the proestrous and estrous phases of the estrous cycle, late pregnancy 
and lactation (Sugiyama et al. 1994). This upregulation is also extensive to the choroid 
plexus, so that access of PRL to the brain might also be enhanced during these periods.  
Conversely, ovariectomy leads to a dramatic downregulation of PRLR expression that 
can be partially restored by estradiol administration (Sugiyama et al. 1994; Shamgochian 
et al. 1995). On the other hand, evidence in the mouse indicates that androgens exert an 
inhibitory role on hypophyseal PRL secretion (O’Hara et al. 2015). Regarding the close 
regulatory relationship of gonadal steroids and PRL, one of the main purpose of this 
work is to further characterise the effect of gonadal steroid regulation on central PRL 
signalling. 
The fourth category of PRL regulation comprises different events associated to 
posttranslational modifications of the PRLR that provide a means to limit or enhance 
PRLR-associated signal transduction. Thus, for instance, short isoforms (thought to be 
non-functional, see section 1.2), are hypothesized to work as dominant negative forms 
of the receptor, sequestering functional forms by heterodimerization (Lesueur et al. 
1991; Berlanga et al. 1997). 
Finally, differential regulation downstream the PRLR might also take place to modulate 
PRL signalling in the brain. In this context, a number of molecular species have been 
I. General Introduction 
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identified to date that exert an inhibitory action on the Jak/STAT pathway of the PRLR. 
These are SOCS (suppressors of cytokine signalling), which inhibit Jak kinases (Pezet et 
al. 1999) and CIS (cytokine-inducible SH2-containing proteins), which compete with STAT 
proteins for the docking sites of the intracellular domain of the PRLR (Masuhara et al. 
1997).  SOCS are responsible, for example, for the disinhibition of hypophyseal PRL 
secretion during lactation (Anderson et al. 2006). 
Although there is evidence discretely supporting each of these levels of regulation, we 
intend to provide a global, integrated view of the changes in PRL signalling taking place 
in the brain of males and females under certain physiological conditions. To do so, we 
will focus on analysing the lasts steps downstream the cascade of PRL signalling, by 
employing the immunohistochemmical detection of phosphorylated STAT5 as a 
functional marker of PRL-derived signalling (see Section B). This methodology provides 
an integrated view of all the aforementioned mechanisms. The first goal of the present 
work is to explore whether basal PRL signalling shows a sexually dimorphic pattern in 
the brain of the mouse. In addition, we aim at analysing the effects of sexual steroids on 
the pattern of PRL signalling in the brain of females (oestrogens, progesterone) and 
males (testosterone). Finally, we focus on the well-known role of PRL in the regulation of 
the maternal condition.  
 CENTRAL ACTIONS OF PROLACTIN AND THE SHAPING OF 
THE MATERNAL BRAIN 
Prolactin was originally identified for its lactogenic function (Riddle et al. 1933a). Today 
we know that the functional complexity of this hormone lies far beyond the promotion 
of mammary gland development and milk production: PRL is synthesized in multiple 
sites and targets a wide array of tissues, subserving more than 300 different biological 
functions (Bennett and Morris 1989). Central functions of PRL in non-maternal 
individuals include, among others, the regulation of different neuropeptidergic systems 
such as corticotropin-releasing factor (CRF), oxytocin or vasopressin (Aguilera et al. 
2008; Donner and Neumann 2009; Blume et al. 2009; Vega et al. 2010; Sirzen-
Zelenskaya et al. 2011), of the hypothalamus-pituitary-adrenal (HPA) axis (Fujikawa et al. 
1995; Fujikawa et al. 2004), pain sensitivity (Nicoletti et al. 1983), sleep and wakefulness 
(Roky et al. 1995; Machado et al. 2017), or grooming behaviour (Drago et al. 1983; 
Drago and Lissandrello 2000). One of the most studied actions of PRL in the central 
nervous system involves the control of sexual behaviour in females and males (Krüger et 
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al. 2002; Egli et al. 2010). This control appears to be sexually dimorphic, a matter that 
will be explored in depth in the first chapter of this work (Study 1). 
In mammals and other vertebrates, successful reproduction requires a broad range of 
adaptations to occur in the mother. In order to meet the demands of motherhood, 
central homeostatic regulation must be readjusted, lactation must be established 
correctly and new behaviours (maternal behaviours) must emerge. Most of these 
physiological and behavioural adaptations originate in changes of the brain during 
pregnancy, favoured by the endocrine signals of this period. These changes must be 
initiated before parturition and persist during postpartum periods, thus requiring 
endocrine agents acting through late pregnancy and lactation.  Lactogenic hormones 
(including PRL) fulfil the former criteria and are good candidates to assume this role. 
During lactation, females display a sustained state of hyperprolactinaemia, granted by 
disinhibition of hypophyseal PRL release (Andrews et al. 2001a) in response to suckling 
stimulation by the pups (Freeman et al. 2000; Cservenák et al. 2010). Consistent with 
the aforementioned criteria, chronic hyperprolactinaemia during the postpartum period 
grants the maintenance of lactation (lactogenesis and galactopoiesis, Freeman et al. 
2000) and other maternal adaptations (see below). During pregnancy, however, 
circulating PRL levels are high during early stages but drop during the second half of 
pregnancy (approximately from day 8-9 in mice and 10 in rats, Soares et al. 2004) until 
the moment of delivery (Fig I.4). Nevertheless, this suppression of hypophyseal PRL 
release is compensated by an alternative source of lactogenic signals: coinciding with 
the drop in hypophyseal PRL, the trophoblast giant cells of the placenta produce the so-
called placental lactogens (PLs) (Yamaguchi et al. 1992). These are proteins closely 
related in sequence to hypophyseal PRL that also bind the PRLR with high affinity (Kelly 
et al. 1976) and initiate the same signalling pathways (Soares et al. 1998a), thus 
mimicking several actions of hypophyseal PRL (Bridges and Freemark 1995; Linzer and 
Fisher 1999). Hence, they are considered functional substitutes of hypophyseal PRL 
during mid- and late pregnancy. One of the main goals of this work is to characterise the 
patterns of lactogenic signalling occurring in the brain during the second half of 
pregnancy in the mouse, as well as to explore the hypophyseal or extrahypophyseal 
source of this signalling. 
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Figure I.4 Profiles of gonadal steroids and lactogenic hormones during pregnancy 
The most relevant endocrine signals of pregnancy are gonadal steroids estradiol (orange) and 
progesterone (green) and PRL (pink). This graph depicts the systemic levels of these hormones 
during pregnancy in the rat and other rodents. After impregnation, PRL secretion adopts a twice-
daily surge profile. Close before mid-gestation, coinciding with the rise in gonadal steroids, the 
placenta begins to produce placental lactogen I (PL-I, blue), which in turn stimulates the 
synthesis of placental lactogen II (PL-II, black). Both PRL structural homologues inhibit the 
production of hypophyseal PRL, which during the second half of pregnancy shows very low 
circulating levels. During the last day(s) pre-term, as a result of a sudden drop in progesterone 
and the consequent elevation of the estradiol/progesterone ratio, there is a pre-term surge of 
hypophyseal PRL. Adapted from Soares et al. (2004). 
 
Consequently, lactogenic hormones (PRL and PL) are considered to initiate and 
subsequently maintain the neural, physiological and behavioural changes directed to 
meet the requirements of motherhood, thus deserving the appellative of “the maternal 
hormones”. Regarding maternal physiology, pre- and postnatal development of the 
offspring is a demanding task requiring a huge energetic investment. In this context, 
lactogenic input is responsible for the regulation of energy metabolism and increase 
food intake in order to assure sufficient resources for this task (Augustine et al. 2008). 
Maternal commitment also requires the proper recognition and identification of the 
offspring (e.g. distinguishing infants from other conspecifics), which in rodents 
(macrosmatic animals) is driven by chemosensory signals. To assist this particular 
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requirement, it is known that lactogenic signals in mice induce neurogenesis in certain 
brain regions related to the processing of pup-derived chemosignals and the formation 
of related memories (Shingo et al. 2003; Larsen and Grattan 2010a). During lactation, 
dams overcome a transient state of anoestrus and become infertile. This process 
appears to be dependent on suckling-induced stimulation of the pups, which leads to a 
PRL-mediated inhibition of luteinizing hormone (LH) pulsatile secretion (Araujo-Lopes et 
al. 2014). Prolactin is also known to modulate oxytocinergic and vasopressinergic circuits 
during pregnancy and lactation, leading to increased oxytocin release in lactating rats 
(Parker et al. 1991) and to the upregulation of hypothalamic oxytocin and vasopressin 
mRNA (Van Tol et al. 1988; Ghosh and Sladek 1995). Furthermore, in order to prepare 
the dam for a better protection of the offspring, lactogenic hormones are involved in the 
modulation of the HPA axis and other limbic regions, directed to the attenuation of the 
stress response and the increase of resilience to stress and anxiety (Torner et al. 2001). 
A remarkable action of PRL in the brain is the stimulation of maternal behaviour, which 
indeed constitutes the focus of the last chapter of this thesis. The following section will 
review in depth the features of this behavioural phenomenon, as well as the available 
evidence on the involvement of PRL on its regulation. 
 PROLACTIN AND MATERNAL BEHAVIOUR 
E.1. INTRODUCTION TO MATERNAL BEHAVIOUR 
Parental behaviour is a variety of species-specific social interactions aimed at increasing 
offspring survival until its reproductive maturity (Numan and Insel 2003). Parental 
behaviour originated in species where reproduction represents a high energetic 
investment (homeothermal species) as an evolutionary strategy to ensure this 
investment and thus increase parental inclusive fitness. The two vertebrate groups that 
best represent these requirements and, consequently, where parental behaviour has 
evolved further are mammals and birds. Even though under certain circumstances males 
may develop parental behaviours (as will be discussed further on this work), in the 
majority of mammalian species (including the rat and the mouse among other research 
models), parental behaviour is carried out by the mother. In mammals this is mostly  due 
to the mother being the ultimate responsible for lactation (Kleiman and Malcolm 1981). 
For the aforementioned reasons, these behaviours are commonly referred to as 
maternal behaviours. Interestingly, in some species, the dam might share maternal care 
with external individuals not directly related to the offspring (Solomon and French 
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1997). This is the case, for instance, of laboratory strains of mice, where non-maternal 
females reared in the same cage as the mother participate in a communal breeding of 
the pups. This phenomenon is termed allomaternal behaviour. 
 
Figure I.5 Components of maternal behaviour in rodents 
Maternal behaviours constitute a heterogenous array of behavioural outputs. In rodents, these are 
classified as pup-directed (upper row) or non-pup-directed (lower row). Pup-directed behaviours 
include seeking the pups and retrieving them into the nest area (pup retrieval, A), nursing of the 
pups in different postures (B) and licking/grooming them (C). Maternal behaviours not directed 
to pups include the territorial defence of the nest site with fierce aggressive outcomes (maternal 
aggression, D), and the building of a nest site close before term (E). 
The expression of maternal behaviours is highly influenced by the degree of 
development of pups at the moment of birth (Rheingold 1963). In this context, a basic 
distinction can be set between precocious species (such as sheep and other ungulates), 
where infants are mobile virtually from the moment of birth, and species that give birth 
to altricial pups, which are unable to move out of the nest for several days or weeks. In 
the latter group, which includes mice and rats (research models of interest in this work), 
but also humans, basic patterns of maternal behaviour can be roughly divided into pup 
directed and non-pup directed behaviours (Gammie 2005) (Fig I.5). The former include 
nursing of the pups, crouching over them to provide warmth, retrieving and grouping 
them into a nest and grooming and licking them, especially their anogenital region to 
facilitate micturition and defecation reflexes. A recent characterization of pup-directed 
behaviours has provided a more restrictive classification of maternal responses. Numan 
and Stolzenberg (2008) differentiated, on the one hand, proactive maternal responses, 
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including pup-seeking and retrieval behaviour and, on the other hand, as reflexive 
maternal responses tied to proximal pup stimulation, such as nursing/crouching. On the 
other hand, non-pup directed maternal behaviours include the building of a nest, 
placentophagia after parturition and the defence of the nest site. The latter is termed 
maternal aggression when it is displayed against conspecifics, which commonly 
represent a threat for pups (engaging, for instance, in infanticidal behaviours) (Lonstein 
and Gammie 2002).  
In addition to ensure immediate survival of the offspring, maternal behaviour has a 
profound impact on the infants´ long-term physical and psychological development. 
Thus, the quality and quantity of received maternal care influences some important 
future phenotypes of the pups , such as cognitive and motor fitness (Rutter et al. 2012), 
HPA axis reactivity (Meaney 2001; Vaiserman 2015), emotionality (Mehta et al. 2009), 
the vulnerability to certain affective disorders (Canetti et al. 1997; Repetti et al. 2002; 
Andersen et al. 2008; Zhang et al. 2013) and even the quality of the future parenting 
style (Francis et al. 1999; Fleming et al. 2002). The impact on these developmental traits 
of the received maternal care is commonly inherited through epigenetic mechanisms 
(Zhang et al. 2013).   
E.2. NEURAL SUBSTRATE OF MATERNAL BEHAVIOUR 
Adult individuals are engaged in different kind of interactions with conspecifics that 
collectively constitute their social behaviours. These include sexual, agonistic (territorial 
aggressions) and affiliative interactions. Social behaviours are under control of the so-
called socio-sexual brain network (SBN; Newman, 1999). The SBN is a phylogenetically 
old and highly conserved neural network (schematically illustrated in Fig I.6 A) 
composed of several nodes fulfil three main features: 1) they are known to be 
implicated in the regulation of various forms of social behaviour; 2) they are reciprocally 
interconnected (to allow for a network-type of activity); and 3) they show abundant 
neurons expressing gonadal steroid receptors (which allows for a dimorphic expression 
of social behaviours). Currently, the SBN includes six major nodes: the medial extended 
amygdala (including the medial amygdala and medial posterior bed nucleus of the stria 
terminalis), the lateral septum (LS), the medial preoptic area of the hypothalamus 
(MPA), the anterior (AH) and paraventricular (Pa) nuclei of the hypothalamus, the 
ventromedial hypothalamic nucleus (VMH) and the midbrain periaqueductal grey (PAG), 
together with other tegmental motor areas.  
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Figure I.6 The Sociosexual Brain Network 
As proposed by Newman (1999, figure modified from original paper) and others (Goodson 
2005), the Sociosexual Brain Network (SBN) is a functional brain network responsible for the 
expression of every social and reproductive behaviour (including maternal behaviour).  
(A) The SBN is composed of six highly interconnected nodes: the medial extended amygdala, 
lateral septum, medial preoptic area, paraventricular and anterior hypothalamus, ventromedial 
hypothalamus and specific midbrain areas (including the periaqueductal grey).  
(B) Early gene expression data and other evidences show distinctive activation patterns across the 
SBN which are specific for each behavioural output (e.g. maternal vs sexual behaviour). 
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Whereas several other brain nuclei might also participate discretely in the control of 
specific social behaviours, the SBN is viewed as the core neural circuitry of the social 
brain, participating in the integration of all social behaviours. Consistent with this idea, 
the expression of each specific social or reproductive behaviour (including the different 
subcomponents of maternal behaviour) would be correlated not to the discrete 
activation of a specific nucleus or a linear circuit, but to distinct relative activation 
patterns of the whole SBN (Fig I.6 B).  
A recurring idea throughout this work is that motherhood requires adaptive changes in 
the brain of dams, leading to the development of successful maternal behaviours. This 
changes target the different nuclei of the SBN driving it into a “maternal state”, in which 
the social behaviour repertoire is biased towards maternal behaviours. In other words, 
under the influence of the endocrine agents discussed above, the socio-sexual brain 
network turns into the maternal brain.  
Neural substrate of proactive maternal responses: importance of motivation 
As introduced earlier, pup-directed maternal care include passive (or reflexive) and 
proactive behaviours (Numan and Stolzenberg, 2008). Proactive maternal behaviours 
are those in which motivation drives the dam towards the pups, and consist of 
appetitive and consummatory components (Hansen et al. 1991). Thus, proactive 
maternal responses are initiated by the mother actively seeking the pups (appetitive) 
and retrieving them to the nest where dams engage in pup licking-grooming 
(consummatory). Conversely, passive-reflexive responses would be elicited by proximal 
pup stimuli (e.g. nursing behaviour). The phenomenon of motivation was defined by 
Pfaff (1982) as an internal process that modifies the way an organism responds to a 
certain class of external stimulus. Hence, motivation would make the individual become 
aroused and direct its attention and behaviour towards a specific incentive stimulus. 
This view of motivated pup-directed maternal responses implies that pups and their 
stimuli have to possess incentive properties. Indeed, Pereira and Morrell (2011) showed 
that early postpartum rats significantly prefer pup-associated versus cocaine-associated 
environments in a conditioned place-preference task. In the same vein, rat dams press a 
bar at a significantly higher rate than virgin females if rewarded with a pup (Lee et al. 
2000), provided they are able to interact with the pup. Altogether, this view requires the 
neural pathways managing reward and motivation to be incorporated to the functional 
system controlling maternal behaviour expression. 
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Interestingly, pup stimuli only acquire incentive properties with pregnancy (or 
alternatively with a hormonal sensitisation mimicking the hormonal milieu of pregnancy, 
see below). Whereas primiparous rat dams exhibit full maternal motivation and the full 
repertoire of maternal behaviours on their first exposure to pups, naïve virgin females 
(which have not undergone pregnancy) display aversive reactions (neophobia) towards 
pups (Numan and Insel 2003). Only after repeated exposure of a virgin female rat to 
pups (for 5-8 days), they become habituated to their presence, approach the pups and, 
when in contact with them, eventually start expressing maternal care. This so-called 
maternal sensitisation, however, renders suboptimal maternal behaviour in which, as 
detailed below, motivation for the pups is relatively low.  
 
Figure I.7 Neural model for approach-avoidance responses to pups in the rat 
Schematic representation of the main neural pathways regulating the response to pups in the 
female rat. This model features two distinctive neural pathways that integrate aversive and 
(proactive) maternal responses, respectively. The master control in this model is the medial 
preoptic area (MPA) of the hypothalamus, which favours either of the two pathways depending 
on the situation.  
Virgin naïve female rats show aversive responses to pups. Pup stimuli reach the MPA, which 
activates the aversion pathway, composed of the anterior and ventromedial hypothalamic nuclei 
(AH/VMH) and the midbrain periaqueductal grey (PAG), with the additional input of the medial 
amygdala (Me).  
During pregnancy, however, the MPA activity is modulated by oxytocin (OXT, red), PRL (green) 
and gonadal steroids (yellow). This leads to the inhibition of the aversive pathway and the 
activation of the maternal pathway, integrated by the ventral tegmental area (VTA) and its 
dopaminergic (DA) projection to the nucleus accumbens/ventral pallidum (Acb/VP). Gonadal 
steroids (Mitra et al. 2003), PRL (Bakowska and Morrell 1997, our results) and OXT (Gimpl and 
Fahrenholz 2001) exert regulatory actions over all the nodes of these pathways. Modified and 
adapted from Numan and Woodside (2010). 
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Numan and Woodside (2010) developed a functional model, based on evidence in rats, 
that integrates the interaction of brain motivation systems and major SBN nodes to 
explain the onset of maternal behaviour and the subsequent shift of aversive into 
proactive (motivated) maternal responses to pups. According to this model (Fig I.7), two 
mutually exclusive pathways control the final response of the individual towards pups. 
The avoidance pathway is integrated by the anterior (AH) and ventromedial (VMH) 
hypothalamic nuclei and those subregions in the periaqueductal grey (PAG) that have 
been shown to mediate defensive responses (Bandler and Shipley 1994; Risold et al. 
1994). Pup-derived chemosensory stimuli would activate the medial amygdala (MeA), 
which in turn, through its projections to the AH/VMH-PAG circuit, would trigger 
avoidance and defensive behaviours. Conversely, the pathway for proactive maternal 
responses is represented by the mesolimbic dopaminergic system connecting the 
ventral tegmental area (VTA) to the nucleus accumbens (Acc) and the ventral pallidum 
(VP). This pathway is mainly responsible for assigning incentive properties to pup stimuli 
(as reviewed above). Numan and Woodside (2010) postulate that DA release in the Acc 
makes ventral pallidum easily excited by pup stimuli.   
In virgin female rats, pup stimuli trigger the activation of the avoidance pathway, 
whereas the maternal pathway is inhibited. Maternal sensitisation of virgin females, in 
turn, represents a progressive inhibition of the avoidance pathway, which is eventually 
out-weighed by attractive tendencies towards pups. However, full activation of the 
maternal pathway is only reached in rats through the endocrine events of pregnancy 
(see section I.5.3). The master-control element in this model, responsible for the 
activation or inhibition of either pathways, is the medial preoptic area (MPA), an 
integrant of the SBN (see above) classically regarded as the key region for the expression 
of maternal responsiveness (Numan 1996). In lactating dams exposed to pups, 
GABAergic (inhibitory) neurons in the MPA express Fos protein, a reliable marker of 
neuronal activity (Lonstein and De Vries 2000). Thus, these inhibitory neural population 
would contribute to suppress the avoidance circuitry in primiparous female rats, 
whereas proactive maternal responses would be activated through direct MPA 
projections to the mesolimbic dopaminergic system (Numan et al. 2005; Numan and 
Stolzenberg 2009). Finally, pup-derived chemo- and somatosensory inputs would reach 
the MPA, Acc and VP from the basolateral (BLA) and basomedial (BMA) nuclei of the 
amygdala, which in turn receive convergent olfactory and vomeronasal inputs from the 
MeA and piriform cortex (Pir) (Martinez-Garcia et al. 2012; Cádiz-Moretti et al. 2016). 
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The whole collection of neural centres and connections involved in the expression of 
proactive maternal responses is depicted on Figure I.8. 
 
Figure I.8 Brain regions and connections involved in maternal behaviour 
Schematic representations of the major brain regions and connections involved in the integration 
of motivated (proactive) maternal responses (A) and maternal aggression (B). Based on available 
evidence from lesion, activation and early gene expression studies. Modified and adapted from 
Gammie (2005). 
 
Neural substrate of maternal aggression 
In contrast to maternal care, maternal aggression is not directed to pups. Substantial 
evidence arising from lesion, genetic and pharmacological manipulation approaches 
(reviewed in Lonstein and Gammie 2002; Numan and Insel 2003; Gammie 2005) support 
the view that maternal aggression and pup-care are coordinated by distinct (but 
overlapping) pathways. Figure I.8 provides an integrated view of the neural centres and 
pathways that have been implicated in the control of maternal aggression, as compared 
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to maternal care. Noteworthy centres in this functional system include, for instance, the 
MeA. The MeA is an integrative centre that presumably conveys chemosensory and non-
chemosensory inputs to effector centres for affiliative, defensive or agonistic behaviours 
(Baum and Bakker 2013; Bergan et al. 2014), including maternal aggression (Unger et al. 
2015). Thus, the MeA also represents one of the main regions engaged in the control of 
both maternal aggression and maternal care. Further nuclei involved in the control of 
both kinds of maternal behaviour include the LS (Flannelly et al. 1986; Gammie 2005), 
the Pa (Consiglio and Lucion; Insel and Harbaugh 1989), the VMH (Hansen and Ferreira 
1986; Hansen 1989; Lin et al. 2011) and, importantly, the MPA and its continuum with 
the BST (Numan 1996). It is noteworthy that all these nuclei represent the key nodes of 
the SBN. 
Maternal aggression is partially facilitated by the decrease in anxiety and fearfulness 
concurrent with the maternal state (Bosch et al. 2005; Bosch and Neumann 2010). Thus, 
bolder dams are fitter to defend their pups from dangerous threats. It is worth noting 
that this decrease in anxiety and fearfulness is achieved by the modulation of some of 
the aforementioned sites, for instance the Pa (as head of the HPA axis, Douglas et al. 
2005) or the BST, as well as other non-convergent sites such as the central amygdala 
(Ce) (Davis and Shi 1999) (which, with the BST, conforms the central extended 
amygdala).  
Nonapeptidergic systems in the regulation of maternal behaviour 
Neuropeptides are well-documented modulators of social and reproductive behaviours 
across vertebrate evolution (Insel and Young 2000). In mammals and other vertebrate 
taxa, research on this matter has focused primarily on nonapeptides (neuropeptides 
composed of nine amino acids), which include two members within mammals: arginine-
vasopressin (AVP) and oxytocin (OXT). Both OXT and AVP share some common features, 
including a high structural similarity (differing only in the third and eighth positions of 
their amino acid sequence) and both are involved in several functions, especially 
regarding central homeostatic and behavioural regulation (Stoop 2012). From this point, 
however, this section will focus specifically on OXT, since part of this work has devoted 
to study specifically the central OXTergic systems.  
Even though our primary interest on OXT relates to its central actions, it is worth 
mentioning that this nonapeptide subserves also important functions as a systemic 
neurohormone. In this regard, OXT is synthesized by magno- and parvocellular 
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neurosecretory hypothalamic neurons populations (mainly located in the 
paraventricular and supraoptic nuclei) and released directly into circulation at the neural 
lobe of the hypophysis (Ross et al. 2009). Systemically released OXT is involved, among 
others, in the stimulation of uterine contractions during labour (Blanks and Thornton 
2003) or of milk ejection during lactation (Nishimori et al. 1996).  In addition to its 
peripheral roles, OXT is also produced and released in different circuits within the brain, 
where it behaves rather as a neurotransmitter or neuromodulator (Otero-García et al. 
2015). There are five major oxytocinergic populations in the brain, located in: 1) the 
ventral aspect of the medial posterior BST; 2) adjacent to the former, the area 
comprising the anterior commissural and anterodorsal nuclei of the preoptic 
hypothalamus (AC/ADP); 3) the Pa and 4) the SO, intermingled in both cases with 
neurosecretory neurons; and 5) the medial amygdala (Otero-García et al. 2015). In 
addition, some scattered OXTergic cells can be also found within circumventricular 
positions in the preoptic and anterior hypothalamus (Otero-García et al. 2015). 
Evidence in the literature firmly supports the idea that brain OXTergic circuits are 
involved in the regulation of the SBN and thus contribute to the control of different 
social behaviours, including for instance social recognition (Gur et al. 2014), pair bonding 
and mother-infant attachment (Numan and Young 2016), agonistic responses 
(Calcagnoli et al. 2014) and, importantly, maternal behaviour (Bosch and Neumann 
2012). First evidence of the involvement of OXT in the control of maternal behaviour 
was reported by Pedersen and collaborators, who stimulated the expression of 
spontaneous maternal care in virgin female mice through the intracerebroventricular 
(ICV) infusion of OXT (Pedersen and Prange 1979; Pedersen et al. 1982). In the same 
vein, ICV infusions of OXT antiserum or OXT antagonists blocked the onset of maternal 
care in steroid-primed virgin (Pedersen et al. 1985; Fahrbach et al. 1985, respectively) 
and postpartum (van Leengoed et al. 1987) female rats. Considering maternal 
aggression, OXT appears to exert regime- and region-dependent effects on the 
expression of this trait by rat dams. For example, acute ICV infusion of OXT had no effect 
on maternal aggression of Wistar rat dams (Neumann et al. 2001), whereas chronic 
infusion did increase indicators of maternal aggression (Bosch and Neumann 2012). In 
addition, heightened aggression in high anxiety-bred (HAB) Wistar rats was found to be 
directly related to increased OXT release in the Pa and Ce (Bosch et al. 2004; Bosch et al. 
2005). Altogether, the brain OXTergic system becomes enhanced during pregnancy and 
postpartum leading to local release of OXT in several brain regions, which contributes to 
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a fine-tuned control of both maternal care and maternal aggression (Bosch and 
Neumann 2012). 
Consistent with the former, it is important to highlight the actions of OXT in the medial 
preoptic area (MPA) as the master control of maternal responsiveness (Numan and 
Numan 1996; Numan and Insel 2003). According to Numan and Woodside’s model 
(2010) for voluntary proactive maternal responses (but see also Fig I.7), OXT plays an 
instrumental role in the priming of the MPA that leads to the inhibition of pup-aversion 
pathways and the activation of the maternal pathways. Supporting this hypothesis, OXT 
receptor expression is induced in this area during pregnancy (Champagne et al. 2001), 
and OXT action on the MPA or on the mesolimbic dopaminergic pathway also increases 
the expression of maternal care in rat dams (Pedersen et al. 1994). However, the exact 
origin of this particular OXTergic input to the MPA and maternal pathway is only 
partially known. There is evidence of OXTergic innervation of the accumbens nucleus 
(Acb) arising from the Pa (Knobloch et al. 2012), but the contribution of other OXT 
population has not yet been examined.  One possibility could be that these projections 
stemmed partially from the AC/ADP region, too. Interestingly, the AC/ADP OXTergic 
population is located exactly between the ventral BST and the MPA, the key region for 
maternal responsiveness in the rat (Numan and Numan 1996) and mouse (Tsuneoka et 
al. 2013). In addition, several lesion studies affecting this area (Numan et al. 2005) or 
fibres of passage between the ventral BST and MPA including the AC/ADP (Numan et al. 
1990) effectively disrupted maternal care. Hence, the AC/ADP OXTergic cell population 
becomes an interesting target in the study of the central control of maternal behaviours, 
a target that we intend to cover in the present work. 
E.3. ROLE OF PROLACTIN IN MATERNAL BEHAVIOUR REGULATION: A 
COMPARATIVE VIEW 
Earlier on this introduction, we proposed that the neural substrate underlying maternal 
behaviour integration is the sociosexual brain network (SBN). In order to acquire a 
maternal profile and allow for the expression of maternal behaviours, the SBN had to 
undergo a process of maternal priming. The ultimate purpose of this is to ensure the 
transient expression of maternal behaviours specifically during the postpartum period 
(or alternatively under the constant interaction with pups). Hence, the critical factors 
mediating this priming correspond to specific signals of this scenario, mainly: pup-
derived cues (sensory factors) and hormonal signals of pregnancy and lactation 
(endocrine factors) (Fig I.9). Importantly, we will see how PRL, our hormone of interest, 
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plays an instrumental role among the latter. Additionally, the experience of previous 
maternal events (experiential factors) might play an additional role, facilitating role, too.  
 
Figure I.9 Main factors influencing the onset of maternal behaviour 
Conceptual model representing the possible factors influencing the onset of maternal behaviours. 
Duing the maternal period, a common, phylogenetically conserved core neural system (the 
Sociosexual Brain Network, SBN) is influenced by different types of factors to enable the 
expression of maternal behaviours. These factors include: endocrine signals of pregnancy and 
lactation (e.g. PRL or gonadal steroids), pup stimulation, previous epigenetic changes or previous 
maternal experiences (both considered experiential factors). These lead to the development of the 
maternal brain from the SBN and to the onset of maternal behaviours. Modified and adapted 
from Numan and Insel (2003). 
 
In Numan and Insel’s (2003) view, inasmuch as the SBN represented the phylogenetically 
conserved core that provides the common features of maternal behaviour expression 
across mammalian evolution, the aforementioned factors driving the process of 
maternal priming  convey a framework for the emergence of interspecies differences 
with adaptive significance in the onset of maternal responsiveness. In other words, how 
and when maternal behaviours are expressed in distinct mammalian species is largely 
dependent on the differential action of critical regulatory factors operating on a 
common neural system, rather than on the divergence of this neural system. Whereas 
the former section analysed the available knowledge on the neural substrate for 
maternal behaviours, this section will focus on how the above mentioned factors, with a 
particular focus on PRL, interact in different species to regulate maternal behaviour 
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expression. This variable action of PRL and other factors is well exemplified by the cases 
of the rat and the mouse.  
As we advanced in the previous section, in the rat, pup-avoiding virgin females become 
spontaneously maternal when undergoing pregnancy. This behavioural conversion is 
mediated by the priming of the MPA, which in consequence favours the activation of the 
maternal pathways over aversion pathways in response to pup-derived sensory input 
(see Fig I.7). Consistent experimental evidence indicates that the major element driving 
this maternal priming in the MPA is the hormonal milieu of pregnancy (Fig I.4), 
specifically PRL and/or placental lactogens acting on top of the proper background of 
gonadal steroid (estradiol and progesterone) levels. Hence, gonadectomised virgin 
female rats treated with estradiol and progesterone in a specific profile mimicking levels 
of late pregnancy showed significantly shortened latencies (1-2 days) to show maternal 
care towards foster pups (Bridges et al. 1985). In turn, these latencies were brought 
back to high levels (6-7 days) when experimental females were hypophysectomised 
(Bridges et al. 1985) or underwent a pharmacological disruption of hypophyseal PRL 
release with the dopaminergic D2 receptor agonist bromocriptine (Bridges and 
Ronsheim 1990). Then, short latencies where restored again in PRL-disrupted animals by 
the grafting of PRL-secreting hypophyseal implants (Bridges et al. 1985) or by systemic 
treatment with exogenous PRL (Bridges and Ronsheim 1990). On a follow-up study,  
Bridges and collaborators obtained the same facilitating effect on the onset of 
allomaternal behaviour by directly infusing PRL (Bridges et al. 1990a) or placental 
lactogen (Bridges and Freemark 1995; Bridges et al. 1996) into the MPA of 
gonadectomised, estrogen-primed, bromocriptine-treated female rats. Altogether, this 
evidence strongly supports the hypothesis that in the rat, the onset of maternal 
behaviour is driven primarily by PRL and/or placental lactogens, acting in a synergistic 
fashion with gonadal steroids in the MPA and possibly other nuclei, too (Bridges et al. 
1999). The sensory stimulation derived from the pups, by contrast, plays a role in the rat 
in the maintenance (rather than the onset) of maternal behaviours during lactation, 
especially the somatosensory stimulation of the nipples and ventral trunk region 
(Numan and Insel 2003). 
In contrast to the rat, virgin female laboratory mice seem not neophobic towards pups, 
but instead show short latencies to express maternal care (Stolzenberg and Rissman 
2011; Martín-Sánchez et al. 2015b). Since these animals have not been subject to 
endocrine signals of pregnancy, one would think that in the mouse, hormones play an 
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accessory (at most) role in the onset of maternal behaviour, whereas other factors such 
as pup-derived sensory stimulation might be more important (Svare et al. 1982). 
However, additional evidence suggests a more critical role of PRL than previously 
thought. First, expression of maternal behaviour in virgin females is restricted to 
maternal care, but it does not include maternal aggression, which is exclusively shown 
by pregnant and lactating females (Mann et al. 1984; Martín-Sánchez et al. 2015a). 
Furthermore, regarding maternal care, PRLR-knockout mice display dramatic deficits in 
this behaviour (Lucas et al. 1998a). Hence, in the context of Numan and Woodside’s 
model (Fig I.7), virgin female mice might show no aversion responses towards pup-
derived sensory inputs, but not necessarily a constitutive activation of the MPA and of 
the pathway for voluntary proactive maternal responses. Precisely at this point is where 
PRL might exert a more critical role in the onset of motivated maternal behaviours, in a 
similar (but not so evident) fashion as in the rat. This regulatory action of PRL could be 
exerted directly on the MPA, on other nuclei within this neural system or indirectly 
through the modulation of other effectors such as oxytocinergic pathways (see section 
1.5.2). One of the aims of the present work will be to better contextualize this possible 
action of PRL in the management of maternal care and maternal aggression, with a 
particular focus on its actions onto the brain OXTergic cells in the preoptic region. 
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 AIMS OF THIS WORK 
The present doctoral thesis intends to gain a deeper insight on the actions of PRL and 
derived lactogenic hormones in the mouse brain. First, we aim at characterising the 
patterns of PRL signalling in the brains of female and male mice under different 
physiological and reproductive conditions. In addition, we want to analyse how these 
patterns are shaped by different endocrine factors. Finally, we also aim at exploring the 
role of central lactogenic signalling in female mice in the context of maternal behaviour 
regulation. The specific aims of this work are: 
 
I. To describe the basic patterns of PRL signalling in the brain of female and male 
mice and to analyse putative dimorphic differences in this respect. 
II. To analyse the specific role of male (testosterone) and female (estradiol and 
progesterone) gonadal steroids in the regulation of these patterns. 
III. To examine the changes in the basal patterns of PRL signalling in the brain of 
female mice occurring during pregnancy and lactation. 
IV. To evaluate the contribution of hypophyseal PRL in contrast to alternative 
lactogenic sources, to the shaping of lactogenic signalling patterns in the female 
brain during the period of pregnancy. 
V. To investigate the action of lactogenic signals onto a specific population of the 
OXTergic circuits of the maternal brain in lactating dams. 
VI. To develop a new behavioural model, based on the proactive maternal response 
of pup retrieval, for the measurement of maternal motivation in the female 
mouse. This test will be used to explore differences in maternal motivation 
between dams and virgin females, as well as the effect of prolonged pup contact 
on maternal motivation of virgin females. 
VII. To explore the possible role of lactogenic signalling in the preoptic area and of the 
OXTergic cells in the same region on the expression of two maternal behaviours: 
motivated pup retrieval and maternal aggression. 
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1.1. RATIONALE AND AIMS 
The key role of prolactin in maternal physiology has traditionally biased 
neuroendocrinological studies towards its effects in the brain of females, whereas the 
dynamics of this hormone in the male brain has drawn less attention. For instance, the 
distribution of the PRL receptor (PRLR) has been documented for the female (Bakowska 
and Morrell 1997; Bakowska and Morrell 2003) but not the male rodent brain. In the 
same vein, the regulatory relationships between PRL and female gonadal steroids 
(estradiol and progesterone) have been characterised at different levels (Sugiyama et al. 
1994; Torner et al. 1999; Furigo et al. 2014a), but the interactions of PRL with 
testosterone in males are only marginally understood (Gill-Sharma 2009; O’Hara et al. 
2015). Male PRL has received some attention in the clinical field, since pathologies such 
as lactotroph adenomas (Capozzi et al. 2015) and some antipsychotic treatments that 
target dopamine D2 receptors (Riecher-Rössler et al. 2009) and thus affect PRL feedback 
mechanism (Besnard et al. 2014) lead to hyperprolactinaemia. In turn, dysregulation of 
PRL release in men yields different forms of sexual dysfunction as well as other clinical 
conditions (Rastrelli et al. 2015). In this regard, it is already known for some decades 
that PRL is directly involved in the control of male copulatory behavior in rats (Drago et 
al. 1981), mice (Bartke et al. 1987) and other rodent models (Shrenker and Bartke 1987). 
In sum, prolactin has also documented roles in male physiology with a presumable 
central component (Bartke et al. 1987)(Bartke et al. 1987)(Bartke et al. 1987) and could 
also share other central functions that to date have been described only in females.  
The experiments carried out in the present study aim to provide a comprehensive 
description of the distribution of PRL-sensitive cells in the brain of the mouse. For this 
purpose, we compared the signaling associated to PRL in the brains of male and female 
mice, identifying sexually dimorphic differences in the distribution and levels of this 
signaling. In addition, we sought to gain a deeper insight on the role of gonadal steroids 
in the shaping of the central responsiveness to PRL in females (estradiol and 
progesterone) and males (testosterone). To achieve these goals, we used the 
immunohistochemical detection of the phosphorylated form of signal transducer and 
activator of transcription 5 (pSTAT5). As introduced before (see section I.2), the STAT5 
protein plays a pivotal role in the main signalling pathway associated to the PRLR, the 
Jak/STAT pathway. Specifically, STAT5 is activated through phosphorylation (pSTAT5) in 
the last step downstream this pathway and translocates to the cell nucleus to mediate 
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the biological effects of PRL signalling (Fig I.2). Hence, the immunohistochemical 
detection of pSTAT5 provides an integrative functional measure of the major component 
of PRL signalling in the brain. 
We first characterised the basic distribution patterns of pSTAT5-ir in males and females. 
In order to overcome the variability due to the estrous cycle (thus anticipating the 
possible influence of gonadal steroids on brain PRL signaling; Sugiyama et al. 1994; 
Furigo et al. 2014; our own observations), we conducted this study using ovariectomized 
females treated with estradiol and progesterone (steroid-primed). The male group, by 
contrast, was gonadally intact. To ensure high and homogenous levels of circulating PRL, 
both experimental groups received injections of a high dose of exogenous PRL before 
perfusion. This allowed mapping the cells of the brain of both females and males that 
respond to PRL, thus revealing possible cases of sexual dimorphism in this feature.  
Furthermore, we compared the levels of pSTAT5-ir between the steroid-primed 
ovariectomized female mice mentioned above (treated with estradiol and progesterone) 
with other ovariectomized females treated either with estradiol alone or with vehicle 
(oil, control group). Concerning males, we explored the contribution of testosterone to 
brain PRL responsiveness by comparing pSTAT5-ir levels of our previous sample of males 
(gonadally intact) with long-term castrated males (which lacked testosterone). 
The main goal of this study is to set the neuroanatomical basis for our understanding of 
the modulatory action of PRL and other lactogens in the brain of males and females.  
This will set the foundations for studying the influence of PRL in the behaviour of males 
and females, which will be analysed in the general discussion.  
1.2. MATERIAL AND METHODS 
1.2.1. ANIMALS  
For the present study, n=30 mice of the CD1 strain (Charles River Laboratories, France) 
were used, 18 females and 12 males, aging between 8 and 24 weeks. These animals 
were housed  in polypropylene cages (145 mm wide, 465 mm long and 215 mm high; 
Panlab) under controlled temperature (24 ± 2 ºC) and lighting conditions (12h:12h; lights 
ON at 8 am), with ad libitum access to food and water. Males were housed individually if 
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intact or in groups (4 to 6 animals per group) if castrated, whereas females were group-
housed (4 to 6 animals per group). Animals were treated throughout according to the 
European Union Council Directive of June 3rd, 2010 (6106/1/10 REV1) and procedures 
were approved by the Committee of Ethics on Animal Experimentation of the University 
of Valencia, where the experiments were performed. 
1.2.2. EXPERIMENTAL DESIGN 
For the purpose of this study, experimental females underwent ovariectomy and a 
subsequent gonadal steroid replacement schedule. After ovariectomy (see section 
1.2.3), females were randomly distributed in 3 experimental groups: (1) group OO 
received vehicle (oil); (2) group EO received estradiol plus vehicle; and (3) group EP 
received estradiol plus progesterone as treatment.  
Males, in turn, were randomly assigned to two experimental groups: (1) Intact males, 
which were left undisturbed; and (2) Castrated males, which underwent orchidectomy 
(section 1.2.3). Both groups received sham subcutaneous implants equivalent to 
females, filled with vehicle.  
After 7 days of hormonal treatment (females) or sham treatment (males), both males 
and females received a PRL supplement in form of a single i.p. injection of ovine PRL 
(Brown et al. 2010). An additional control group of gonadally intact males (n=3) was 
processed without receiving any PRL injections. This allowed evaluating the basal levels 
of PRL signalling in the brain of adult males, for which there are no details in the 
literature. For further details on the gonadal replacement treatment and/or the 
administration of PRL, the reader is referred to section 1.2.4. Forty five minutes after 
PRL supplementation (during the peak of PRL signalling and STAT5 phosphorylation in 
response to a PRL challenge, Brown et al. 2010), animals were transcardially perfused. 
Then, brain tissue was extracted and processed (section 1.2.5) for the 
immunohistochemmical detection of pSTAT5 (section 1.2.6). The resulting patterns of 
pSTAT5 immunoreactivity (pSTAT5-ir) were analysed and compared qualitatively and 
quantitatively (sections 1.2.7 and 1.2.8). For the first part of this study, we compared the 
patterns of intact males and females of group EP in search for sexually dimorphic 
differences. Second, we evaluated the effect of estradiol and progesterone on PRL 
signalling in the female brain by comparing the patterns of pSTAT5-ir of experimental 
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females (groups OO, EO and EP). Finally, we explored the effect of testosterone on PRL 
signalling in the male brain by comparing the patterns of pSTAT5-ir of experimental 
males (groups Intact and Castrated). 
1.2.3. OVARIECTOMY AND ORCHIDECTOMY 
Experimental females underwent ovariectomy at 10 weeks of age, whereas males of 
Castrated group were orchidectomized at approximately 12 weeks of age. Both surgical 
procedures were conducted under i.p. ketamine (Imalgene 500, Merial, Toulouse, 
France, 75mg/kg) and medetomidine (Domtor 1mg/ml, Esteve, Barcelona, Spain, 1 
mg/kg). Animals also received butorphanol tartrate 1% (Torbugesic, Fort Dodge, Girona, 
Spain, 20 µl s.c.) for pain control and sedation. Ovariectomy was performed through two 
incisions at both sides of the lumbar region of the back, whereas orchidectomy was 
performed via a single midline incision on the scrotal sac. After surgery, i.p. atipamezol 
hydrochloride (Antisedan, Pfizer, New York, USA, 1 mg/kg) was administered to reverse 
anaesthesia and facilitate awakening and restoration. Animals were left at least 7 days 
of recovery. 
1.2.4. HORMONE TREATMENTS 
As anticipated before, experimental females received either vehicle (oil, group OO), 
vehicle plus estradiol (group EO) or estradiol plus progesterone (group EP), as part of the 
gonadal steroid replacement schedule. In accordance with the experimental induction of 
the estrous cycle (Rissman et al. 1997), estradiol was administered on a slow-release 
profile during 7 days, by means of the subcutaneous placement of silastic tubing 
implants (Dow Corning Corporation) filled with 20 µg/ml β-estradiol (Sigma, St Louis, 
MO, USA) diluted in sunflower oil. Silastic tubing had an inner diameter of 1.67 mm and 
an outer diameter of 2.41 mm, and implants were cut to a length of 20 mm.  
By contrast, progesterone (Sigma, St Louis, MO, USA) was administered to females 
acutely in a 500 µg subcutaneous injection, diluted in sunflower oil, in the morning of 
the seventh day of estradiol (or vehicle) treatment. Three hours after progesterone 
administration, females received a 5 mg/kg i.p. dose of ovine PRL (Sigma, St Louis, MO, 
USA) and perfused 45 minutes later (Brown et al. 2010). The administration of PRL 
granted homogeneous supraphysiological levels of circulating PRL, thus allowing 
evaluation of steroid influence on PRL signalling excluding the documented effects of 
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estradiol on hypophyseal PRL release (Maeda et al. 1996). Males, in turn, received 
equivalent subcutaneous implants filled with vehicle during seven days. During the 
morning of the seventh day, they were administered ovine PRL (as with females) and 
perfused 45 minutes later. 
1.2.5. TISSUE COLLECTION AND HISTOLOGICAL PROCESSING 
Animals were given an overdose of sodium pentobarbital (Vetoquinol, Madrid, Spain) 
and were transcardially perfused with 4% paraformaldehyde in 0.1M phosphate buffer 
(PB), pH 7.4. Brains were carefully extracted and post-fixed overnight through 
immersion in the same fixative, then cryoprotected by immersion in 30% sucrose in 
0.01M PB until they sank (2-3 days), indicating the complete penetration of the 
cryoprotectant in the tissue. Then, brains were cut using a freezing microtome (Microm 
HM-450, Walldorf, Germany)  in five parallel series of 40 µm thick coronal sections and 
series stored in PB-30% sucrose at -20ºC. 
1.2.6. IMMUNOHISTOCHEMISTRY FOR pSTAT5 
Immunohistochemistry was conducted in free-floating sections under light shaking at 
room temperature (25oC) unless otherwise stated. Immunohistochemistry protocol was 
adapted from Brown et al. (2010; 2011). Tissue sections were thoroughly rinsed 
between stages for at least three 10-min washes in TRIS-buffered saline, 0.05M, pH 7.6 
(TBS). After thawing, sections underwent an initial antigen retrieval step, consisting in 2 
sequential 6 minutes incubations in 0.01 M TRIS buffer (TB), pH 10 at 85oC, and brought 
quickly to room temperature in between. Tissue was then incubated in (a) 1% hydrogen 
peroxide (H2O2) for 30 minutes, for endogenous peroxidase inhibition, (b) 2% BSA, 2% 
goat serum and 0.3% Triton X-100 in TBS for 1h, in order to block unspecific labelling, (c) 
rabbit anti-pSTAT5 primary antibody (pSTAT5 Tyr694; Cell Signalling Technology, 
Beverly, MA) diluted 1:500 in TBS plus Triton X-100 0.1% for 72 h at 4ºC, (d) biotinylated 
goat anti-rabbit IgG (Vector Laboratories, Peterborough, UK) 1:200 in TBS for 90 minutes 
and (e) avidin-biotin-peroxidase complex (ABC Elite kit; Vector Laboratories) in TBS for 
90 minutes. Peroxidase label was developed using 0.005% 3-3’-, diaminobenzidine 
(Sigma) and 0.01% H2O2 in TB pH 7.6 for about 15 minutes, obtaining thereby a brown 
nuclear staining. Sections were rinsed in TB and mounted onto gelatinized slides, 
dehydrated in alcohols, cleared with xylene and coverslipped with Entellan. 
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1.2.7. ANALYSIS OF pSTAT5 IMMUNOREACTIVITY 
We analysed tissue preparations using an optical microscope Leitz DMRB (Leica AG, 
Germany). For the qualitative mapping of the corresponding patterns of pSTAT5-ir 
distribution in intact males and ovariectomized, steroid-treated females, we registered 
the presence or absence of pSTAT5-ir in every single brain site for each specimen of the 
respective groups. Regarding the quantitative assessment of the levels of PRL signalling 
in the respective experimental groups, we analysed the density of cells showing pSTAT5 
immunoreactivity (pSTAT5-ir) in selected brain sites showing pSTAT5 expression in both 
females and males. To do so, we designed representative frames of the chosen nuclei 
(Fig 1.1)  using the stereotaxic atlas of Paxinos and Franklin (2004), and we obtained 
photomicrographs of these frames in both hemispheres using a digital camera (Leica 
DFC495) attached to the same microscope. Image processing and analysis was 
conducted on Image J. Briefly, we subtracted background light and converted the RGB 
colour image to greyscale by selecting the green channel. Then, we binarised the 
greyscale image setting the 75% of the mode of the histogram as a threshold, thus 
including every pixel below this threshold as positively labelled. We filtered smaller 
noise particles by an additional processing consisting of the following Image J 
commands: “fill holes”; “open” (3 iterations) and “watershed”. Particles were 
additionally filtered by area (larger than 70 µm2, corresponding to an approximate 
diameter of 9.4 µm) and finally counted automatically by Image J. We calculated the 
mean (interhemispheric) density of pSTAT5-imunoreactive cell nuclei for each specimen 
by dividing the mean value of these counts for both hemispheres by the area of the 
respective frame. 
1.2.8. STATISTICAL ANALYSIS 
Statistical analysis of the resulting data was performed on the SPSS software package. 
After checking for normality (Kolmogorov-Smirnov test with Lilliefors’ correction) and 
homogeneity of variances (Levene's test), we performed three different statistical 
comparisons. First, we compared levels of pSTAT5-ir density between Intact males and 
EP females, in search for sexually dimorphic differences of quantitative nature. Only part 
of the samples of part of the brain nuclei fulfilled the criteria for a parametric analysis, in 
case of which they were subject to an independent t-test. The samples of the remaining 
nuclei were subject to a non-parametric Kruskal-Wallis ANOVA. Second, we compared all 
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three groups of experimental females (OO; EO and EP) in order to examine possible 
effects of gonadal steroids in PRL signalling. In this case, the samples were not fit for a 
parametric analysis, so we ran a non-parametric Kruskal-Wallis ANOVA for each of the 
surveyed nuclei. Since this comparison included more than two groups, we used 
Dunnett´s post-hoc method for multiple comparisons to further analyse significant 
differences revealed by the Kruskal-Wallis ANOVA test. Last, we checked for the effect of 
orchidectomy on male pSTAT5-ir levels by comparing both groups of males, Intact and 
Castrated. Once again, the samples of part of the nuclei were subject to a parametric 
independent t-test and the rest to a non-parametric Kruskal-Wallis ANOVA. For each 
statistical test, we applied a significance level of 0.05. 
1.3. RESULTS 
1.3.1. MAPPING OF pSTAT5 IMMUNOREACTIVITY IN THE FEMALE AND MALE 
MOUSE BRAIN 
In this section, we compare the distribution of pSTAT5-ir in the brains of ovariectomized, 
steroid-primed and PRL supplemented female mice with gonadally intact, PRL 
supplemented male mice. Immunohistochemistry for pSTAT5 in the examined tissue 
rendered a defined staining restricted to the cell nucleus. For this and the following 
descriptions, we will adhere to the neuroanatomical terminology proposed by Paxinos 
and Franklin (2004, see abbreviation list). 
A Patterns of pSTAT5 immunoreactivity in the brain of ovariectomized, 
steroid-primed virgin female mice 
Our sample of ovariectomized, steroid-primed females displayed a common pattern of 
pSTAT5-ir with little interindividual variation. This pattern is depicted in Figure 1.1, 
which shows the common labelling for males and females (dark blue) and labelling 
exclusively present in females (red). Immunoreactivity for pSTAT5 in females was 
widespread in the basal telencephalon and hypothalamus, but was also found within 
thalamic, midbrain and brainstem structures. Remarkably, the choroid plexus appeared 
positively labelled in the whole sample of females (not shown) This is likely related to 
their role in PRL transport to the brain (Mangurian et al. 1992; but see Brown et al. 
2015). 
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Figure 1.1 Mapping of pSTAT5 immunoreactivity in the brains of male and female mice 
Representative camera lucida drawings of coronal sections of the mouse brain showing the 
distribution patterns of pSTAT5-ir in female and male mice. Pink dots represent pSTAT5 
expression exclusive of ovariectomized, steroid-primed females. Dark blue dots encode 
overlapping expression of pSTAT5-ir in both the female and male specimens. Each dot 
represents approximately 4 cell nuclei labelled for pSTAT5. Shaded areas illustrate the counting 
frames designed for the AVPe/VMPO region (Fig. 1.1a), the Pa (Fig. 1.1e), and the Arc, VMHvl, 
VMHc and VMHdm, DM and MePD (all frames in Fig. 1.1f) as part of the quantitative analysis 
performed in this work (see below). Approximate distance to bregma is enclosed for each 
section. 
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Telencephalon 
Within the telencephalon, pSTAT5-ir was detected in the amygdaloid region, the bed 
nucleus of the stria terminalis (BST) and the lateral septum (LS). In the amygdala, the 
medial posterodorsal nucleus (MePD) contained a very rich population of labelled cells 
which occupied the whole area of this nucleus (Fig 1.1f, 1.2AI). Furthermore, the medial 
central (CeM, Fig 1.1e) and the basomedial (BMA, not shown) nuclei of the amygdala, 
the anterior nucleus of the cortical amygdala (ACo), the intramygdaloid BST (BSTia) and 
the amygdalohippocampal area (AHi) showed scarce labelling in some of the specimens 
(Fig 1.1f). In the BST, pSTAT5-ir was observed in the medial anterior and medioventral 
nuclei (BSTMA and BSTMV, respectively, Figs 1.1a and b) and in the medial posterior 
divisions of the nucleus (BSTMPM; BSTMPI and to a lesser extent, BSTMPL, Figs 1.1c and 
d). Finally, pSTAT5-ir was moderately present in the septal region, especially in the 
ventral and intermediate aspects of the lateral septum (LSV and LSI, Figs 1.1a and b) and 
in the area comprising the triangular septal nucleus (TS) and the septofimbrial nucleus 
(SFi, Figs 1.1a-c and 1.2BI), in addition to the subfornical organ (SFO, Fig 1.1c and d). 
Diencephalon 
In the hypothalamus, pSTAT5-ir was present in all of the major rostrocaudal divisions, 
with densest labelling found within juxtaventricular sites, but some labelling also 
present in more lateral compartments. In the preoptic hypothalamus (Figs 1.1a-d and 
1.2CI), labelling was most prominent in the vascular organ of the lamina terminalis 
(VOLT, Fig 1.1a), the anteroventral periventricular (AVPe, Figs 1.1a-c), the ventromedial 
preoptic (VMPO, Figs. 1.1a-c) and the periventricular (Pe, Figs 1.1c and d) nuclei. In 
addition, other sites displayed scattered pSTAT5-ir, namely the medial preoptic area 
(MPA, Figs 1.1a-d), the medial (but not central or lateral) division of the medial preoptic 
nucleus (MPOM, Figs 1.1c and d), the lateral preoptic nucleus (LPO, Figs 1.1a-d), or the 
area comprising the anterior commissural nucleus and the anterodorsal preoptic nucleus 
of the hypothalamus (AC/ADP, Figs 1.1b-d).  
In the anterior hypothalamus (Fig 1.1e and 1.2DI), the paraventricular nucleus (Pa) 
displayed pSTAT5-ir principally in its ventral (PaV) and medial parvocellular (PaMP), but 
also in the medial and lateral magnocellular populations (PaMM and PaLM, respectively) 
and the posterior aspect of the nucleus (PaPO). Further pSTAT5-ir was observed in some 
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specimens in the lateral hypothalamic region (LH) and, exceptionally, in the 
subparaventricular nucleus (SPa) and in the anterior hypothalamic area (AHA).  
 
Figure 1.2 Representative examples of pSTAT5 immunoreactivity in the brain of female 
and male mice 
Photomicrographs illustrating pSTAT5 labelling in representative brain sections in an 
ovariectomized, steroid-primed female supplemented with PRL (I), an intact, PRL-supplemented 
male (II), a castrated, PRL supplemented male (III) and a intact control male, not supplemented 
with PRL (IV).  Sections correspond to the preoptic hypothalamus (A), the paraventricular region 
in the anterior hypothalamus (B), the tuberal hypothalamus (C), the caudal septum (D) and the 
medial posterior amygdala (E). The approximate distance to bregma is indicated in each section. 
Scale bars correspond to 100 µm. 
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In the tuberal region of the hypothalamus (Fig. 1.1f and 1.2EI), the retrochiasmatic 
region (RCh) displayed scattered labelling, whereas the arcuate nucleus (Arc) showed 
high levels of pSTAT5-ir, with some immunoreactive cell nuclei overextending into the 
median eminence (ME). In addition, pSTAT5-ir was present in the dorsomedial (DM) and 
ventromedial (VMH) hypothalamic nuclei. Within the latter, pSTAT5-ir density was 
higher in the ventrolateral division (VMHvl) but also moderately present in the central 
and dorsomedial divisions (VMHc; VMHdm). Finally, the medial tuberal nucleus (MTu), 
the perifornical nucleus (PeF), the magnocellular lateral hypothalamic nucleus (MCLH) 
and the posterior hypothalamic region (PH) appeared exceptionally labelled for pSTAT5 
in some specimens of the aforementioned groups. 
The thalamic region, in turn, was generally devoid of pSTAT5-ir, with the exception the 
posterior intralaminar complex (PIL, Fig 1.1g). Other thalamic sites displayed pSTAT5-ir 
anecdotally: the zona incerta (ZI, Figs 1.1e and f), the medial habenula (MHb, Fig 1.1e), 
the precommissural nucleus (PrC, not shown) and the subparafascicular nucleus (SPF, 
not shown).  
Midbrain and brainstem 
In the midbrain and brainstem regions, pSTAT5-ir was noticeable mainly in the lateral 
(LPAG) and dorsomedial (DMPAG) divisions of the periaqueductal grey (Figs 1.1g and h), 
as well as in the dorsal raphe nucleus (DR, Fig 1.1h). Finally, pSTAT5-ir was also present 
in the parabrachial nucleus (PB), both in its medial (MPB) and lateral (LPB) aspects, and 
in the locus coeruleus (LC) (Fig 1.1i). 
B Patterns of pSTAT5 immunoreactivity in the brain of male mice 
Immunolabelling for pSTAT5 in the brain of gonadally-intact male mice was only present 
after exogenous PRL administration, whereas non-supplemented male mice virtually 
lacked any immunoreactivity in the brain, except for the arcuate nucleus (Arc, Fig 1.2 
EIV) and scarce labelled cells in the Pe (not shown). Still, PRL-supplemented male mice 
showed a more restricted distribution of pSTAT5-ir than ovariectomized, steroid-primed 
females. Importantly, the male pattern was a fraction of that of females. In other words, 
no brain structure displayed pSTAT5-ir exclusively in males. Immunolabelling for pSTAT5 
in the brain of gonadally-intact male mice was virtually restricted to the hypothalamus, 
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with labelled cells also present in a few telencephalic structures (Figs 1.1 and 1.2). In 
contrast to females, no pSTAT5-ir was found within thalamic, midbrain or brainstem 
structures. In the telencephalon, pSTAT5-ir was observed mainly in the septum, 
specifically in the TS/SFi area (Figs 1.1 a-c and 1.2BIV). Furthermore, the SFO (Figs 1.1 c 
and d) also contained some immunoreactive cells. In the amygdala, the MePD displayed 
scarce pSTAT5-ir, with very few immunolabelled cells restricted to the upper corner of 
the nucleus, in close contact to the BSTia (Figs 1.1f and 1.2AIV). This distribution 
contrasts strongly with that of female mice, where the whole nucleus shows densely 
labelled pSTAT5-immunoreactive cells. 
In the hypothalamus, pSTAT5-ir was present in the preoptic, anterior and tuberal 
regions. In the preoptic region (Figs 1.1a-d and 1.2CIV), pSTAT5-ir was concentrated in 
the juxtaventricular nuclei, namely the VOLT, the AVPe, the VMPO and the Pe. As in 
females, the adjoining MPA also displayed a few immunolabelled cell nuclei (Figs. 1.1a-
d). In the anterior hypothalamus, pSTAT5-ir was once again restricted to juxtaventricular 
structures, namely the Pa and the Pe (Fig. 1.1e and 1.2DIV). In the Pa, labelling was 
limited to the medial aspect of the nucleus, mainly to the ventral (PaV), medial 
magnocellular (PaMM) and medial parvocellular Pa (PaMP) subdivisions, with very few 
labelling observed in the lateral aspect of the nucleus (PaLM) or the SPa. In the tuberal 
hypothalamus (Fig. 1.1f and 1.2EIV), the Arc displayed abundant pSTAT5-ir, with some 
immunolabelled cells displaced into the ME. Moreover, the RCh displayed some 
scattered immunolabelling as well as the DM (in some males). Finally, pSTAT5-ir was 
observed in the VMH, with higher levels in the VMHvl and sparse labelling in the VMHc 
and VMHdm. 
1.3.2. QUANTITATIVE ANALYSIS OF pSTAT5-IR DENSITY IN IMMUNOREACTIVE 
AREAS OF THE FEMALE AND MALE MOUSE BRAIN 
To check for additional, quantitative cases of sexual dimorphism in PRL-derived 
signalling, we analysed the density of pSTAT5-ir in the main nuclei showing pSTAT5-ir in 
intact males and ovariectomized, steroid-primed females. We designed counting frames 
for the following brain nuclei: the AVPe/VMPO region, the Pa, the Arc, the DM, the 
VMHvl, the central and dorsomedial VMH (VMHc), the MePD and the SFi (anatomical 
location of frames included in Fig 1.1).  
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Then, we assessed the mean interhemispheric density of pSTAT5-ir and performed 
separate statistical tests on each of the analysed nuclei. When data fulfilled the criteria 
for a parametric statistical analysis (the AVPe, the Arc, the Pa and the VMHvl), we 
performed t tests for independent samples. For the remaining nuclei (the DM, the 
VMHc, the MePD and the SFi), we performed a non-parametric Mann-Whitney test. The 
results of these analyses are illustrated on Figure 1.3.  
 Figure 1.3 Quantitative analysis of pSTAT5 immunoreactivity in selected brain regions 
of female and male mice 
Assessment of pSTAT5-ir density (pSTAT5-positive cell nuclei/mm2) in the major brain regions 
with expression of pSTAT5-ir in ovariectomized, steroid-primed virgin female mice and intact 
male mice, both PRL-supplemented. Bar histograms show mean interhemispheric pSTAT5-ir 
density ± SEM in gonadally-intact, vehicle-treated males (n=6; black) and ovariectomized females 
treated with estradiol plus progesterone (n=6; green). Counting frames for each of the analysed 
nuclei are included in Fig. 2.1. Statistical analysis was applied independently to each brain region 
(independent t-test for parametric data or Mann-Whitney test for non-parametric data, see 
Results). *P ≤ 0.05; **P ≤ 0.01; (*) P ≥ 0.06. 
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Females showed a general trend towards higher levels of pSTAT5-ir than males. This 
effect only reached statistical significance in the Arc (t(10)=3.043, p=0.012), the DM 
(U=32.0; p=0.026) and the MePD (U=30.0; p=0.004), although the AVPe/VMPO also 
showed a strong trend towards higher pSTAT5-ir density in females (t(9)=2.183; 
p=0.057). Additional examples of the distribution of pSTAT5-ir in the analysed nuclei of 
males and ovariectomized, steroid-primed females are shown on Figure 1.2.  
1.3.3. EFFECT OF PROGESTERONE AND ESTRADIOL ON BRAIN PROLACTIN 
SIGNALLING IN THE FEMALE MOUSE BRAIN 
To further explore the putative role of gonadal steroids in modulating central PRL 
signalling in the female brain, we compared our previous sample of ovariectomized 
virgin females treated with estradiol and progesterone (group EP) with two additional 
groups of ovariectomized virgin females: vehicle-treated (group OO) and estradiol-
treated (group EO). After a general inspection of the patterns of pSTAT5-ir in these 
groups, we designed a new set of counting frames including up to 12 brain regions 
involved in the management of social and reproductive behaviours and in the control of 
PRL release (Newman 1999; Ben-Jonathan and Hnasko 2001b; Gammie 2005), which at 
first glance displayed potential differences in pSTAT5-ir density due to the steroid 
treatment. These counting frames are depicted in Figure 1.4 and include the following 
brain sites: the LSV, BSTMPM, CeM and MePD in the telencephalon; the AVPe, AC/ADP, 
MPO, Pa, Arc and VMHvl in the hypothalamus; the PIL in the thalamus and the LPAG in 
the midbrain. 
Separate non-parametric one-way Kruskal-Wallis ANOVA tests for the density of 
pSTAT5-ir in each brain region revealed significant differences in pSTAT5-ir density 
between OO, EO and EP groups in 5 out of the 12 analysed nuclei (Fig. 1.6). Discrete 
inter-group differences were further explored with Dunnett´s post-hoc method for 
multiple comparisons, which revealed significant effects generally consisting of an 
important increase in pSTAT5-ir density affecting one or both groups treated with 
estradiol (EO and EP) as compared to the vehicle group (OO). All of the telencephalic 
nuclei included in this analysis showed significant differences in pSTAT5-ir density except 
for the CeM (p=0.246). In the MePD (χ2 (2)=9.748; p=0.001), the EP group displayed 
significantly higher pSTAT5-ir density than the OO group (p=0.007), whereas differences 
between the EO and OO group did not reach significance. In the BST region, we found a 
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trend towards inter-group differences in the BSTMPM (χ2 (2)=5.558; p=0.062). In the 
septal region, we found a significant effect in the LSV (χ2 (2)=11.263; p=0.004), where 
pSTAT5-ir density of the EO and EP groups are again significantly higher than the OO 
group (p=0.004 and p=0.038, respectively).  
 Figure 1.4 Anatomical location of counting frames for ovariectomized, steroid-primed 
females 
Semi-schematic camera lucida drawings of selected coronal sections featuring the counting 
frames (red) chosen for pSTAT5-ir quantification in ovariectomized, steroid-primed female mice 
(groups OO; EO and EP; see Fig. 2.5). Frames include: a) the LSV; b) the AVPe; c) the 
BSTMPM; d) the AC/ADP; e) the MPO; f) the Pa; g) the CeM; h) the VMHvl and ventrolateral 
adjoining area; i) the Arc; j) the MePD; k) PIL and adjoining posterior thalamic region and l) the 
VLPAG. Approximate distance to bregma enclosed for each section. Scale bars: 500 µm. 
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 Figure 1.5 Gonadal steroid influence in pSTAT5 immunoreactivity of the female mouse 
brain 
Assessment of pSTAT5-ir density (pSTAT5-positive cell nuclei / mm2) in three groups of 
ovariectomized virgin female mice with different gonadal steroid treatments, within 12 brain 
regions involved in the management of social and reproductive behaviours and in the control of 
PRL release (Newman 1999; Ben-Jonathan and Hnasko 2001b; Gammie 2005). Bar histograms 
show mean interhemisferic pSTAT5-ir density ± SEM in ovariectomized virgin female mice 
treated with: vehicle (group OO; white; n=6), estradiol (group EO; light green; n=6) or estradiol 
+ progesterone (group EP; dark green; n=6). Non-parametric Kruskal-Wallis ANOVA with 
Dunnett´s post-hoc pairwise comparisons was applied separately to each brain region. *p ≤ 0.05; 
**p ≤ 0.01. 
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In the preoptic hypothalamus, a significant effect of the treatment was observed in the 
AC/ADP (χ2 (2)=9.182; p=0.010) but not in the AVPe/VMPO (p=0.806) and MPOM 
(p=0.08). In the AC/ADP, post-hoc analysis determined that the EO group had 
significantly higher pSTAT5-ir density than the control (p=0.01) whereas differences 
between the control and EP group are only marginally significant (p=0.07). No significant 
effects of steroids were found in the remaining hypothalamic nuclei (anterior 
hypothalamus, Arc and VMH) (p>0.4). 
Finally, the thalamic PIL displayed significant inter-group differences (χ2 (2) =8.510; 
p=0.014), as well as the midbrain VLPAG (χ2 (2) =10.900; p=0.004) with significantly 
increased levels of pSTAT5-ir relative to control in the EP group for the PIL (p= 0.015) 
and in both the EO (p=0.007) and the EP (p=0.024) groups for the VLPAG. 
1.3.4. EFFECT OF TESTOSTERONE WITHDRAWAL IN PROLACTIN SIGNALLING IN 
THE MALE MOUSE BRAIN 
Finally, we explored the putative role of testosterone in the regulation of PRL-derived 
signalling in the male brain. We compared pSTAT5-ir density between our previous 
group of intact males and a sample of long-term castrated males (Fig 1.6). For this 
comparison, we returned to the original set of frames, comprising those brain regions 
with pSTAT5-ir in male specimens. This frames are depicted on Figure 1.1 and include 
the SFi and MePD in the telencephalon and the AVPe, Pa, Arc; VMHvl, VMHc and DM in 
the hypothalamus.  In this case, only the Arc and AVPe fulfilled the criteria for 
parametric analysis. Hence, we performed an independent t-test for these two nuclei 
and a non-parametric Mann-Whitney test for the rest. The results of this statistical 
comparison are illustrated on Figure 1.6 and reveal a significant effect of testosterone 
withdrawal in diminishing the levels of pSTAT5-ir in the Pa (U= 33.00; p=0.004), in both 
the ventrolateral and central /dorsomedial VMH (U= 30.00, p=0.015 for both frames) 
and in the SFi (U= 26.00, p=0.05). Figure 1.2 provides some photographic examples of 
the appearance of pSTAT5-ir of intact and castrated males in the analysed sites. 
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 Figure 1.6 Effect of testosterone withdrawal in pSTAT5 immunoreactivity of the male 
mouse brain 
Assessment of pSTAT5-ir density (pSTAT5-positive cell nuclei/mm2) in gonadally-intact male 
mice and castrated male mice within the major brain regions showing pSTAT5 expression in the 
male mouse brain. Bar histograms show mean interhemispheric pSTAT5-ir density ± SEM in 
intact, PRL-supplemented males (n=6; black) and castrated, PRL-supplemented males (n=6; 
white). Counting frames for each of the analysed nuclei are shown in Fig. 1.1. Statistical analysis 
was applied independently to each brain region (independent t-test for parametric data or Mann-
Whitney test for non-parametric data). *P ≤ 0.05; **P ≤ 0.01. 
1.4. DISCUSSION 
The present study examined the distribution of PRL-derived signalling in the female and 
male CD1 mouse brain. We compared the central patterns of pSTAT5-ir in 
ovariectomized, steroid-primed female mice and gonadally intact male mice, both 
administered exogenous PRL. We evaluated pSTAT5-ir levels in qualitative terms 
(distribution in the brain) and quantitative terms (assessment of pSTAT5-ir density in 
selected brain nuclei). As expected, we found more restricted patterns (Fig 1.1) and 
lower levels (Fig 1.3) of pSTAT5-ir in males than in females, with several regions showing 
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sexually dimorphic expression of pSTAT5-ir. Following this descriptive analysis, we 
evaluated the contribution of the gonadal steroids estradiol and progesterone to PRL 
signalling in the female brain. For this task, we conducted a hormonal substitution 
experiment on ovariectomized virgin female mice, comparing pSTAT5-ir density after 
vehicle, estradiol-vehicle and estradiol-progesterone treatment, respectively. We found 
a generalised enhancement of PRL-derived signalling after estradiol treatment, which 
was locally modulated by progesterone in different ways (Fig 1.5). In males, we 
evaluated the contribution of testosterone to central PRL signalling by comparing 
pSTAT5-ir density in castrated versus intact males. We found that, in a number of nuclei, 
PRL-derived signalling decreased significantly after testosterone withdrawal (Fig 1.6). In 
this section, we will first comment on the observed sexually dimorphic differences in 
distribution and density of pSTAT5-ir. Then, we will discuss the role of estradiol and 
progesterone in the regulation of central PRL signalling in female mice. Finally, we will 
focus on the male brain to discuss on the role of testosterone as a putative regulator of 
central PRL signalling and on the mutual regulatory relationship of PRL and testosterone.  
1.4.1. ON THE METHOD: pSTAT5 IMMUNODETECTION ON PROLACTIN-
SUPPLEMENTED MICE 
In this experiment, distribution and levels of PRL responsiveness were assessed in brain 
tissue of gonadally intact males and of ovariectomized, steroid-primed female mice. In 
order to avoid any bias due to variable or low circulating PRL levels, both experimental 
females and males were supplemented with a standard dose of exogenous PRL. This 
supplementation allowed for a controlled increase of circulating PRL, granting 
homogenous supraphysiological levels and access of the hormone to the brain and 
therefore a maximal and (relatively) constant brain response on the experimental 
animals.  
The methodological approach chosen to evaluate central PRL responsiveness in this 
experiment (and the main strategy of choice throughout the present work) is the 
immunohistochemical detection of pSTAT5. This protein (pSTAT5) is the phosphorylated 
(active) form of Signal Transducer and Activator of Transcription 5 (STAT5), a key 
element in the Jak/STAT signalling pathway of the long form of the PRLR (PRLR-l) that, 
once phosphorylated, will translocate to the cell nucleus to mediate the biological 
effects of PRL signalling (Fig I.2). The specific detection of pSTAT5 results in an 
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advantageous approach to assess PRL actions in the brain, in comparison to other 
histological strategies like, for instance, PRLR immunohistochemistry (IHC) or in situ 
hybridisation (ISH). Both of these alternative strategies are limited to assess the 
distribution of the mRNA (ISH) or the protein (IHC) of the PRLR, but they do not take into 
account putative posttranslational or posttranscriptional (ISH) modifications modulating 
the receptor’s activity or sensitivity. On the contrary, pSTAT5 immunodetection provides 
a downstream functional measure for PRL-derived signalling, identifying the signalling 
effectively occurring in the tissue in response to the binding of PRL to its receptor. 
However, this methodology is not without limitations. First, it does not show signalling 
independent of STAT5 phosphorylation (Buonfiglio et al. 2015) such as that occurring 
through other signalling pathways associated to the PRLR-l (Fig I.2) or through the short 
PRLR isoforms (PRLR-s) (Goupille et al. 1997; Binart et al. 2010). Regarding the former, it 
is indeed unavoidable to miss certain amount of PRL-derived signalling through 
alternative pathways of the PRLR-l, but, remarkably, the Jak/STAT pathway is generally 
considered the main signalling pathways of the PRLR-l (for more details, see section I.2). 
Concerning the PRLR-s, evidence suggests that these variants are non-functional or do 
not relate to the major endocrine actions of PRL (Lesueur et al. 1991). Instead, other 
studies conclude that the PRLR-s represent a dominant negative form of the receptor, 
which by dimerization inhibits the functional PRLR-l (Berlanga et al. 1997). Furthermore, 
expression levels of the PRLR-s remain unchanged during the estrous cycle and are 
similar in virgin, pregnant and lactating female rats (Sugiyama et al. 1994; Nogami et al. 
2007). This supports the view that the PRLR-s variants are not directly involved in 
reproduction. This is one of the reasons why we (and others) focus in the signalling 
cascade of the long form of the PRLR for analysing the putative role of PRL in maternal 
physiology and behaviour.  
A further limitation of pSTAT5 detection, however, is the potential crosstalk between 
signalling associated to PRL and growth hormone (GH) or leptin. All three hormones bind 
to receptors of the type-I cytokine receptor superfamily and appear to relate to STAT5, 
among other pathways (Bennett et al. 2005; Gong et al. 2007). Nevertheless, our 
material belonging to male mice not supplemented with exogenous PRL (Fig 1. IV) is 
devoid of pSTAT5-ir (except for the Arc and Pe), indicating that most pSTAT5-ir is 
attributable to PRL supplementation. This has also been shown for virgin female mice 
(Brown et al. 2010). Altogether, pSTAT5 immunostaining can be considered a reliable 
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marker for the activation of the PRLR-l, which in turn represents the major component 
of lactogenic signalling in the brain. 
1.4.2. SEXUALLY DIMORPHIC PROLACTIN SIGNALLING IN THE MOUSE BRAIN 
Prolactin signalling in the female mouse brain 
Herein, we report novel findings of the patterns of PRL-derived signalling in the brains of 
PRL-supplemented CD1 virgin females, which were ovariectomized and treated with 
estradiol and progesterone. This model was chosen at the expense of freely-cycling 
virgin females, based on previous observations that the latter display substantial rates of 
interindividual variability in the extension and intensity of the brain patterns of pSTAT5-
ir (see Chapter 2). Ovariectomized, steroid-primed virgins, on the contrary, are a valid 
model to emulate the proestrous/estrous phase of the estrous cycle (Akinci and 
Johnston 1993; Rissman et al. 1997), and provided relatively homogenous pSTAT5-ir 
patterns. For a more extensive description of the variable patterns of pSTAT5-ir found in 
the brains of freely-cycling virgins, the reader is referred to chapter 2 of the present 
work. 
Immunoreactivity for pSTAT5 in ovariectomized, steroid-primed females treated with 
estradiol and progesterone was extensive in the amygdala (medial and central nuclei), 
basal telencephalon (lateral septum and BST), hypothalamus (preoptic, anterior and 
tuberomammilary regions) and, to a lesser extent, to discrete thalamic (habenula), 
midbrain (PAG) and brainstem (raphe nuclear complex and lateral parabrachial nucleus) 
structures (Fig 1.1). Importantly, this pattern shows a substantial overlap with the 
circuitry integrating the Sociosexual Brain Network (SBN) and other associated nuclei. 
The SBN is the neural network involved in the expression of social and reproductive 
behaviours (see Introduction and Newman 1999). This observation suggests a strong 
connection between PRL and female sociosexual behaviour regulation, which will be 
thoroughly analysed in the following chapters of this work, especially regarding 
maternal behaviour. 
The distribution of pSTAT5-ir in the brain of the female mouse was first published by 
Brown et al. (2010), who analysed central pSTAT5-ir after PRL supplementation in virgin 
females of the inbred strain C57BL/6J. Remarkably, the pattern of pSTAT5-ir they 
observed was relatively reduced as compared to the one reported in the present work, 
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carried out in ovariectomized, steroid-primed CD1 females also with exogenous 
administration of PRL. This is possibly due to differences in gonadal steroid input, as our 
females were primed with estradiol and progesterone (modelling proestrous/estrous) 
and females of the cited work were in diestrous. Moreover, these observations could 
also underlie interstrain differences between CD1 (outbred) and C57/BL6J (inbred) 
animals, mirroring documented behavioural interstrain differences in, for instance, 
allomaternal behaviour expression (Parmigiani et al. 1999). Importantly, our pSTAT5-ir 
pattern fits the distribution of the mRNA for the PRLR  much closer than the pattern of 
pSTAT5-ir found in C57BL/6J mice (Brown et al. 2010). This suggests either a mismatch in 
the brain of C57BL/6J mice between the distribution of the mRNA and the receptor 
protein (likely due to posttranscriptional, posttranslational or other regulatory 
mechanisms) or some kind of inhibition of central PRL signalling, as compared to the 
CD1 strain.  
Prolactin signalling in the male mouse brain 
Our study reveals a clear sexual dimorphism in PRL-derived signalling in the mouse brain 
upon exogenous PRL administration, in favour of females. Female mice display richer 
and more extensive patterns of pSTAT5-ir than males, an expected outcome regarding 
the close link of PRL with female reproduction. The analysis of the socio-sexual brain of 
males and females of different rodents and other mammals has revealed several cases 
of sexual dimorphism, which would be related to the dimorphic expression of many 
social behaviours, such as aggression and sexual behaviour (Bayless and Shah 2016). In 
most occasions these sexual dimorphism favours males. For instance, the medial 
preoptic area shows a larger nucleus an higher cell density in the brain of males than in 
females (He et al. 2013; Tsuneoka et al. 2017). A similar case has been reported for the 
posterodorsal division of the medial amygdala (Morris et al. 2008). In addition, all the 
centres of the socio-sexual brain show a characteristic innervation by arginine-
vasopressin (AVP) fibres that, again, is denser in males than in females (Rood et al. 2013; 
Otero-Garcia et al. 2014).   
Our findings represent an additional case to the short list of female-biased sexually 
dimorphic traits. As we will discuss in the next chapter, this is likely related to the close 
relationship of PRL to maternal behaviour and physiology. In fact, whereas the 
distribution of PRL-derived signalling in the female mouse brain has focused substantial 
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research, this work is, to our knowledge, the first descriptive analysis of the action of 
PRL in the male mouse brain. Our results indicate that the male mouse brain is indeed 
sensitive to PRL, despite the lower connection of this hormone to male physiology and 
behaviour. However, male mice displayed lower levels of PRL signalling in terms of 
extension and density of the pSTAT5-ir patterns, as compared to ovariectomized, 
steroid-primed virgin females. Moreover, patterns of pSTAT5-ir in males were a fraction 
of those of female mice. In other words, we found no single brain structure labelled in 
males but not in females. 
Structures in the male brain positively labelled for pSTAT5-ir are located mainly in the 
hypothalamus (the AVPe and VMPO, MPA, Pe, Pa, Arc, DM and VMH) and, to a lesser 
extent, in the telencephalon (SFi in the septum and MePD in the amygdala), with no 
additional pSTAT5-ir detected in any of the remaining brain divisions (Fig 1.1). In 
contrast to females, most of the major nodes of the SBN (the lateral septum, BST, 
medial amygdala or PAG, see Fig I.6) are unresponsive to PRL in males, even under high 
circulating levels of the hormone (e.g. exogenous administration). This indicates, as 
advanced before, a lower implication of PRL in the regulation of sociosexual behaviour in 
males, as compared to females, even though it does not exclude a minor role in some 
male-specific behaviours (see General discussion). According to our quantitative analysis 
(Fig 1.3), pSTAT5-ir density was significantly lower in males than in females in part of the 
nuclei with expression of pSTAT5 in both sexes (the AVPe/VMPO, Arc, DM and MePD). 
No significant difference on pSTAT5-ir density was found in the rest of the analysed 
nuclei. 
Furthermore, it is worth noting the brain of male mice lacking systemic PRL 
supplementation is virtually devoid of pSTAT5-ir, except for the Arc (Fig. 1.2) and some 
cells in the anterior periventricular hypothalamus (not shown). These results suggest, in 
the first place, that PRL is indeed the source of all the signalling we report, whereas any 
other endocrine agents signalling through the Jak/STAT pathway, such as growth 
hormone (Furigo et al. 2016), do not contribute substantially to STAT5 phosphorylation 
in the brain. In addition, it indicates that in basal conditions PRL signalling in the male 
brain is very low, probably due to low circulating levels of the hormone (Sinha et al. 
1977; Guillou et al. 2015). In fact, the presumed location of the TIDA neurons (as 
revealed by tyrosine hydroxylase immunohistochemistry), the dorsal aspect of the Arc 
(Li et al. 1999), displays scarce pSTAT5-ir in the control male mouse (not supplemented 
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with PRL, Fig 1.2 IV), supporting the view of very low or even null circulating PRL levels in 
these male mice. Despite this observations, basal levels of circulating PRL might not 
always be negligible, as Sinha et al (1977) reported periodic serum PRL peaks during the 
dark period in male mice of the C3H/St strain.  
In line with these observations, PRL would influence the brain of males especially under 
some physiological conditions in which there is substantially increased hypophyseal or 
extra-hypophyseal PRL release. This might happen in relation with stress (Torner et al. 
2004), as well as after copulatory behaviour (Kamel et al. 1977).  
1.4.3. PROLACTIN SIGNALLING IN THE FEMALE MOUSE BRAIN: REGULATION BY 
ESTRADIOL AND PROGESTERONE 
Progesterone and estradiol are well-documented modulators of PRL signalling. For 
instance, they upregulate PRLR expression during proestrous and oestrous  (Sugiyama et 
al. 1994) and increase PRLR mRNA levels in pituitary lactotrophs (Scully et al. 1997) and, 
consequently, circulating PRL levels (Freeman et al. 2000). In this work, we intended to 
provide an integrative view of how the gonadal steroids ultimately contribute to shape 
the central patterns of PRL signalling. For this purpose, we conducted a hormonal 
substitution experiment on ovariectomized virgin female mice in which we assessed the 
effect of controlled doses of estradiol (EO) or estradiol plus progesterone (EP) on the 
central levels of pSTAT5-ir induced by administration of exogenous PRL (Fig 1.5). The 
results of this analysis revealed a general trend towards an increase of pSTAT5-ir density 
after estradiol treatment (with or without progesterone). This trend reached significance 
in the MePD, the LSV, the AC/ADP, the thalamic PIL and the VLPAG. Of these, only the 
LSV and the VLPAG display a significant increase in both the EO and EP groups, whereas 
the increase found in the MePD and the PIL groups reached significance only in the EP 
group and that found in the AC/ADP only in the EO group.  
Altogether, this reflects a rather complex regulation of PRL signalling by gonadal 
steroids. Our results suggest that indeed, estradiol exerts a positive modulation of 
lactogenic signalling. On top of it, progesterone might display either a synergistic action 
(pSTAT5-ir density in the MePD and PIL only increases significantly when both gonadal 
steroids are administered together), no significant effect (in the LSV and the VLPAG the 
significant increase is maintained in both estradiol-treated groups regardless of 
progesterone) or even a possible antagonizing effect (the AC/ADP experiments a 
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significant increase in the EO group, which is not paralleled by the EP group). This duality 
of progesterone fits previous findings in the literature. On the one hand, progesterone 
has been shown to act synergistically with estradiol, potentiating the positive regulatory 
effects of the former on, for instance, hypophyseal PRL release and PRLR-l expression 
(Sugiyama et al. 1994). On the other hand, some studies have reported a progesterone-
mediated downregulation of PRLR in the MPA during late pregnancy in the rat, which 
temporarily blocks the onset of maternal behaviour until progesterone levels drop close 
to parturition (Bridges and Hays 2005). Altogether, our findings and previous evidence in 
the literature suggest that estradiol-progesterone interaction on central PRL action is 
dual and region-dependent.  
Surprisingly, our results do not fit completely the colocalisation of PRLR (Bakowska and 
Morrell 1997) and estrogen receptor α (ERα) with pSTAT5-ir, as published by Furigo et 
al. (2014a). According to this study, several sites where we have found no apparent 
differences in pSTAT5-ir density related to gonadal steroid treatment do express 
abundant ERα receptors co-localising with pSTAT5-ir, e.g. the AVPe, the medial MPO, 
the Arc or the VMHvl. Aside from some possibly relevant methodological differences 
(different PRL dosage and exposition time, for instance), this apparently contradictory 
results might have different explanations. On the one hand, it is possible that PRL 
signalling were dissociated from gonadal steroid regulation in some regions, depending 
on the function of PRL in those regions. For example, in the Arc, it is likely that levels of 
lactogenic signalling respond directly to circulating PRL levels, as the primary function of 
this nucleus is the feedback control of PRL secretion. Consistent with this, estradiol and 
progesterone are known to modulate this function through regulation of the expression 
of angiotensin II receptors in the arcuate nucleus (Donadio et al. 2006). On the other 
hand, estradiol regulation of PRL signalling might not always have a positive valence. 
According to the existing literature, estradiol regulates the expression of Suppressor of 
Cytokine Signalling (SOCS) protein family, responsible for downregulating signalling 
through the PRLR. For example, estradiol enhances the activity of SOCS3 promoter in the 
mouse (Matthews et al. 2005), and chronic estradiol treatment increases the expression 
of mRNA for SOCS3 and cytokine-inducible SH2-containing protein (CIS) in the rat 
(Anderson et al. 2008), both of which decrease PRL signalling (Krebs and Hilton 2001). 
Thus, the final levels of lactogenic signalling we report might result of the balance of 
opposed regulatory elements and might not simply reflect the direct crosstalk of PRL 
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with ER-expressing cells. In sum, central lactogenic signalling is influenced by circulating 
levels of estradiol and progesterone in a dual, complex and anatomically heterogeneous 
fashion. 
1.4.4. PROLACTIN AND TESTOSTERONE: MUTUAL NEUROENDOCRINE 
REGULATION 
One of the main outcomes of the present work is the identification of a putative 
regulatory role of testosterone in PRL signalling in the male mouse brain. Long term 
testosterone ablation through orchidectomy led to a significant decrease in pSTAT5-ir 
density in the SFi, the Pa and both the central/dorsomedial and lateral VMH (Fig 1.6). 
This indicates a positive regulatory role of testosterone on PRL signalling in those brain 
regions. The actual mechanism of this positive regulation of testosterone on PRL 
signalling is not clear, but it is not likely related to the control of systemic PRL levels or 
the access of PRL to the brain. First, this effect cannot be attributed to an increased 
release of hypophyseal PRL, since our experimental males were supplemented with 
exogenous PRL. Moreover, testosterone has documented inhibitory effects on 
hypophyseal PRL release in male rats (Gill-Sharma 2009) and mice (O’Hara et al. 2015). 
Therefore, in spite that testosterone appears to inhibit hypophyseal PRL release it 
nevertheless enhances neural responsiveness to PRL in certain brain regions. This effect 
is also not likely explained by a facilitated access of systemic PRL to the brain, as our 
results reveal that the positive effect of castration on pSTAT5-ir is not generalised but 
rather specific and restricted to discrete brain sites. Hence, our findings point to a 
regulation of PRL receptor expression or the modulation of PRL signalling downstream 
the PRL receptor in specific neural populations. Further research is required to elucidate 
the specific action of testosterone on PRL signalling in male mice. 
An additional question of interest is the identity of the actual biological modulator of 
PRL signalling we report here. Testosterone can be locally metabolized into two different 
neuroactive steroids: it can be reduced to dihydrotestosterone (Melcangi et al. 2015), 
which binds to androgen receptors, or aromatised to estradiol (Naftolin et al. 1975) that 
then binds to estrogen receptors. Our results make it very unlikely that this regulation 
occurs through the aromatisation of testosterone to estradiol. Although all the nuclei 
where PRL signalling is affected by castration express at least one form of estrogen 
receptor (Mitra et al. 2003), none of the examined  brain nuclei displays aromatase 
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activity in the male mouse brain (Stanić et al. 2014). Moreover, none of these nuclei is 
affected by estradiol treatment in our ovariectomized, steroid-primed females (Fig 1.4). 
In favour of a direct action of testosterone or of its reduced metabolite, all of the 
examined nuclei express androgen receptors, with the Pa and VMH showing very high 
levels (Stanić et al. 2014). Hence, the effect of testosterone on PRL signalling that we 
report here is likely conveyed through the androgen receptor and involves testosterone 
itself or a derivate androgen, but not estradiol. 
In addition to the reported regulation of testosterone on central PRL signalling, our data, 
together with evidence in the literature, advance a reciprocal regulatory action of PRL 
on the hypothalamus-pituitary-gonadal (HPG) axis and ultimately on testosterone 
release. According to the literature, PRL appears to upregulate the HPG axis and 
testosterone secretion in males. For instance, Bartke et al. (1987) reported increases in 
FSH and LH in hyperprolactinaemic male mice, and Chandrashekar and Bartke (1988) 
observed that exogenous PRL infusions stimulate the increase in serum testosterone in 
male rats, whereas immunological disruption of endogenous prolactin eliminated this 
effect. This regulatory action of PRL on the HPG axis likely occurs through the kisspeptin 
system. Kisspeptin plays an essential role in reproduction, as it regulates gonadotropin-
releasing hormone (GnRH) expressing neurons in the brain (Dungan et al. 2006), which 
constitute the key element of the HPG axis. Therefore, the expression of PRL receptors 
by kisspeptin neurons (Kokay et al. 2011) allows for a direct role of PRL on HPG axis 
control and testosterone secretion. In this context, our results provide support for the 
hypothesis that the brain kisspeptin system is subject to PRL regulation in male mice, 
too, since our sample of male mice displayed substantial pSTAT5-ir in the hypothalamic 
nuclei containing kisspeptin-positive neurons (Semaan et al. 2013), the Arc and the AVPe 
(Figs 1.1a-c, 1.1f, 1.2a and 1.2c). Nevertheless, this possibility requires being 
experimentally proven by assessing the coexpression of kisspeptin and pSTAT5 
immunoreactivity in the aforementioned nuclei. 
Altogether, our results and previously published evidence in mice and rats suggest that 
PRL and testosterone have complex and reciprocal regulatory actions. On the one hand, 
testosterone inhibits hypophyseal PRL release in male mice (O’Hara et al. 2015), but it 
also appears to enhance PRL signalling in some brain nuclei (Fig 1.6). On the other hand, 
PRL might act onto hypothalamic kisspeptin neurons to ultimately stimulate the release 
of testosterone by the testes. 
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1.4.5. CONCLUSIONS 
The study of the actions of PRL in the brain is traditionally biased towards females, 
because of the paramount role of PRL on female reproduction and motherhood. Here, 
we report a comparative study of the patterns of PRL responsiveness in the female and 
male brains. Our findings indicate that adult female and male mice systemically 
supplemented with PRL display sexually dimorphic brain patterns of pSTAT5-ir as a result 
of central PRL-derived signalling. In qualitative terms, female mice display a relatively 
extensive pSTAT5-ir pattern encompassing most nodes of the socio-sexual brain 
network. In contrast, males show a reduced pattern of pSTAT5-ir with scarce labelling in 
the socio-sexual brain circuitry. Additionally, a quantitative analysis of brain nuclei with 
common pSTAT5 expression in both males and females revealed higher pSTAT5-ir 
density in females in most of the analysed nuclei. This indicates that PRL has a sexually 
dimorphic role in the regulation of social behaviours.   
Furthermore, we report novel evidence of the regulatory roles of estradiol and 
progesterone, on the one hand, and testosterone, on the other, in the shaping of the 
central responsiveness to PRL in females and males, respectively. In females, estradiol 
exerts a generalised stimulation of PRL signalling, whereas progesterone displays 
regional differences, acting either synergistically with estradiol, neutrally or antagonizing 
its effect. In males, testosterone exerts a positive regulatory effect on the 
responsiveness to PRL of a number of brain centres, as seen by the significant decrease 
in pSTAT5-ir density in castrated male mice, in comparison to intact males. Despite the 
relatively reduced responsiveness to PRL of the male brain, our findings reflect that PRL 
may play relevant roles in male physiology and behaviour that have been understudied.  
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2.1. RATIONALE AND AIMS 
During pregnancy and lactation, the brain undergoes a series of adaptations, changes in 
the regulation of physiology and behaviour, which allow the female to better face the 
challenges of motherhood. One of the major agents setting up these maternal 
adaptations in the brain is PRL, rightfully termed “the maternal hormone”. In this study, 
we sought to explore the impact of PRL on the female brain during the critical periods of 
pregnancy and lactation. Using the immunohistochemmical detection of pSTAT5 as a 
measure of central lactogenic signalling, we characterised the distribution of pSTAT5-ir 
in the brains of late-pregnant females, lactating dams and virgin, freely-cycling females 
as controls of the basal state. During the second half of pregnancy, evidence suggests 
that hypophyseal PRL expression is impaired and other non-hypophyseal lactogenic 
signals operate instead (Soares et al. 1998b; Soares 2004), e.g. the so-called placental 
lactogens (PLs). These are PRL homologues of placental origin that signal through the 
PRLR (Soares et al. 1998b) and are known to share several of the functions of PRL, for 
example the promotion of maternal behaviours (Bridges et al. 1996). Hence, we also 
aimed at identifying the contribution of non-hypophyseal lactogenic sources like PLs to 
the modulation of brain function during the period of late pregnancy. To do so, we 
included an additional group of late-pregnant females in the analysis, where 
hypophyseal PRL release was pharmacologically depressed by means of bromocriptine 
(see section 2.2.3). 
2.2. MATERIAL AND METHODS 
2.2.1. ANIMALS 
For the present study, a total of n= 32 adult female CD1 mice (Charles River 
Laboratories, France) were used, aging between 8-12 weeks. Animals were housed in 
polypropylene plastic cages (145mm wide, 465 mm long and 215 mm high; Panlab), in 
groups of 4 to 6 animals, with ad libitum access to food and water and under controlled 
temperature (24 ± 2 ºC) and lighting conditions (12h:12h; lights ON at 8 am). Animals 
were treated throughout according to the European Union Council Directive of June 3rd, 
2010 (6106/1/10 REV1) and procedures were approved by the Committee of Ethics on 
Animal Experimentation of the University of Valencia, where the experiments were 
performed. 
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2.2.2. EXPERIMENTAL DESIGN 
For this experiment, n=27 animals were randomly assigned to a total of 4 groups: (1) 
Virgins (n=7); (2) late-pregnant females (n=6); (3) bromocriptine-treated, late-pregnant 
females (n=8), and (4) lactating dams (n=6). In order to obtain a more natural image, 
albeit more variable, of the appearance of PRL signalling in the virgin female brain, for 
the Virgin group we chose to use freely-cycling virgin females, where neither gonadal 
steroid levels were controlled experimentally nor estrous cycle was restricted to a 
particular phase. Regarding groups 2, 3 and 4, mating was ensured by pairing these 
females with a stud male for a period of 4 days (the mean length of a full estrous cycle), 
counting the first day as pregnancy day 1 (PD1). Following impregnation, females were 
housed in pairs until the day of perfusion. Females of Late-pregnant (2) and 
Bromocriptine late-pregnant (3) groups were perfused on presumed pregnancy day (PD) 
18, but the exact pregnancy day (PD14-18) was assessed post-mortem evaluating the 
developmental stage of the respective foetuses through anatomical signs such as the 
differentiation of the eyelids, tongue, whiskers or fingers. References for this evaluation 
can be found at www.emouseatlas.org. In addition, late-pregnant females of group 3 
underwent a pharmacological treatment with bromocriptine that abolished virtually any 
release of hypophyseal PRL (for further details, see section 2.2.3). Females of Lactating 
group (4) were perfused on postpartum day (PPD) 6. After perfusion of the experimental 
females, brain tissue was collected and processed for pSTAT5 immunohistochemistry 
(section 2.2.4), and the resulting immunoreactivity patterns analysed qualitatively and 
quantitatively (section 2.2.5). 
2.2.3. PHARMACOLOGICAL INHIBITION OF HYPOPHYSEAL PROLACTIN 
Bromocriptine is a dopamine D2 receptor agonist that selectively targets pituitary 
lactotrophs, emulating the dopaminergic inhibition exerted by the Tuberoinfindibular 
(TIDA) and Periventricular-hypohyseal (PHDA) Dopaminergic neurons upon hypophyseal 
PRL release (see section I.3 and Fig I.3). Consequently, bromocriptine treatment leads to 
the virtual inhibition of hypophyseal PRL discharge. Treatment for Bromocriptine group 
(3) consisted in two sequential subcutaneous (s.c.) injections of 100 µg of bromocriptine 
(2-Bromo-α-ergocriptine, Sigma-Aldrich, St. Louis, USA) diluted in 10% ethanol, 19 and 2 
hours prior to perfusion (Sjoeholm et al. 2011). This resulted in an approximate dose of 
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2 mg/kg of body weight per injection. A similar bromocriptine treatment schedule 
drastically decreased pSTAT5-ir in the brain of a sample (n=5) of freely cycling virgin 
female mice (Table 2.1), leaving only some faint, residual labelling. This bromocriptine 
treatment produced a mean 90.34 % reduction in the analysed brain nuclei. This 
demonstrates an effective inhibition of hypophyseal release of PRL by the bromocriptine 
treatment we have applied. 
Mean pSTAT5-ir 
density 
VIRGIN (n=7) VIRGIN + BRC (n=5) REDUCTION (%) 
AC/ADP 189.44 14.56 92.31 
Arc 4223.72 260.87 93.82 
AVPe 4349.54 343.75 92.10 
BSTMPM 1042.86 42.19 95.96 
CeM 425.00 0 100 
LSV 225.54 21.40 90.51 
MePD 250.57 30.70 87.75 
MPO 433.57 88.19 79.66 
Pa 323.02 73.98 77.10 
PIL 157.82 0 100 
VLPAG 468.04 89.04 80.98 
VMHvl 1262.63 77.38 93.87 
                Mean reduction percentage 90.34 
 
Table 2.1 Bromocriptine drastically reduces brain pSTAT5-ir density on virgin female 
mice 
Two s.c. 100 µg bromocriptine injections, 19 and two hours prior to perfusion, produced 
reductions of pSTAT5-ir in the analysed nuclei of the virgin female mouse brain ranging from 
77.10% to 100%, with a mean reduction of 90.34 %.   
2.2.4. TISSUE COLLECTION, HISTOLOGICAL PROCESSING AND pSTAT5 
IMMUNOHISTOCHEMISTRY 
Animals were perfused transcardially under sodium pentobarbital anaesthesia (Dolethal; 
Vetoquinol, Madrid, Spain). Then, brain tissue was extracted and processed for 
immunohistochemistry. For a complete description of this process, see Section 1.2.5. As 
for the immunohistochemmical detection of pSTAT5, we applied the same protocol 
described in section 1.2.6. Briefly, tissue underwent the following steps: (a) an antigen 
retrieval step under 0.01 M TRIS buffer (TB), pH 10 at 85oC; (b) an endogenous 
peroxidase inhibition under 1% hydrogen peroxide in TB-saline (TBS); (c) a one hour 
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blockade of unspecific labelling under 2% BSA, 2% goat serum and 0.3% Triton X-100 in 
TBS; (d) a 72 hour incubation in primary antibody (Rabbit anti-pSTAT5 pSTAT5 Tyr694; 
Cell Signalling Technology, Beverly, MA) diluted 1:500 in 0.1% Triton X-100 TBS; (e) a 90 
minute incubation in secondary antibody (biotinylated goat anti-rabbit IgG , Vector 
Laboratories, Peterborough, UK) 1:200 in TBS and (f) a 90 minute incubation in avidin-
biotin-peroxidase complex (ABC Elite kit; Vector Laboratories) in TBS. A permanent, 
brown nuclear staining was obtained through development with 0.005% 3-3’-, 
diaminobenzidine (Sigma). Finally, sections were mounted onto gelatinized slides, 
dehydrated in alcohols, cleared with xylene and coverslipped with Entellan. 
2.2.5. ANALYSIS OF pSTAT5 IMMUNOREACTIVITY 
Both the qualitative and quantitative assessments of pSTAT5-ir in this study were 
conducted following the same methodology as previously described (section 1.2.7). For 
the qualitative mapping of the corresponding patterns of pSTAT5-ir distribution in 
freely-cycling virgins, late-pregnant females and lactating dams, we registered the 
presence or absence of pSTAT5-ir in every single brain site for each specimen. For the 
quantitative assessment of the levels of PRL signalling, we analysed the density of cells 
showing pSTAT5 immunoreactivity (pSTAT5-ir) in a selection of 13 nuclei belonging to 
the socio-sexual brain and/or involved in the regulation of maternal behaviours. After 
designing the respective counting frames and obtaining the matching 
photomicrographs, we conducted the same image analysis in the Image J software as 
described in our previous study (section 1.2.7). Finally, we calculated the mean 
(interhemispheric) density of pSTAT5-imunoreactive cell nuclei for each specimen by 
dividing the mean value of these counts for both hemispheres by the area of the 
respective frame. 
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Figure 2.1 Appearance of pSTAT5 immunoreactivity in the brains of late-pregnant, 
lactating and virgin female mice 
Photomicrographs showing the pattern of pSTAT5 immunoreactivity of the BST-MPA region in 
a) a postconception day 14-pregnant female; b) a day 14 pregnant-female treated with 
bromocriptine; c) a postpartum day 6 lactating dam and three different virgin females with 
different staining density (d-f). Immunohistochemistry for pSTAT5 resulted in a specific nuclear 
labelling (arrows on inset a’). The pattern of pSTAT5-ir was constant among late-pregnant and 
lactating females (a-c), with a high number of tightly packed immunostained cells in the BST-
MPA continuum. Conversely, the pattern of pSTAT5 immunostaining in virgin females showed a 
remarkable inter-individual quantitative variability, ranging from barely no staining (d), a 
moderate staining density (e), to an exceptionally high density similar to that in late-pregnant 
females and dams (f). Every section is approximately 0.25 mm posterior to Bregma. Scale bars: 
250 µm; 50 µm (inset). 
2.2.6. STATISTICAL ANALYSIS 
Statistical analysis was conducted using IBM SPSS Statistics 22 software package. After 
checking for normality (Kolmogorov-Smirnov test with Lilliefors’ correction) and 
homogeneity of variance (Levene's test), we performed a separate one-way ANOVA test 
on each of the analysed brain regions to assess inter-group differences (Virgin, Late-
pregnant and Lactating groups) on the mean pSTAT5-ir density. We performed an 
additional set of one-way ANOVAs for the respective brain regions comparing the Late-
pregnant and Bromocriptine groups, in search of significant differences attributed to 
bromocriptine treatment. Statistically significant differences (p≤0.05) were further 
explored by means of post-hoc pairwise comparisons with Bonferroni’s correction. 
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2.3. RESULTS 
2.3.1. DISTRIBUTION OF pSTAT5 IMMUNOREACTIVITY IN THE BRAINS OF 
VIRGIN, PREGNANT AND LACTATING MICE 
As stated in the previous study, immunohistochemistry for pSTAT5 produced a specific 
and discrete immunoreactivity restricted to the cell nucleus. We found apparent 
differences in the patterns of pSTAT5-ir between late-pregnant and lactating females, on 
the one hand, and virgin females, on the other. Whereas pregnant and lactating females 
showed a homogenous pattern of pSTAT5-ir distribution with minor inter-individual 
qualitative differences, virgin females displayed a variable degree of immunolabelling. In 
this section, we focus on describing the pattern of pSTAT-5-ir in the brain of 
pregnant/lactating females. Then, we briefly describe the variable immunostaining 
observed in virgin females (Fig 2.1), which in general terms matches the previous 
mapping conducted in ovariectomized, steroid-primed virgin female mice (see Study 1). 
A Immunoreactivity for pSTAT5 in the brain of pregnant/lactating female 
mice 
A close analysis of the immunoreactivity for pSTAT5 in these females indicates no 
apparent qualitative differences between both groups, with very few exceptions (see 
below). Therefore, we first describe the common pattern of distribution of pSTAT5-ir in 
both experimental groups under the common pattern shared by late-pregnant and 
lactating females. 
Importantly, the choroid plexus showed some degree of immunostaining in every 
animal, regardless of physiological state (not shown). In addition, in pregnant/lactating 
females, quite abundant cell labelling was present in the cerebral hemispheres (septum, 
amygdala, extended amygdala and, to a lesser extent, cortex), diencephalon (mainly in 
the hypothalamus but also in some thalamic and pretectal nuclei), midbrain 
(periaqueductal grey and laterodorsal tegmentum) and hindbrain. 
Telencephalon 
Immunolabeling for pSTAT5 in this major brain division was present mainly in subpallial 
structures, but appeared also in a small number of pallial areas. Within the pallial 
telencephalon, neither the neocortical region nor the hippocampal formation showed 
pSTAT5-ir. As for the olfactory cortical areas, the olfactory bulbs were also devoid of 
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pSTAT5-ir, whereas immunolabelled cells were present in the dorsal taenia tecta (DTT, 
Fig 2.2a). Furthermore, several nuclei in the cortical amygdala contained pSTAT5-ir, 
namely the nucleus of the lateral olfactory tract (LOT, Fig 2.2e), the anterior cortical 
amygdaloid nucleus (ACo, Figs 2.2e and f), the basomedial amygdaloid nucleus (BMA 
and BMP, Figs 2.2g and h), the ventral basolateral amygdaloid nucleus (BLV, Fig 2.2f) and 
the amygdalohippocampal area (AHi, Fig 2.2h). It is noteworthy that the pallial 
telencephalon is one of the few brain sites where the pSTAT5-ir pattern of our pregnant 
and lactating females showed a certain degree of variability. This variability affects 
mainly the piriform cortex (Pir), where pSTAT5 immunoreactivity was observed in just 
one animal (a bromocriptine-treated pregnant female; see Fig 2.2d) and the cortical 
amygdala. Here, inter-individual variability did not correlate with the physiological status 
of our experimental groups, as it was observed across untreated pregnant, 
bromocriptine-treated pregnant and lactating females. Hence, 7 out of 18 animals 
displayed pSTAT5-ir in the ACo, 6 in the LOT, 7 in the BLV and only 3 animals in the BMP 
and AHi. In all these cases, immunoreactive cell bodies were sparse and faintly stained. 
By contrast, the BMA showed pSTAT5-ir in all the animals. 
In the subpallial telencephalon, pSTAT5-ir was abundant in the septum, the extended 
amygdala (EA) and the anterodorsal amygdaloid area (AAD). Within the EA, both the 
central and medial EA displayed immunolabelling. Thus, pSTAT5 was present in the 
medial and central nuclei of the amygdala, in different subnuclei of the bed nucleus of 
the stria terminalis (BST), as well as in the sublenticular substantia innominata (SI, Fig 
2.4a) and the interstitial nucleus of the posterior limb of the anterior commissure (IPAC, 
Figs 2.2c-e).  
The medial extended amygdala (MEA) displayed pSTAT5-ir in all of its nuclei. Within the 
amygdala proper, pSTAT5-ir was moderately dense in the anterior (MeA, Fig 2.3b), 
posteroventral (MePV, Fig 2.3c) and, especially, the posterodorsal (MePD, Fig 2.3c) 
nuclei of the medial amygdala, as well as in the intramygdaloid division of the BST 
(BSTIA, Fig 2.3c). In addition, a high density of immunolabelled cells was observed in the 
medial (BSTMPM), lateral (BSTMPL) and (with a lower density) intermediate (BSTMPI) 
nuclei of the posteromedial BST (Figs 2.1 a-c and 2.2d).  
As for the central extended amygdala (CEA), within the central amygdaloid nucleus, 
pSTAT5-ir was almost restricted to the medial division of the Ce (CeM, Figs 2.3b and 
2.3c), although a small number of cells also appeared in the lateral Ce (CeL, Fig 2.3c). 
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Within the BST, most of the nuclei in the anterior and lateral BST displayed abundant 
labelling: the medial anterior (BSTMA, Fig 2.3a), medial ventral (BSTMV, Fig 2.3g) and 
lateral nuclei of the BST (ventral BSTL, posterior BSTL, dorsal BSTL, Figs 2.2c and d), with 
the exception of the juxtacapsular nucleus (BSTLJ, Fig 2.2c).  
Within the basal cerebral hemispheres, we observed pSTAT5-ir cells in a portion of the 
ventral striato-pallidum located between the diagonal band nucleus and the shell of the 
nucleus accumbens, named as medioventral striato-pallidum (Otero-Garcia et al. 2014)  
because of its relationship with structures of the ventral striatum and pallidum, or 
ventral septal area (Rood and De Vries 2011), given its apparent continuity with the 
lateral septum (see Fig 2.2b).   
In the septum, we found pSTAT5-ir within the different nuclei of its lateral division (LSV, 
LSI, and LSD, Fig 2.2b and 2.3a) and in the septo-hypothalamic nucleus (SHy, not shown). 
Some structures in the medial and posterior septal regions contained pSTAT5-ir, too, 
such as the septohipocampal (SHi, Fig 2.2b) and septofimbrial (SFi, Fig 2.3a) nuclei and 
the bed nucleus of the anterior commissure (BAC, Fig 2.2d). Finally, pSTAT5 
immunostaining was found in the subfornical organ (SFO, Fig 2.2d).    
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Figure 2.2 Distribution of pSTAT5 immunoreactivity in the brains of late-pregnant, 
lactating and virgin female mice 
Semi-schematic camera-lucida drawings of coronal sections through the brain of a 
postconception day 14-pregnant female (specimen M1392) treated with bromocriptine before 
perfusion (see text).  Each red dot represents 3-4 immunoreactive cells. Since the distribution and 
density of immunostained cells was similar in other late-pregnant and lactating females, this figure 
illustrates the canonical pattern of pSTAT5-ir in the brain of both groups of females. The 
background colours in the sections encode a frequency score for the presence of pSTAT5 
immunostained cells in the brain of virgin females: no pSTAT5-ir in any virgin female (white); 
pSTAT5-ir in 1 to 2 specimens (blue); pSTAT5 in 3 to 5 specimens (pink); pSTAT5-ir in 6 to 7 
animals (orange). Approximate distance to Bregma is indicated for each section.  
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Diencephalon 
Immunoreactivity for pSTAT5 was abundant in many structures of the diencephalon of 
late pregnant and lactating females, including hypothalamic, thalamic and pretectal 
nuclei. Apparent pSTAT5-ir was observed in the four major rostro-caudal divisions of the 
hypothalamus, as well as in the three medio-lateral compartments (periventricular, 
medial and lateral). Figure 2.4 illustrates the appearance of the pSTAT5-ir pattern in 
representative examples of the aforementioned sites. 
The preoptic region (Fig 2.1, Fig 2.4a) displayed high levels of pSTAT5 expression in the 
structures surrounding the third ventricle, namely in the anteroventral periventricular 
(AVPe), ventromedial preoptic (VMPO) and median preoptic (MnPO) nuclei, as well as 
the periventricular nucleus (Pe) and the vascular organ of the lamina terminalis (VOLT, 
not shown). The medial region of the preoptic hypothalamus displayed widespread 
pSTAT-ir, too. Labelling was present in the medial preoptic area (MPA) and in every 
division of the medial preoptic nucleus (MPO, Figs 2.1a-c), as well as in dorsal preoptic 
structures such as the nucleus of the anterior commissure (AC, Figs 2.1a-c) or the 
anterodorsal preoptic nucleus (ADP). Finally, within the lateral compartment, the bed 
nucleus of the stria medullaris (SM, not shown), the lateral preoptic (LPO) and the 
ventrolateral preoptic (VLPO, not shown) areas displayed scattered pSTAT5 positive 
cells. 
In the anterior hypothalamus (Figs 3.2e-f and 2.4b), the most outstanding pSTAT5-ir cell 
groups corresponded to the paraventricular (Pa) and supraoptic nuclei (SO, including its 
retrochiasmatic region, SOR), with a high density of immunostained neurons. Within the 
Pa complex, labelled cells were observed not only in its magnocellular division (medial, 
PaMM; lateral, PaLM), but also in the remaining subnuclei, PaAP, PaDC (not shown), PaV 
(Fig 2.2e) and PaPo, (Fig 2.2f). Other nuclei containing magnocellular neurosecretory 
neurons, such as the suprachasmatic nucleus, were remarkably devoid of pSTAT5 
immunostaining. Additional sparser populations of pSTAT5-positive cells were present in 
the subparaventricular nucleus (SPa) and Pe within the juxtaventricular compartment, 
through the anterior hypothalamic area (AHA, AHC and AHP, Fig. 2.2e-f), lateroanterior 
(LA, Fig 2.2e) and circular (Cir, Fig 2.2e) nuclei of the medial compartment, and in the 
lateral hypothalamic area (LH). 
In the tuberal hypothalamus (Fig 2.4c), the highest density of pSTAT5-ir cells was 
observed in the arcuate nucleus (Arc), presumably including the TIDA neurons (Yip et al. 
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2012). Remarkably, a few cells extended from this cluster into the median eminence 
(ME, Fig 2.2g). In the medial compartment, dense groups of labelled cells were observed 
in the dorsomedial (DM) and the ventromedial nuclei (VMH). Within the VMH, the 
highest levels of pSTAT5-ir corresponded to the ventrolateral subdivision (VMHvl), while 
the central (VMHc) and dorsomedial VMH subnuclei (VMHdm) showed only scattered 
and faintly stained cells (Fig 2.4c). Interestingly, the cluster of immunostained nuclei in 
the VMHvl is not confined to the boundaries of the VMH but extends further laterally 
into the ventromedial aspect of the lateral hypothalamic area (see Fig 2.4c). The rest of 
the LH displayed a moderate-to-low density and intensity of immunolabeling. Other 
centres showing pSTAT5-ir in the tuberal hypothalamus include the subincertal (SubI, Fig 
2.2g), perifornical (PeF) and the medial tuberal (MTu) nuclei, as well as the 
magnocellular (MCLH) and parasubthalamic (PSTh, Fig 2.4e) divisions of the lateral 
hypothalamic area. 
In the premammillary hypothalamus (Fig 2.4e), a dense population of pSTAT5-ir cells 
was observed in the ventral premammillary nucleus (PMV). In the dorsal premammillary 
nucleus (PMD), pSTAT5-ir was absent in lactating females and present only in half of the 
animals in the pregnant groups. Finally, the medial supramammillary nucleus (SuMM), 
the submammillothalamic nucleus (SMT) and the posterior hypothalamic area (PH, Figs 
2.2h and 2.4e) displayed scattered immunostaining.  
Immunoreactivity for pSTAT5 was observed in several of the nuclear groups of the 
thalamus. Labelling was present in the ventral thalamus, in some nuclei of the midline 
dorsal thalamus and habenular complex, in several visual and auditory thalamic nuclei 
and in the posterior-intralaminar thalamic complex.  
In the prethalamus, labelling was present in the zona incerta (ZI, Figs 2.2f-h) and the 
reticular thalamic nucleus (Rt, Figs 2.2e and f). The Rt showed a variable staining 
frequency in our sample: labelling was only observed in approximately 50% of the late-
pregnant females examined, in which staining was relatively weak and sparse as 
compared to other regions of the brain.  
In the midline thalamus, a few cells were visible in the ventral reuniens nucleus (VRe, Fig 
2.2g) and a larger population of pSTAT5 immunoreactive cells was seen in the 
paraventricular nucleus (PV, Fig 2.2g). Next to the PV, some pSTAT5-ir cells were found 
within the caudalmost levels of the habenular complex, which represents a notable 
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exception to the generally stable pattern of pSTAT5-ir. First, staining in the medial 
(MHb) and lateral (LHb) habenula was not present in lactating females (where the 
habenular complex is completely blank), but only in some pregnant females, either 
untreated or treated with bromocriptine. In these animals, labelling in the habenula was 
variable and heterogenous: the MHb appeared only occasionally stained, whereas the 
LHb was labelled in 50% of the animals (see Fig 2.4d for a case where both subdivisions 
are positively labelled and Fig 2.2g for a different case). 
Several nuclei of the visual thalamus displayed pSTAT5 immunolabelling. Within the 
lateral geniculate complex, labelled cells were seen especially in the intergeniculate 
leaflet (IGL, Fig 2.2h), but also in the ventral geniculate nucleus (VLG), almost restricted 
to its parvocellular subdivision (VLGPC, Fig 2.2h). Furthermore, it is noteworthy that a 
small number of immunolabelled cells was found in an unnamed location near to the 
dorsal division of the medial geniculate nucleus (Fig 2.2i). 
However, the largest populations of immunostained cells appeared in several nuclei of 
the posterior thalamus, including the lateral posterior (LP, Fig 2.2h), parafascicular (PF) 
and subparafascicular (SPF, with its parvocellular part, SPFPC) nuclei (Fig 2.2h), the 
retroethmoid nucleus (REth, not shown), the prerubral field (PR, Fig 2.2h), the posterior 
intralaminar complex (PIL) and the triangular part of the posterior thalamus (PoT). These 
last two nuclei (PIL and PoT) form a dense and remarkable population of 
immunolabelled cells in the posterior thalamus, in which a few cells seem to be 
displaced caudoventrally into an unnamed area just dorsal to the substantia nigra pars 
compacta (see Figs 2.2i and 2.4f). 
The pretectum comprises the limit between the thalamus and the midbrain (Martinez-
Ferre and Martinez 2012). There, structures immunolabelled for pSTAT5 included the 
posterior (PPT) and olivary (OPT) pretectal nuclei (both immunostained in half of the 
pregnant and lactating animals, see Fig. 2.2h), the precommissural nucleus (PrC, not 
shown), flanking the posterior commissure and the nucleus of the posterior commissure 
(PCom), including its magnocellular division (MCPC). Exceptionally, the subcommissural 
organ (SCO, Fig 2.2h), unlike the rest of the reviewed circumventricular organs, 
appeared devoid of pSTAT5 immunoreactivity.  
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Figure 2.3 Representative examples of pSTAT5 immunoreactivity brain of late-pregnant 
and lactating female mice I 
Photomicrographs showing the pSTAT5-ir pattern in representative telencephalic, midbrain and 
brainstem regions of pregnant and lactating mice. Sections include the lateral septum and anterior 
BST (a); the central anterior amygdala (b), the central and medial posterior amygdala (c); the 
periaqueductal grey (d); the parabrachial complex (e) and the nucleus of the solitary tract and 
surrounding structures (f). Sections b and f correspond to a postconception day 14 pregnant 
female (specimen M1435), sections a and d to a bromocriptine-treated, day 14 pregnant female 
(specimen M1392) and sections c and f to a postpartum day 6 lactating dam (specimen M13111). 
The approximate distance to Bregma is indicated in each section. Scale bars: 250 µm. 
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Figure 2.4 Representative examples of pSTAT5 immunoreactivity in the brain of late-
pregnant and lactating female mice II 
Photomicrographs showing the pSTAT5-ir pattern in representative diencephalic regions of 
pregnant and lactating mice. Sections include the preoptic hypothalamus (a), the paraventricular 
and supraoptic nuclei in the anterior hypothalamus (b), the arcuate and ventromedial nuclei in the 
tuberal hypothalamus (c), the habenular complex of the thalamus (d), the premammillary 
hypothalamic region (e) and the posterior thalamic region (f). Sections a and b correspond to a 
postconception day 14-pregnant female (specimen M1435), sections c and d to a bromocriptine-
treated, day 15-pregnant female (specimen M1392) and sections e and f to a postpartum day 6 
lactating dam (specimen M13111).The approximate distance to Bregma is indicated in each 
section. Scale bars: 250 µm.  
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Midbrain and brainstem 
In the midbrain, lactotroph-derived signal transduction was observed mainly in the 
periaqueductal grey (PAG), but also in the adjoining lateral tegmentum and, further 
dorsally, in the superior colliculus (see Fig 2.3d). The PAG displayed a heterogeneous 
pSTAT5-ir. The most prominent labelling corresponded to the lateral PAG (LPAG). 
Secondly, the ventrolateral (LPAG) and dorsomedial (DMPAG) columns showed 
moderate immunoreactive cells. Finally, the dorsolateral PAG (DLPAG) displayed sparse 
immunoreactive cells. The Edinger-Westphal nucleus (EW, Fig 2.2i), embedded between 
the LPAG and the oculomotor nuclei, was also positively labelled for pSTAT5, as were the 
nucleus of Darkschewitsch (Dk) and the interstitial nucleus of Cajal (InC) (both located 
lateral to the anterior periaqueductal grey, PAG, see Fig 2.2i). 
Dorsal to the PAG, some immunostained cells appeared in the deep (DpG and DpWh, 
the latter seen in Fig 2.3d) and intermediate (InG and InWh, Fig 2.2i) layers of the 
superior colliculus and in the intercollicular nucleus (InCO, Fig 2.4d). Within the 
tegmentum, pSTAT5-it was present in the deep mesencephalic area (DpMe, Fig 2.3d), 
the nucleus of the brachium of the inferior colliculus (BIC, Fig 2.2j) and the 
interpeduncular nucleus (IP, Fig 2.2i).  
In the rhombencephalon, pSTAT5-ir was remarkably absent in the cortex and deep 
nuclei of the cerebellum. By contrast, the pons showed a complex pattern of pSTAT5-ir. 
In the pontine tegmental region, pSTAT5-immunoreactive cells appeared in the 
pedunculopontine tegmental nucleus (PPTg, Fig 2.2j), the dorsomedial tegmental 
nucleus (DMTg, Fig 2.2k), the laterodorsal tegmental nucleus (LDTg, Fig 2.3e) and in 
Barrington´s nucleus (Bar, Fig 2.3e), which displayed a small number of weakly stained 
cells. Scattered immunostained neurons appeared in the oral (PnO, Fig 2.2j) and caudal 
parts (PnC, Fig 2.2k) of the pontine reticular formation. Furthermore, the locus coeruleus 
(LC) and the parabrachial complex (PB) displayed relatively abundant immunostaining 
(Fig 2.3e). Within the parabrachial complex, the highest labelling density was seen in the 
central (LPBC) and external (LPBE) parts of the lateral parabrachial nucleus (LPB), with 
the rest of this nucleus (LPB) and the medial parabrachial nucleus (MPB) containing a 
lower density of immunoreactive cells.  
The raphe nuclear complex displayed ample pSTAT5-ir. At rostral levels, the median 
(MnR), dorsal (DR) and the caudal linear (CLi) nuclei of the raphe were positively stained 
for pSTAT5 (Fig 2.2j). Caudally, pSTAT5-ir was still observed in the DR, in the pontine 
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nucleus (PnR, Fig 2.2k) and in the raphe magnus (RMg, Fig 2.2k). Finally, the raphe 
obscurus (ROb) in the caudalmost region of the hindbrain (Fig 2.2l) also displayed 
pSTAT5 immunostained cells. 
As for the reticular nuclei, pSTAT5-ir appears in the the subcoerulear nucleus, ventral 
and dorsal divisions (SubCV and SubCD, respectively, the latter seen in Fig 2.3e). More 
caudally, sparse immunoreactive cells appear in the dorsal and ventral medullary (MdD, 
MdV, the latter seen in Fig 2.3f) and intermediate (IRt) reticular nuclei, in the ambiguus 
nucleus (Amb) and, laterally, along the spinal trigeminal nucleus (SP5), in close contact 
with the spinal trigeminal tract (see Fig 2.2l). Finally, like other circumventricular sites, 
the area postrema (AP) and the adjoining nuclei, i.e. nucleus of the solitary tract (Sol) 
and dorsal motor nucleus of the vagus (10N), showed prominent pSTAT5-ir, as seen in 
Figure 2.3f. 
B Immunoreactivity for pSTAT5 in the brain of freely-cycling virgin female 
mice 
As a rule, virgin females showed less labelling than pregnant and lactating ones. In fact, 
the patterns of pSTAT5-ir observed in virgin females were always a fraction of the one 
described for pregnant/lactating females, so that no brain centre was labelled for 
pSTAT5 in virgins but not in pregnant/lactating females. However, virgin females showed 
a substantial inter-individual variability in the presence of pSTAT5 immunolabelled cells 
in several brain regions. This variability contrasts with the homogenous patterns 
previously described for pregnant/lactating females, and even for ovariectomized, 
steroid-primed virgins (Study 1). We have illustrated this variability by establishing a 
frequency score for each brain site, according to the proportion of virgin females of our 
sample (n=7) showing pSTAT5 immunoreactive cells in that site. This score is color-coded 
in Figure 2.2 and comprises four categories: no labelling in any virgin female (clear 
background), low frequency of pSTAT5-ir (1-2 animals, blue background); c) 
intermediate frequency of pSTAT5-ir (3-5 animals, pink background); d) high frequency 
of pSTAT5-ir (6-7 animals; orange). We also provide an additional example of the 
qualitative differences in pSTAT5-ir that our female sample displayed in the BST-MPA 
region (Fig. 2.1).  
According to our results, only two nuclei in the whole brain showed labelling 
consistently in every virgin female of our sample: the Arc (Figs 2.4c and c’) and the 
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MePD (Figs 2.4e and e’). Three more brain centres displayed pSTAT5-ir in most animals, 
namely the LSV (Figs 2.4d and d’), the ventrolateral VMH (Fig 2.4c and c’) and the rostral 
and ventrolateral PAG (Figs 2.4f and f’). By contrast, the majority of the analysed nuclei 
showed labelling in 3-5 of the 7 animals. Finally, some brain regions labelled in 
pregnant/lactating groups were totally devoid of pSTAT5-ir in the whole sample of virgin 
females. These include portions of the allocortex (DTT; EnD), and specific nuclei of the 
amygdala (AAD-AAV; LOT; BLV), basal telencephalon (BAC), thalamus or pretectum (Rt; 
LHb; PPT; LP; PF) and dorsal and pontine tegmental nuclei (Bar; LDTg; DMTg and RMg). 
This pattern matches in general terms the distribution of pSAT5-ir in ovariectomized, 
steroid-primed virgin females (Study 1). Even though the variability of the current 
sample is higher, those brain nuclei more intensely and more consistently labelled (the 
Arc; MePD; LSV or the LPAG) coincide with those nuclei that showed more abundant 
labelling among ovariectomized, steroid-primed virgins.  
2.3.2. QUANTITATIVE ANALYSIS OF pSTAT5 IMMUNOREACTIVITY IN SELETED 
BRAIN NUCLEI OF VIRGN, PREGNANT AND LACTATING MICE 
We assessed the density of pSTAT5 immunoreactive cell nuclei in 13 brain regions 
chosen according to their relevance in the context of maternal behaviour regulation. 
These regions comprise several nodes of the sociosexual brain: the LSV, the MePD, 
BSTMPM, AC/ADP, MPO, VMHvl and adjoining tuberal region (hypothalamic aggression 
locus) and LPAG (Newman 1999). We also included the magnocellular neurosecretory 
nuclei (Pa and SO) and other sites that are also involved in the regulation of maternal 
behaviours (CeM, AVPe and PIL; Bosch and Neumann 2010; Scott et al. 2015) or related 
aspects of motherhood (Cservenák et al. 2013), despite not being part of the sociosexual 
brain network. Finally, we also analysed the Arc, given its role in the feedback control of 
hypophyseal PRL release (Ben-Jonathan and Hnasko 2001a; Sapsford et al. 2012). The 
exact frames applied for each of these nuclei are depicted in Figure 2.5. 
To explore the variation of pSTAT5-ir density between virgin, pregnant and lactating 
groups, we performed a separate one-way ANOVA on each of the sampled nuclei. The 
results of this analysis are summarized in Figure 2.6 and reveal statistically significant 
inter-group differences in pSTAT5-ir density in most of these brain regions. The main 
effects revealed by ANOVA were further explored using post hoc Bonferroni multiple 
comparisons. The results of this post hoc analysis indicate that virgins generally showed 
significantly less pSTAT5-ir density than one or more of the remaining groups.  
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The ANOVA of the density of pSTAT5-ir revealed significant differences between groups 
within the nuclei of the extended amygdala, namely the CeM (F2,15=22.071, p<0.001), 
MePD (F2,15=8.016, p=0.004), and BSTMPM (F2,15=6.243, p=0.012) and in the septal 
region (LSV;  F2,15=5.219, p=0.019) (Fig 2.6a). Post-hoc comparisons indicate that, in the 
CeM, pSTAT5-ir density was significantly higher in pregnant than in virgin females 
(p<0.001) or lactating dams (p=0.001). On the other hand, the density of 
immunoreactive cells in lactating dams was similar to that of virgins (p=0.174). 
Concerning the MePD, labelling density was significantly higher in pregnant females 
than in virgin females (p=0.005) and in lactating dams compared to virgin females 
(p=0.037), whereas both pregnant females and lactating dams displayed very similar 
labelling density (p=0.949). Regarding the BSTMPM, labelling density in pregnant 
females was significantly higher than in virgins (p=0.012), but similar to that of lactating 
dams (p=0.836). On the other hand, although the average density of pSTAT5 
immunoreactive cells was higher in dams than in virgin females, this difference did not 
reach significance (p=0.091). Finally, the LSV showed a significant increase in pSTAT5-ir 
density in the brain of pregnant females as compared to that of virgin females (p=0.027), 
but pregnant and lactating females showed identical levels (p=1), whereas the apparent 
differences between virgin and lactating groups were not significant (p=0.093). 
In the preoptic hypothalamus (Fig 2.6b), significant differences in labelling density were 
observed in the AC/ADP (F2,15=5.141, p=0.020) and MPO (F2,15=8.345, p=0.004), but not 
in the AVPe (F2,15=0.522; p=0.605). In the AC/ADP, post-hoc comparisons indicate that 
virgin females had significantly lower pSTAT5-ir density than lactating dams (p=0.035), 
as well as a trend to lower pSTAT5-ir than pregnant females (p=0.067). By contrast, 
pregnant and lactating dams showed identical density of immunolabelled cells (p=1). For 
the MPO, one of the key nodes of the maternal brain, lactating dams showed 
significantly higher pSTAT5-ir density than virgin females (p=0.003), whereas the rest of 
the comparisons did not reach significance (p≈0.25 for both comparisons).  
In the anterior hypothalamus (Fig 2.6b), the paraventricular (F2,15=10.099, p=0.002) and 
supraoptic nuclei (F2,15=52.827, p<0.001) showed significant inter-group differences. In 
the Pa, both pregnant and lactating groups showed similar densities of pSTAT5-ir 
(p=0.715), which are significantly higher than in virgin females (p=0.002 and p=0.02, 
respectively).  
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Figure 2.5 Anatomical location of pSTAT5-ir counting frames 
Semi-schematic camera lucida drawings of selected coronal sections featuring the counting 
frames (red) chosen for the quantitative assessment of pSTAT5-ir: a) LSV; b) AVPe; c) 
BSTMPM; d) AC/ADP; e) MPO; f) SO; g) Pa; h) CeM; i) VMHvl and ventrolateral adjoining 
area; j) Arc; k) MePD; l) PIL and adjoining posterior thalamic region; m) VLPAG. Approximate 
distance to Bregma enclosed in each section. Scale bars: 500 µm.  
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Figure 2.6 Quantification of pSTAT5-ir density in selected brain regions of virgin, late-
pregnant and lactating female mice 
Assessment of pSTAT5-ir density (pSTAT5-positive cell nuclei / mm2) in 13 brain regions of 
relevance in the context of maternal behaviours (Newman 1999; Gammie 2005). Bar histograms 
show mean interhemisferic pSTAT5-ir density ± SEM in virgin female mice (n=7; green); PD 14-
18 late-pregnant mice (n= 5; yellow) and PPD6 lactating dams (n=6; orange). Statistical analysis 
(one way ANOVA with Bonferroni post-hoc comparisons) was applied independently to each 
brain region. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001. 
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In the SO, pregnant females displayed significantly higher pSTAT5-ir density than virgin 
females and lactating dams (p<0.001), whereas lactating dams also displayed 
significantly higher levels than virgin females (p=0.049).  
In the tuberal hypothalamus (Fig 2.6c), the VMHvl and laterally adjoining area showed 
significant inter-group differences in pSTAT5-ir density (F2,15=16.673, p<0.001). Thus, 
virgin females displayed significantly lower labelling density than pregnant females 
(p=0.004) and lactating dams (p<0.001), whereas pregnant females and lactating dams 
showed similar labelling density (p=0.687). Conversely, the ANOVA revealed no 
significant differences in labelling density in the sampled area of the arcuate nucleus 
(F2,15=2.502; p=0.115). 
Similarly, no group effect was observed in the PIL within the posterior thalamus 
(F3,22=1.194, p=0.335; see Fig 2.6c). Finally, in the periaqueductal grey (LPAG) the ANOVA 
revealed a significant group effect (F2,15=7.475, p=0.006). The post hoc analysis indicates 
that pregnant and lactating groups showed significantly higher labelling density than 
virgins (p=0.029 and p=0.012, respectively) and identical between each other (p=1). 
Summarizing, this quantitative analysis reveals that in most of the analysed brain regions 
pSTAT5-ir density (as a measure of lactogenic activity) increased significantly during 
pregnancy and/or lactation. Furthermore, levels of pSTAT5-ir in the analysed structures 
do not differ between late-pregnancy and lactation, with the exception of the CeM and 
the SO, where labelling density significantly decreases from late-pregnancy to lactation. 
2.3.3. INHIBITION OF HYPOPHYSEAL PROLACTIN RELEASE DURING LATE 
PREGNANCY: EFFECT ON BRAIN pSTAT5 IMMUNOREACTIVITY 
In order to evaluate any possible effect of impairment of hypophyseal PRL release on 
the levels of central lactogenic signalling, we compared pSTAT5-ir density between our 
sample of late-pregnant females and an additional group of late-pregnant females, 
treated with bromocriptine to suppress hypophyseal PRL release. After checking for 
normal distribution and variance homogeneity, we performed a t-test for independent 
samples for each of the analysed nuclei. T-tests revealed no significant differences 
between treated and non-treated pregnant females in any case (Fig 2.7). P-values were 
always equal or higher than 0.2, with the single exception of the CeM, where a trend 
towards significance was found (p=0.064). Therefore, our results confirm no significant 
effect of bromocriptine treatment in pSTAT5-ir density in late-pregnant females. 
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 Figure 2.7 Quantification of pSTAT5-ir density in selected brain regions of late-pregnant 
female mice: effect of bromocriptine 
Comparison of pSTAT5-ir density (pSTAT5-positive cell nuclei / mm2) in the former 13 brain 
regions between PD 14-17 pregnant female mice (n=5; dark yellow) and PD14-17 pregnant 
female mice treated with two 100 µg s.c. doses of bromocriptine, 19 and 2 hours prior to 
perfusion, in order to depress hypophyseal PRL release (n=8; light yellow). Bar histograms show 
mean interhemisferic pSTAT5-ir density ± SEM. Statistical analysis (one way ANOVA with 
Bonferroni post-hoc comparisons) was applied independently to each brain region. *P ≤ 0.05; 
**P ≤ 0.01; ***P ≤ 0.001. 
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2.4. DISCUSSION 
In the present study, we have characterised the variation of lactogenic signalling in the 
brain throughout the reproductive cycle of the female mouse, namely the basal state 
(virgins), late-pregnancy and lactation. This work is, to our knowledge, the first 
functional analysis of the central lactogenic activity in in mice including the critical 
period of pregnancy. In qualitative terms, we have found a common and widespread 
pattern of pSTAT5-ir (as a measure of lactogenic signalling) in pregnant and lactating 
females that starkly contrasts with the variable but relatively reduced patterns found in 
virgin females. In quantitative terms, we have found that lactogenic signalling strongly 
increases during pregnancy and/or lactation as compared to the basal condition (virgin 
females). This apparent increase, in addition, is not produced by PRL of hypophyseal 
origin, but rather by other available lactogenic sources, as suggested by the evidence 
that bromocriptine treatment has no significant effect in reducing the levels of pSTAT5-ir 
of late-pregnant females. 
In this section, we will focus on discussing our findings relative to pregnancy and 
lactation. We will first briefly review our data on freely-cycling virgin female mice and 
compare them with our previous findings on virgins (Study 1). Then, we will review how 
lactogenic signalling changes with pregnancy and lactation in the analysed regions and 
hint some possible functional implications of these findings. Finally, we will discuss 
which lactogenic agents may be responsible for those changes.  
2.4.1. PROLACTIN SIGNALLING IN THE BRAIN OF FREELY-CYCLING VIRGIN 
FEMALE MICE 
The distribution of pSTAT5-ir in the brain of the female mouse has been thoroughly 
examined in the previous chapter of this work, using ovariectomized, steroid-primed 
virgin females supplemented with exogenous PRL as experimental model. In this study, 
however, we employed a more naturalistic approach and included a group of freely-
cycling virgin females (lacking any kind of PRL supplementation) as a comparative 
control of the basal PRL responsiveness in females. Consequently, we obtained a sample 
of pSTAT5-ir patterns with a relatively high variability. Most of the patterns in this 
sample were relatively reduced, but a small number of animals exceptionally displayed 
high levels of pSTAT5-ir resulting in rich patterns.  
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As pointed by our previous findings that gonadal steroid regulate levels of PRL signalling 
in several brain regions (Study1) and those of others (Sugiyama et al. 1994; Scully et al. 
1997), the most feasible source to explain the variable levels of pSTAT5-ir in our sample 
are gonadal steroids. Circulating PRL has been shown to be under the influence of other 
physiological factors such as age (Parkening et al. 1982), circadian rhythms (Sinha et al. 
1977) or stress (Gala 1990). This source of variability was minimized by using females of 
the same age (2 to 3 months), which were perfused during the same time window 
(11:00 to 13:00 in a 12:12 light-dark cycle, lights ON at 8:00; see Materials and Methods) 
and group-housed to avoid stress derived from social isolation.  
Despite the aforementioned variability, freely-cycling virgins display similar patterns to 
our previous description (Study 1) of pSTAT5-ir in the brain of ovariectomized, steroid-
primed females. For example, those nuclei with higher labelling prevalence and density 
among freely-cycling virgins (e.g. the LSV or MePD, Fig 2.2) are those presenting higher 
labelling density among ovariectomized, steroid-primed virgins (see Study 1, Figs 1.1 and 
1.5). Similarly, some brain regions lacking pSTAT5-ir in ovariectomized, steroid-primed 
virgins might present labelling among freely-cycling virgins (e.g. the LSD in the septum, 
the lateral BST or several midbrain and brainstem regions), but this labelling tends to be 
scarce and present only exceptionally in few individuals. In sum, our current and 
previous data on central PRL signalling in virgin female mice suggests that PRL can exert 
a broad degree of activity within the brain. Depending on gonadal steroid regulation and 
other intrinsic and extrinsic factors, PRL signalling in the female brain can range from a 
virtual absence to moderately high levels. 
2.4.2. SIGNIFICANCE OF LACTOGENIC SIGNALLING IN THE BRAIN DURING 
PREGNANCY AND LACTATION 
Pregnant and lactating mice displayed a rich, widespread and constant pattern of 
lactogenic responsiveness with minor variations throughout the whole brain. Levels of 
lactogenic signalling were highest among hypothalamic and telencephalic nuclei, but 
also apparent in thalamic, midbrain and brainstem regions.  
Remarkably, as was brought into attention before (see Section 1.4.1), one of the 
limitations of the use of pSTAT5 as a functional marker of central PRL-derived signalling 
is its possible crosstalk with signalling of leptin and growth hormone (Furigo et al. 2016), 
which also involves the Jak/STAT pathway. In this context, it is important to discuss on 
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the specificity of the patterns of lactogenic responsiveness obtained in pregnant and 
lactating females, although the high levels of PLs likely account for most (if not all) of the 
pSTAT5 immunolabelling observed. Regarding leptin, STAT3 is the main STAT member 
associated with the leptin receptor (Ladyman et al. 2012), whereas STAT5 
phosphorylation associated with leptin signalling has been reported only in the arcuate 
nucleus (Gong et al. 2007; Mütze et al. 2007) and has not been replicated in all studies 
(Vaisse et al. 1996). As for GH, regions of the brain showing high levels of expression of 
GH receptors and responsiveness to GH (detected by pSTAT5-ir; Furigo et al., 2016), 
such as the hippocampus and dentate gyrus (Burton et al. 1992) or layers 2, 3, 5 and 
especially layer 6 of the cerebral cortex (Lobie et al. 1993), show no pSTAT5 labelling in 
any of our mice, neither in virgin nor in pregnant or lactating females. This suggests that 
GH signalling in the brain is taking place through alternative pathways, e.g. those 
involving Src kinases (Waters 2015). Moreover, Brown and collaborators (2011) 
demonstrated, by means of the pharmacological suppression of hypophyseal PRL 
release with bromocriptine, that pSTAT5-ir in lactating dams is completely attributable 
to PRL signalling. In sum, the reliability of pSTAT5 immunostaining as a functional marker 
for the activation of the PRLR-l is extensive to the brain of pregnant and lactating 
females.  
Despite the variability in pSTAT5-ir found in our sample of virgin females, our results 
confirm, both at a qualitative (Fig 2.2) and quantitative (Fig 2.6) level, that pregnancy 
and lactation are associated with a significant increase in the lactogenic signalling in the 
brain. According to our results, 10 out of 13 total brain nuclei experimented a significant 
increase in pSTAT5-ir density during pregnancy and/or lactation as compared to basal 
levels among virgins.  
Exceptions to this outcome among the structures we have analysed are the AVPe (Fig 
2.6b), the Arc and the thalamic PIL (Fig 2.6c), with comparable pSTAT5-ir density 
between virgins and pregnant/lactating females. These findings do not fit previous data 
(Brown et al. 2011) reporting an increase in pSTAT5-ir during lactation and after 
exogenous PRL administration in the AVPe and Arc of C57 animals (PIL was not analysed 
in the cited work). Remarkably, Brown et al. (2011) found no associated increase in PRLR 
expression in these nuclei in lactating dams, but were able to induce a comparable 
increase in pSTAT5-ir in virgin females by administering exogenous PRL. Therefore, 
heightened levels of circulating PRL occurring during the lactation period were likely 
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causing the increase in pSTAT5-ir of C57 dams found in this work. These data suggest 
that the lack of inter-group differences in our animals would be due to virgins of the CD1 
strain having relatively high (as compared to C57) basal levels of circulating PRL. 
Supporting this view, the AVPe and the Arc are located next to circumventricular organs 
(the VOLT and the ME, respectively), thus having privileged access to systemic PRL 
(Ganong 2000).  
As for the region we refer to as PIL, the cell cluster we have quantified corresponds to a 
discrete population that does not exactly match the PIL proper, but rather extends from 
the medial border of this nucleus into the adjoining region of the posterior thalamus (Fig 
2.2i). This work is the first description of such population, clearly defined by pSTAT5 
immunostaining (Fig 2.3l). This region is known to be a relay station for ascending 
somatosensory information of the ventral region of the body, which allows suckling 
stimulation to trigger the release of PRL during lactation (Cservenák et al. 2013). 
Therefore, it is tempting to suggest a role of pSTAT5-ir in this region in feedback 
regulation of suckling-induced PRL release through a central modulation of sensitivity to 
suckling stimulation. In this context, however, our results revealing comparable levels of 
pSTAT5-ir in virgin and late-pregnant females and in lactating dams are surprising. The 
functional meaning of this finding is unclear, but maybe could be related to the peculiar 
maternal behaviour of mice (as compared to rats), where virgin females display nearly 
spontaneous maternal care (Stolzenberg and Rissman 2011; Martín-Sánchez et al. 
2015b). 
Focusing on the rest of the analysed nuclei (10), these can be grouped in different 
categories according to the time course of the observed increase in pSTAT5-ir. 
Importantly, 8 of them displayed a statistically significant increase in pSTAT5-ir density 
already during pregnancy (CeM; MePD; LSV; BSTMPM; Pa; SO; VMHvl and LPAG). This 
suggests that the maternal adaptations of the brain mediated by lactogenic agents occur 
before parturition and, in most cases, are maintained subsequently during lactation. 
Supporting this view, it has been shown that mRNA expression of the long form of the 
PRLR (which signals through the JaK/STAT5 pathway) is markedly increased in the brain 
of female rats at mid- and late gestation, and this elevated mRNA levels are maintained 
during the lactation period (Sugiyama et al. 1994). Remarkably, in two of these nuclei, 
the CeM and SO (Fig 2.6), pSTAT5-ir density peaked during pregnancy and decreased 
after parturition, so that, in the case of the CeM, levels of pSTAT5-ir were comparable in 
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dams and virgin females. This evidence further stresses the importance of gestation in 
the development of the maternal brain, since in the CeM and the SO pregnancy rather 
than postpartum seems the critical period of lactogenic action, when maternal 
adaptations would be taking place.  
Finally, the two remaining nuclei, the AC/ADP and the MPO, underwent a moderate 
increase during pregnancy, but this rise only reached statistical significance during 
lactation (Fig 2.6b). Hence, the critical window of lactogenic input in the AC/ADP and 
MPO appears to be the period of lactation. This suggests a specific role of these nuclei in 
the maintenance of maternal behaviours during lactation (see Tsuneoka et al. 2013; 
Bridges 2015). 
Indeed, the most feasible agents to relate to this process are gonadal steroids, estradiol 
and progesterone. On the one hand, it is well-known that these hormones play a critical 
role in the physiology of pregnancy and parturition (Fig I.4). On the other hand, our 
previous work (Study 1) shows how pSTAT5-ir is under regulatory control of gonadal 
steroids. Still, some of the nuclei analysed in the present study display a significant 
increase in pSTAT5-ir density associated with pregnancy and/or lactation, which is not 
paralleled by virgin, ovariectomized and steroid-primed females (Study 1). These nuclei 
include the CeM, BSTMPM, MPO, Pa, SO and VMHvl, which show enhanced lactogenic 
signalling specific to pregnancy and lactation, but not by estradiol or estradiol plus 
progesterone treatment. This suggests that in these nuclei, the increase in pSTAT5-ir 
during pregnancy is not related solely to the high levels of estradiol or progesterone 
during mid-to-late pregnancy, but rather to a more complex and pregnancy-specific 
background of gonadal steroid levels, with increasing estradiol and decreasing 
progesterone (Fig I.4). Alternatively, other factors specific to pregnancy and lactation, 
e.g. high levels of circulating placental lactogens (gestation) or PRL (lactation), could be 
contributing to shape this scenario. 
Altogether, the findings of this study reinforce the major role of lactogenic hormones in 
adapting the female physiology and behaviour to the demands of motherhood (Grattan 
et al. 2001). But, most importantly, our results lend strong support to the hypothesis 
that the critical period for the development of these maternal adaptations is pregnancy, 
as the measured increases in lactogenic signalling occur prepartum in most of the 
analysed structures. These adaptations include, for instance, the lactogenic modulation 
of the release of oxytocin and vasopressin by the magnocellular neurosecretory cells in 
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the Pa and SO (Parker et al. 1991; Ghosh and Sladek 1995; Sirzen-Zelenskaya et al. 
2011), the attenuation of stress response at the level of the Pa (Torner et al. 2002), the 
promotion of hyperphagia (Sauvé and Woodside 2000; Augustine et al. 2008) or the 
induction of neurogenesis in olfactive areas (Shingo et al. 2003; Larsen and Grattan 
2010b)to mediate the recognition of the future offspring (albeit not mediated by the 
Jak/STAT pathway in this case, Torner 2016). But importantly, one of the major 
outcomes of this process is the prepartum development of maternal behaviours 
(Slotnick et al. 1973; Lonstein and Gammie 2002; Gammie 2005; Brunton and Russell 
2008). The implication of PRL and other lactogenic agents in the regulation of maternal 
behaviours will be treated thoroughly in the following chapters of this work (see General 
discussion). 
2.4.3. SOURCE OF BRAIN LACTOGENIC ACTIVITY DURING LATE PREGNANCY: 
EFFECT OF HYPOPHYSEAL PROLACTIN INHIBITION 
An additional issue in the context of the lactogenic development of the maternal brain is 
the actual origin and identity of the intervening lactogenic agents. As introduced before, 
the pituitary gland is not the only source of PRL in the body (Freeman et al. 2000). 
Likewise, PRL is not the only available lactogenic molecule, as it coexists with an array of 
related peptides with variable degrees of structural homology and common binding and 
signalling features (Soares et al. 1998b; Soares 2004). It is well-established that 
hypophyseal PRL plays an instrumental role during lactation, as, in response to the 
suckling stimulus of the pups, high amounts of this hormone are released from the 
pituitary and lead to milk production (lactogenesis) and ejection (galactopoiesis) 
(Bintarningsih et al. 1958; Freeman et al. 2000). This process is granted by a disruption 
of the negative feedback control of PRL on its own secretion, which leads to a general 
state of hyperprolactinaemia (Anderson et al. 2006) and an increased access and 
signalling of hypophyseal PRL to the brain during lactation (Brown et al. 2011). 
Conversely, during pregnancy the release of hypophyseal PRL appears to be depressed, 
coinciding with high levels of lactogenic signals of placental origin, the so-called 
“placental lactogens” (Robertson and Friesen 1981; Kishi et al. 1991; PLs, Soares 2004).  
In his study, we aimed at providing direct evidence of the actual role of hypophyseal PRL 
during the period of pregnancy. For this purpose, we inhibited hypophyseal PRL release 
in a sample of late-pregnant females by means of bromocriptine. First, bromocriptine 
administration did not result in any interruption or alteration of pregnancy in the 
  
92 
 
experimental females, every pregnancy was brought correctly to term. Most 
importantly, bromocriptine treatment resulted in no significant decrease in pSTAT5-ir 
density in the analysed structures, as compared to non-treated pregnant females (Fig. 
3.7). Hence, these findings provide for the first time a functional confirmation of the 
suppression of lactogenic input to the brain from a hypophyseal source. Administration 
of this treatment ensured that most, if not virtually all the pSTAT5-ir found in the brain 
during late pregnancy is due to non-hypophyseal sources. Arguably, the alternative 
lactogenic agents operating during pregnancy are most likely PLs. Placental lactogens 
are known to access the brain (Bridges and Lupini 1991), to bind the long form of the 
PRLR (Bridges et al. 1996) and even to stimulate maternal behaviour when infused  
intracerebrally (Bridges and Freemark 1995). However, it is also possible that central 
neurons producing PRL might also be recruited during pregnancy (Paut-Pagano et al. 
1993; Grattan and Kokay 2008). In fact, there is evidence in the rat suggesting that this is 
the case for the regulation of the stress response and in response to suckling in the Pa 
and MPA (Torner et al. 2004).  Altogether, our findings strongly support the idea that the 
tuning of the socio-sexual brain for motherhood is initiated before parturition mostly by 
non-hypophyseal lactogenic sources, likely placental lactogens, and maintained 
subsequently during lactation by high levels of hypophyseal PRL, as suggested by the 
inhibitory effect of bromocriptine in the presence of neuronal pSTAT5 in lactating mice 
(Brown et al. 2011).  
2.4.4. CONCLUSIONS 
This work explores the physiological variation of PRL-like signalling in the brain of female 
mice through different reproductive stages. Virgin female mice show variable but 
generally low pSTAT5-ir. This immunoreactivity shows a dramatic increase with 
pregnancy, resulting in a widespread pattern that remains mostly unaltered during 
lactation. Inhibition of hypophyseal PRL release in pregnant females by means of 
bromocriptine treatment has no effect on the levels of PRL-like signalling, thus 
suggesting that placental lactogens (or centrally produced PRL) are responsible for the 
greater part of the observed lactogenic signalling. Our work provides evidence that the 
maternal brain is being extensively shaped by lactogenic agents during pregnancy, prior 
to delivery and lactation, including regions involved in the management of maternal 
behaviours. 
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Maternal Behaviour, Prolactin and Oxytocin – 
Analysis of Specific Maternal Behaviours and 
pSTAT5/Oxytocin Expression in the AC/ADP 
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3.1. RATIONALE AND AIMS 
As introduced before, the expression of mammalian maternal behaviour depends mainly 
on the regulatory action of two different types of factors (Fig. I.9). On the one hand, 
hormones of pregnancy and lactation, including gonadal steroids and, importantly, PRL, 
provide a large-scale modulation of the brain into a maternal state, preceding the birth 
of pups and during their early postnatal development. On the other hand, pup-derived 
stimuli access the maternal brain as a direct consequence of pup exposure to trigger and 
modulate the expression of maternal behaviour. The relative contribution of each kind 
of factor differs among species and is also different for each component of maternal 
behaviour (see section I.5.2). 
Concerning pup-directed maternal care, studies conducted in the rat reveal that pup-
derived stimuli elicit radically different reactions in virgin females and dams. As 
introduced before, virgins show avoidance or aversion towards pups (Fleming and 
Luebke 1981), whereas in dams, pup stimuli have powerful reinforcing properties, 
leading to the expression of proactive maternal responses (Hauser and Gandelman 
1985; Fleming et al. 1989; Lee et al. 2000; Mattson et al. 2001). Therefore, rat dams, but 
not virgins, are fully motivated for pups, as a result of the endocrine input of pregnancy. 
Conversely, virgin females might only show partial motivation towards pups after 
prolonged maternal sensitisation (Seip and Morrell 2008). The question remains 
whether this scenario is translatable to the mouse, considering the evident differences 
with the rat in the onset of pup-directed maternal behaviour. In other words, it is still 
not known if full maternal motivation in female mice can be reached only through pup-
derived stimulation, as suggested by the nearly-spontaneous allomaternal care observed 
in mice (Martín-Sánchez et al. 2015b), or if, as for maternal aggression, a previous 
endocrine priming is necessary for its expression. 
The first aim of the present study is to assess the relative contribution of pregnancy and 
pup-derived stimuli to the development of maternal motivation and the expression of 
motivated (proactive) maternal responses in female mice. For this purpose, we have 
developed a new behavioural test (based on the pup retrieval paradigm), termed 
“motivated pup retrieval test” (see section 3.2.1), which allows to assess maternal 
motivation in a more specific manner than conventional pup retrieval tests. In order to 
determine whether pup-derived stimulation is enough to induce fully motivated 
maternal care or, in contrast, endocrine agents are increasing motivation for pups, we 
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have compared the performance in the motivated pup retrieval test of three different 
experimental groups of female mice: lactating dams, godmothers and pup-naïve virgins. 
Godmothers are virgin females subject to a process of maternal sensitisation by 
cohabitating with a (non-experimental) maternal female, which grants continuous 
access and interaction with pups from the moment of their birth (Martín-Sánchez et al. 
2015b; Martín-Sánchez et al. 2015a). Lactating dams are exposed to both endocrine 
signals of pregnancy and lactation and pup-derived stimuli, whereas godmothers are 
exposed only to continuous infant-derived sensory stimulation. Conversely, virgin 
females gain access to pups exclusively during behavioural testing and hence will serve 
as negative controls. 
The nonapeptide oxytocin (OXT) plays an instrumental role as a neuromodulator of 
maternal behaviours, both maternal care (including proactive maternal responses, see 
Fig I.9) and maternal aggression (Bosch and Neumann 2012). The second aim of this 
study will be to analyse how both long-term pup exposure and PRL (as a major hormone 
of pregnancy and lactation) might modulate maternal behaviours by acting upon central 
OXTergic circuits. Specifically, we will focus our attention in a single population of OXT 
neurons, located in the anterior commissural/anterodorsal preoptic region of the 
hypothalamus (AC/ADP) (Otero-García et al. 2015). This OXT neuron cluster occupies a 
privileged location in the medial preoptic (MPA) region of the hypothalamus and MPA-
ventral BST continuum, the well-established key region for the expression of maternal 
behaviour (Numan et al. 1988; Morgan et al. 1999; Pereira and Morrell 2009; Tsuneoka 
et al. 2013).  Hence, we will analyse the effect of PRL onto OXT-expressing neurons in 
our three experimental groups and we will also explore possible correlations between 
PRL/OXT expression and coexpression in the AC/ADP and motivated pup retrieval 
scores. Thus, we will search for possible indications on the involvement of PRL and OXT 
in the AC/ADP region in the regulation of maternal motivation. 
The contribution of pregnancy and sensory stimuli to the expression of maternal 
aggression has been already advanced in the work of the former member of our lab, Ana 
Martín-Sánchez (Martín-Sánchez et al. 2015b; Martín-Sánchez et al. 2015a). According 
to her findings, virgin female mice become easily sensitised through pup contact to 
express allomaternal care. Conversely, these females do not become aggressive towards 
other conspecifics even if they become maternal towards pups: only lactating female 
mice express maternal aggression. This evidence strongly suggests that maternal 
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aggression is heavily dependent on endocrine factors whereas maternal care might be 
hormone-independent in mice. In the present work, we will also explore the 
immunohistochemmical expression of OXT and pSTAT5 in the AC/ADP of this additional 
experimental sample of lactating dams, godmothers and virgin female mice tested for 
maternal aggression. Likewise, we will also search for possible correlations between 
scores of maternal aggression and AC/ADP expression of OXT and pSTAT5. With this 
approach, we intend to gain a deeper insight on the role of the AC/ADP and its 
interaction with PRL and pup-derived stimuli in the regulation of different components 
of maternal behaviour. 
3.2. MATERIAL AND METHODS 
3.2.1. ANIMALS, EXPERIMENTAL DESIGN AND BEHAVIOURAL TESTING 
Maternal motivation 
In this experiment, a total of n=66 female mice of the CD1 strain (Janvier, France) were 
used. Of these, 26 animals arrived on pregnancy day 10 to our animal facility, together 
with 40 virgin females of the same age (10 weeks). At the moment of arrival females 
were pair-housed in polypropylene cages (145 mm wide, 465 mm long and 215 mm 
high; Panlab) under controlled temperature (24 ± 2 ºC) and lighting conditions (12h:12h; 
lights ON at 8 am), with ad libitum access to food and water. Animals were treated 
throughout according to the European Union Council Directive of June 3rd, 2010 
(6106/1/10 REV1) and procedures were approved by the Committee of Ethics on Animal 
Experimentation of the Jaume I University of Castellón, where the experiments were 
performed. 
Experimental groups (lactating dams, godmothers and virgins, Fig 3.1) were arranged at 
the moment of arrival of the animals: 10 pregnant females were randomly assigned to 
the lactating dam group and 10 virgin females were randomly assigned to each of the 
Godmother and Virgin groups, respectively. Of the remaining pregnant females (16), 10 
were used as non-experimental, accompanying females of experimental godmothers, 
and the remaining six served as pup-donor mothers for the behavioural testing of 
experimental virgin females. As for the remaining virgin females (10), these were used 
as non-experimental accompanying females of experimental dams. The whole housing 
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design is illustrated on Figure 3.1 A. The morning after parturition, litters were culled 
down to 8 pups to ensure homogeneous interaction with pups, as some aspects of 
maternal behaviour are influenced by litter size (Maestripieri and Alleva 1991). One of 
the pregnant females was removed from the experiment due to problems during labour. 
This left a total sample size of n=9 lactating dams, n=10 godmothers and n=10 virgins. 
 
Figure 3.1 Experimental design for the motivated pup retrieval test 
(AI-AIII) Housing conditions for the females of each experimental group. (AI) Dams (n=9, red) 
were housed together with a non-experimental accompanying female, in order to balance the 
design. (AII) Godmothers (n=19, blue) were housed together with a non-experimental dam, 
which provided the pups. (AIII) Virgins (n=10, green) were housed together with a non-
experimental virgin and lacked any pups in their home cages. 
(B) At the time of the test, experimental and accompanying females were removed from their 
home cage and the following setup was prepared (left): barriers were placed in the distal corners 
of the home cage and pups were placed as shown (4 pups remained in the nest and 2 pups were 
placed on each of the distal corners past the barriers). Right: screen capture of a video recording 
of a motivated pup retrieval test. 
(C) Experimental timeline. The day of parturition was considered postpartum day (PPD) 0. Later 
on PPD0, litters were culled down to 8 pups each. Each experimental female underwent three 
consecutive trials in the morning of PPD2, PPD3 and PPD4, respectively. On PPD5, 
approximately 24 hours after the last trial, experimental animals were perfused.  
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The experimental design consisted of a modified pup retrieval paradigm, in which 
experimental females were forced to retrieve the pups off the nest site by climbing a 10 
cm high wire-mesh barrier. The actual height of the barrier to provide the proper 
difficulty to the task, as well as the duration of the behavioural recording had been 
validated on a previous pilot test (data not shown). At the beginning of each trial, 
experimental and accompanying females were both briefly removed from their home 
cages in order to arrange the experimental settings (Fig. 3.1B). First, two barriers were 
placed on each of the distal (related to the nest site’s position) corners of the home-
cage. Then, with the help of a spoon, 2 pups were carefully placed on each of the distal 
corners, separated by the barriers. The remaining 4 pups were left on the nest site, in 
order to prevent the experimental females from building a new nest site on one of the 
distal corners during the test. Finally, the experimental female was placed back again in 
the home cage and behavioural recording started.  
Starting on the morning of PPD2, experimental animals underwent three daily 10 minute 
trials daily until PPD4 (Fig 3.1C). Since behavioural testing was performed on the 
animals’ home cage and it was of relevance for the experiment to collect data on the 
first exposure of the animal to the experimental conditions, no previous habituation was 
performed. After these trials, on the morning PPD5, experimental animals were 
transcardially perfused and brain tissue collected (see section 3.2.3). 
Video recordings of the behavioural trials were analysed by an observer blind to the 
experimental conditions. The behavioural measures registered during this analysis 
included: latency to the first contact with pups, latency to retrieve each of the 4 
displaced pups, total time of contact with pups and number of barrier crossings by the 
experimental animal. 
Maternal aggression 
The behavioural analysis of this experiment was performed by Ana Martín-Sánchez, 
former member of our lab, and published elsewhere (Martín-Sánchez et al. 2015a). 
Briefly, n=27 adult female mice of the CD1 strain were randomly assigned to three 
different experimental groups: lactating dams (n=9), godmothers (n=9) and virgins (n=9). 
Each female was housed with another non-experimental female (for details, see Martín-
Sánchez et al. 2015a; 2015b) but just allowed configuring balanced dyads for the three 
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experimental groups: experimental dams were housed with accompanying females in 
the same way than experimental godmothers were housed with accompanying dams. 
Experimental females were subject to maternal aggression tests (based on a resident-
intruder paradigm), where they were confronted to an intact male and a castrated male 
(as negative controls) in two consecutive days, in a counterbalanced fashion. For the 
purpose of the current study, we will focus on the data collected during confrontation 
with intact males. Maternal aggression tests had a duration of 5 minutes and were 
performed daily on postpartum days (PPD) 3 to 5, coinciding with the peak of maternal 
aggression in dams. Tests were video-recorded and evaluated by a person blind to the 
experimental conditions. Scores of attack and refusal behaviours were collected using 
SMART 2.5 event-recording software (Panlab, Barcelona, Spain). In the current analysis, 
we focus on the following measures of aggressive behaviour: latency to first attack, total 
duration of attacks, number of attacks and mean attack duration. 
3.2.2. TISSUE COLLECTION AND HISTOLOGICAL PROCESSING  
From this point, the same experimental procedures were performed for both the 
maternal aggression and the maternal motivation samples. Animals were transcardially 
perfused with saline and then 4% paraformaldehyde, brain tissue was collected, 
postfixed in the same fixative, cryoprotected and cut in 4 parallel series of 40 µm-thick 
frontal sections using a freezing microtome, to be stored at -20ºC. For further details on 
these procedures, the reader is referred to Section 1.2.5. 
3.2.3. DOUBLE-LABEL IMMUNOFLUORESCENCE FOR pSTAT5 AND OXYTOCIN 
One of the four parallel series of each animal was used to perform a double-label 
immunofluorescence for pSTAT5 and OXT. Immunofluorescence was conducted in free-
floating sections under light shaking at room temperature (25oC) unless otherwise 
stated. Tissue sections were thoroughly rinsed between stages for at least three 10-min 
washes in TRIS-buffered saline, 0.05M, pH 7.6 (TBS). After thawing and before antibody 
incubation, sections underwent: a) two sequential antigen retrieval steps, consisting of a 
20-minute incubation in 1% hydrogen peroxide (H2O2) and 1-2% sodium hydroxide 
(NaOH) in water, pH>13, and a 10 minute incubation in glycine 0.3% and sodium 
dodecylsulfate (SDS) 0.03% in TBS; b) a 30 minute incubation in 1% sodium borohydride 
(NaBH4) to block tissue autofluorescence; c) a 60 minute incubation in 4% normal goat 
serum and 0.03% Triton-X100 in TBS to block unspecific labelling. After these steps, 
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tissue sections were incubated for 72 hours at 4ºC in both primary antibodies 
simultaneously: rabbit anti-pSTAT5 monoclonal antibody (pSTAT5 Tyr694; Cell Signalling 
Technology, Beverly, MA) diluted 1:500 and mouse anti-oxytocin monoclonal antibody 
(Dr. Harold Gainer, NIH Cat#PS38) diluted 1:200. After incubation in primary antibody 
and rinsing, tissue was incubated for 90 minutes in a mixture of both secondary 
fluorescent antibodies: Alexa Fluor 488-conjugated goat anti rabbit IgG (Jackson 
ImmunoResearch, 111-545-003) diluted 1:250 and Rhodamine Red-X-conjugated goat 
anti mouse IgG (Life Technologies, Oregon, USA) diluted 1:250. Prior to mounting, 
sections were counterstained for 45 seconds in DAPI (600 nM 4', 6-diamino-2-fenilindol; 
Thermo Scientific, IL, USA) to allow for cytoarchitectural analysis. Finally, sections were 
rinsed, mounted in gelatine-coated slides and coverslipped with the fluorescent 
mounting medium Fluorsave (Calbiochem, USA). 
3.2.4. ANALYSIS OF HISTOLOGICAL PREPARATIONS 
Immunofluorescence was analysed using a Leica TCS SP8 confocal system (Leica AG, 
Germany), mounted on an inverted microscope. Triple scans for DAPI, Alexa Fluor 488 
(conjugated to pSTAT5) and Rhodamine Red X (conjugated to OXT) were performed. 
Excitation wavelengths were 405 nm for DAPI, 488 nm for Alexa Fluor 488 and 559 nm 
for Rhodamine Red-X, whereas emission wavelengths included 461, 520 and 591 nm 
respectively. Stacks of sequential Z-sections of the AC/ADP region (sampling frame 
illustrated on Fig. 3.2) of both hemispheres of each experimental animal were obtained 
with a 20x magnification and 4-μm separation between neighbour optical sections. After 
sampling, confocal stacks were reviewed by an observer blind to the experimental 
groups and a few of them were discarded due to technical shortcomings relative to the 
microscope sampling. 
Histological variables of interest were quantified employing different procedures, each 
adapted to the nature and limitations of the given variable. First, OXT immunoreactive 
cell number was counted manually by a blind observer. In this counting protocol, the 
AC/ADP OXT cell population was identified and cells were counted for each of the stack 
levels, avoiding to count single cells present in more than one level. Then, mean 
interhempispheric values were calculated for each animal.  
Concerning pSTAT5, the total density of pSTAT5-immunoreactive cell nuclei was counted 
automatically using ImageJ software. Using a smaller sampling frame (Fig. 3.2), a single 
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8-bit image of the green channel of the stack was obtained by flattening the different Z-
sections of the stack. This image underwent a smooth median filter (2 pixel radius) to 
prevent that the granulated disposition of pSTAT5 imunofluorescence impaired 
subsequent steps of the protocol. Then, the image was binarised using the 200% of the 
median grey value of the image’s histogram as a threshold. After binarising, the image 
was further processed using the following ImageJ commands: Fill holes; Open; 
Watershed. Particle number was obtained excluding particles smaller than 25 square 
microns in area (corresponding approximately to 8 microns in diameter), and the final 
density value was obtained by dividing this count by the sampling frame area, and 
expressed in number of cells/square millimetre. Then, mean values for both 
hemispheres were calculated for each animal. 
 
Figure 3.2 Anatomical location of the sampling frames for the AC/ADP region 
Confocal stacks of the AC/ADP region were sampled at the approximate level of Bregma – 0.30 
mm (blue frame). For the quantification of pSTAT5 density in the AC/ADP region, we 
employed a frame of 290 µm height and 270 µm width (equivalent to the one used in chapter 1), 
which covered most of the AC/ADP region (green frame). To analyse the expression of pSTAT5 
among OXT positive and OXT negative neuron populations, we employed a smaller frame (220 
µm x 220 µm, red frame) centred on the OXT population (red dots). 
 
An additional histological analysis was performed to estimate the relative input of PRL 
over OXT-positive and OXT-negative neuron populations of the AC/ADP. For this 
purpose, an additional manual counting of pSTAT5-positive, OXT-positive, double-
positive and double-negative neurons (Fig 3.8) was performed by an observer blind to 
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the experimental conditions of the stacks. Importantly, neurons were identified and 
differentiated from glial cells using the DAPI staining of the stack (blue channel), 
according to the size of the nucleus, the appearance and condensation of the chromatin 
and the presence and size of the nucleoli. Once these counts were obtained, the mean 
interhemispheric percentage of pSTAT5 immunoreactivity was calculated for both OXT-
positive and OXT-negative cell populations. 
3.2.5. STATISTICAL ANALYSIS 
All of the following statistical procedures were performed using IBM SPSS Statistics 22 
software package. 
Behavioural data 
Methodological details on the statistical treatment of maternal aggression data can be 
found in Martín-Sánchez et al. (2015a). Regarding motivated pup retrieval, we first 
searched for possible differences between experimental groups in the access and 
potential interaction with pups, by analysing the following variables: latency to first 
contact with pups, total time of pup contact and number of barrier crossings. Since data 
for these variables were not normally distributed, we performed separate Kruskal Wallis 
ANOVAs for each trial to search for differences between experimental groups. Then, we 
performed log rank (Kaplan-Meier) tests in search for significant differences in the 
survival distributions of the latencies to the retrieval of the first and the fourth pup of 
each of the three trials. Finally, we were interested in assessing the learning or 
improvement of the experimental groups in the task. Since latencies were not normally 
distributed among our experimental groups, we ran separate Wilcoxon signed-rank tests 
for matched pairs. To do so, we considered the latencies of each experimental animal to 
retrieve the first pup and compared the distributions of these latencies during the first 
trial with those in the second and third trials, respectively. 
Histological data 
To analyse the expression of OXT and pSTAT5 in the AC/ADP of our experimental 
samples, we performed separate 1-way ANOVAs with Bonferroni post-hoc comparisons 
for each sample for both the number of OXT-immunoreactive neurons and the density 
of pSTAT5-immunoreactive cells. To compare the relative input of pSTAT5 over OXTergic 
and non-OXTergic cell populations of the AC/ADP, we first searched for significant 
effects of the experimental group and significant differences in the expression of pSTAT5 
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between both populations. Thus, we performed two-way mixed ANOVAs (independent 
factor experimental group; repeated measures factor cell population) for each 
experimental sample. Following this comparison, we looked further for significant 
differences between experimental groups by performing separate one-way ANOVAs 
(with experimental group as independent factor) with Bonferroni post-hoc comparisons 
for each sample and each cell population. 
Correlational analysis 
Finally, we tested the association of our behavioural and histological variables in a 
correlational analysis. For the sample tested for maternal aggression, the following 
behavioural parameters were included: latency to first attack, total number of attacks, 
total attack duration and mean attack duration. For the sample tested for motivated pup 
retrieval, we included the latencies to retrieve the first and fourth pups during the third 
trial and the total number of pups retrieved throughout all three trials of the 
experiment. Regarding histological measures, we included number of OXT-
immunoreactive neurons, density of pSTAT5-ir, the percentage of OXT positive neurons 
showing pSTAT5 immunoreactivity (pSTAT5-ir) and the percentage of non-OXT cells 
showing pSTAT5-ir. First, distribution of all variables was analysed in search for 
normality. Normally distributed variables were tested using a Pearson’s correlation. 
Variables that did not present a normal distribution were logarithmically transformed to 
apply Pearson’s correlation. If after transformation the variable was not distributed 
normally, a non-parametric Spearman correlation was applied. For both experimental 
samples (motivated pup retrieval and maternal aggression), correlations were tested for 
each experimental group separately. We considered the possibility of analysing all the 
females of each experiment together as a common, global sample. However, the 
correlations obtained in this global analysis might be spurious or misleading because 
only some of the experimental groups actually expressed the behaviours measured: only 
dams expressed aggressive behaviour, whereas only dams and godmothers retrieved 
pups. Hence, behavioural scores for Virgins (retrieval) and Virgins and Godmothers 
(maternal aggression), are categorically null or censored. Therefore, we restricted the 
correlational analysis within those groups that did actually perform the respective 
behaviour.  
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Figure 3.3 Dams, Godmothers and Virgins show equivalent contact with pups in the 
motivated pup retrieval test 
Bar histograms show mean + SEM values of: A) the number of barrier crossings into the 
compartment where pups were placed; B) the latency to establish the first contact with a pup; and 
C) the total time of contact with pups. One-way ANOVAs of these measures revealed no 
statistically significant differences among Dams (n=9), Godmothers (n=10) or Virgins (n=10) in 
neither of the three consecutive trials, indicating equivalent access and interaction with pups. 
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Figure 3.4 Dams, Godmothers and Virgins show distinct performance in the motivated 
pup retrieval test 
Survival plots indicating the accumulated proportion of Dams (red line), Godmothers (blue line) 
and Virgins (green line) successfully retrieving the first pup (left column) and fourth pup (right 
column) in each of the three 10 minute trials (rows). Hatched lines in the plots indicate censored 
cases in the analysis, i.e. animals that did not complete the retrieval of that specific pup. Log-rank 
(Kaplan Meier) analysis of the aforementioned trials and pups revealed significant differences 
between dams and godmothers (*) and dams and virgins (#) already during the first trial (A and 
B). These differences became more marked during the second trial (C and D) and persisted 
during the third trial (E and F). During the third trial, additional significant differences in retrieval 
appeared between godmothers and virgins ($) in the first-pup retrieval (E), of which only a non-
significant trend persisted in the fourth-pup retrieval (($) p=0.067). (Log-rank test; *p<0.05; 
**p<0.01; ***p<0.001).  
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3.3. RESULTS 
 
3.3.1. MOTIVATED PUP RETRIEVAL EXPERIMENT 
Behavioural Analysis 
First, we checked for possible differences in the time that the experimental animals 
interacted with the pups behind the barriers. Kruskal Wallis tests revealed no significant 
differences during any of the three trials among experimental groups in the latency 
(p=0.610; p=0.306; and p=0.670 for each trial, respectively) or the total time in contact 
with pups (p=0.322; p=0.116; and p=0.245 for each trial, respectively) or the number of 
barrier crossings (p=0.804; p=0.772; and p=0.397 for each trial, respectively) (Fig. 3.3). 
These results indicate that all three groups had equivalent access and interaction with 
pups.  
Then, we ran separate survival log-rank tests (Kaplan-Meier) to explore differences in 
the distributions of the retrieval latencies for the first and the fourth pups in each trial 
between dams, godmothers and virgins (Fig. 3.4). During the first trial (PPD2), the 
survival distributions of the latency to retrieve the first pup significantly differed 
between dams and godmothers (χ2(2)=4.194, p=0.041) as well as between dams and 
virgins (χ2(2)=6.389, p=0.011), but not between godmothers and virgins 
(χ2(2)=1.0p=0.317). Regarding retrieval of the fourth pup, however, no significant 
differences between experimental groups were found (p=0.146). During the second trial 
(PPD3), survival distributions of the latencies to first and fourth pup retrieval were both 
significantly different between dams and godmothers (χ2(2)=8.198, p=0.004 for pup 1; 
χ2(2)=10.715, p=0.001 for pup 4) and between dams and virgins (χ2(2)=15.764, p<0.001 
for pup 1; χ2(2)=16.989, p<0.001 for pup 4), but once again no differences were found 
between godmothers and virgins (p=0.265 and p=0.146, for pup 1 and 4 respectively). 
Finally, during the third trial (PPD4), all three groups differed significantly in their first 
and fourth pup retrieval survival distributions. Dams showed statistically significant 
differences with godmothers (χ2(2)=9.591, p=0.002 for pup 1; χ2(2)=6.981, p=0.008 for 
pup 4) and virgins (χ2(2)=21.837, p<0.001 for pup 1; χ2(2)=16.989, p<0.001 for pup 4). 
For the first time, godmothers and virgins differed significantly in the latency to first pup 
retrieval (χ2(2)=6.389, p=0.011) and the analysis rendered a trend toward significance in 
the retrieval of the fourth pup (χ2(2)=3.353, p=0.067). In the godmother group, 50% (Fig 
3.4 E) of the females retrieved the first pup, whereas 30% completed the whole task 
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retrieving the fourth pup (Fig 3.4 F). Conversely, none of the naïve virgin females 
retrieved any pup in the whole trial. 
 
Figure 3.5 Dams, Godmothers and Virgins show different improvement profiles in the 
motivated pup retrieval test 
Mean + SEM latencies to retrieve the first pup in Dams (red line), Godmothers (blue line) and 
Virgins (green line) during all three trials of the experiment. In order to evaluate the improvement 
of the experimental groups in the motivated pup retrieval test, we compared for each group the 
latency to first-pup retrieval during each trial with the latency displayed during the previous trial, 
using separate Wilcoxon signed-rank tests for matched pairs. According to this analysis, dams 
showed a significant decrease in the retrieval latency already in trial 2, whereas godmothers 
started to show significant differences later on trial 3, indicating a slower improvement as 
compared to dams. By contrast, virgins virtually did not perform any retrieval. (Wilcoxon test; 
*p<0.05; **p<0.01). 
Finally, we assessed the improvement of each experimental group in the motivated pup 
retrieval task by comparing first-pup retrieval latencies between trials 1 and 2, and 1 and 
3, by means of a Wilcoxon signed-rank test for matched pairs (Fig. 3.5). When matching 
trials 1 and 2, only dams differed significantly in their latencies to retrieve the first pup 
(Z=-2.666, p=0.008), whereas godmothers (Z=-1.604, p=0.109) and virgins (Z=-1.000 
p=0.317) did not. On the other hand, when comparing trials 1 and 3, dams (Z=-2.803, 
p=0.005) and godmothers (Z=-2.023, p=0.043), did show statistically significant 
differences in their retrieval latencies, whereas virgins did not (Z=0, p=1.0). These 
findings indicate that in a three trial motivated pup retrieval paradigm, dams rapidly 
improve in the task of retrieving pups (already during trial 2), whereas godmothers 
display a slower and weaker improvement (measurable only in trial 3) and virgins show 
no improvement at all. 
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Figure 3.6 Representative confocal images of pSTAT5 and Oxytocin 
immunofluorescence in the AC/ADP of Virgins, Godmothers and Dams 
Representative z-projections of whole confocal stacks of the AC/ADP region of a virgin (row 
A), godmother (row B) and dam (row C) specimen, tested for motivated pup retrieval. Column I 
shows pSTAT5-ir (green channel), which is located mainly in the cell nucleus but also in the 
cytoplasm. Column II shows OXT-immunoreactive somata (red channel). Column 3 shows the 
merge of green and red channels. The lowermost row (D) shows a magnified inset (blue boxes on 
row C) of a single z-level of the confocal stack for green (DI), red (DII) and merge (DIII) 
channels, respectively. Light green arrowheads in the merge inset (DIII) indicate cells 
immunoreactive only for pSTAT5 (green), pink arrowheads indicate somata immunoreactive only 
for OXT (red), and blue arrowheads point to double-labelled cells for pSTAT5 (green) and OXT 
(red). Approximate distance to bregma of the samples is -0.30 mm (see Fig 3.2). Scale bars 
represent 200 µm for A, B and C and 50 µm for D. 
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Figure 3.7 Representative confocal images of pSTAT5 immunoreactivity over OXT-
positive and OXT-negative neurons in the AC/ADP 
Representative extracts from a single z-level of a confocal stack of a specimen tested for maternal 
aggression. These extracts illustrate four different quantified neuron phenotypes: 1) pSTAT5-
positive, OXT-negative neurons; 2) pSTAT5-negative, OXT-positive neurons; 3) double positive 
neurons for OXT and pSTAT5; and 4) double negative neurons for OXT and pSTAT5. 
(A) These neuron phenotypes were identified using all three colour channels: red for OXT-ir, 
green for pSTAT5-ir and blue for DAPI nuclear staining. AI depicts the composite of red (OXT) 
and blue (DAPI) channels. AII depicts the composite of green (pSTAT5) and blue (DAPI) 
channels. AIII depicts the triple composite (OXT, pSTAT5 and DAPI). Colored frames 
correspond to insets of B, C and D, showing all four neuron phenotypes. Scale bars: 50 µm. 
(B) Detail insets for double positive neurons for OXT and pSTAT5 (orange arrowheads) in the 
OXT+DAPI (BI), pSTAT5+DAPI (BII) and triple OXT+pSTAT5+DAPI (BIII) composite 
channels. 
(C) Detail insets for OXT-negative, pSTAT5-positive (blue arrowheads) and for OXT-positive, 
pSTAT5-negative (blue arrows) neuron phenotypes ) in the OXT+DAPI (CI), pSTAT5+DAPI 
(CII) and triple OXT+pSTAT5+DAPI (CIII) composite channels. 
(D) Detail inset featuring double negative neurons (green arrowheads). Neurons were 
differentiated from glial cells (green arrows) using the DAPI channel. In the image, neurons show 
big nuclei with dispersed euchromatine and evident nucleoli, whereas glial cells show sall nuclei 
with condensed heterochromatine. 
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Immunoreactivity for Oxytocin and pSTAT5  
In this part of the study, we sampled the number of OXT-immunoreactive neurons and 
density of pSTAT5-immunoreactive neurons at a specific anatomical level of the AC/ADP 
(Fig 3.2). Figure 3.6 depicts an extract of the confocal stacks obtained during the 
sampling. One-way ANOVA revealed no statistically significant effect of experimental 
group in the number of OXT-immmunoreactive neurons (Fig 3.8 A), but found significant 
differences between experimental groups (F(2, 25)=4.819, p=0.017) in the density of 
pSTAT5-ir (Fig 3.8 B). According to Bonferroni post-hoc comparisons, dams differed 
significantly from virgins (p=0.015), whereas godmothers differed neither from dams 
(p=0.213) nor from virgins (p=0.734).  
Then, we compared the percentage of pSTAT5 immunoreactive neurons amongst the 
OXT positive population of the AC/ADP and the surrounding OXT negative cells of this 
region. Descriptive examples of the appearance of pSTAT5 and OXT double 
immunofluorescence in the AC/ADP of dams, godmothers and virgins are illustrated in 
Figure 3.7. White arrowheads point to pSTAT5-positive/OXT-positive cells, white arrows 
point to pSTAT5-positive/OXT-negative cells and yellow arrowheads signal pSTAT5-
negative/OT-positive neurons. 
We performed a two-way mixed ANOVA in search of significant differences between 
experimental groups and neuron populations (OXT positive and OXT negative 
populations, respectively) (Fig 3.8 C and D). We found differences in percentage of 
pSTAT5 expression between populations only by trend (F(1)=3.422, p=0.082), whereas 
there was no significant effect of the experimental group (F(2)=0.320, p=0.730) or the 
interaction of both factors (F(2)=0.908, p=0.422). Afterwards, we performed separate 
one-way ANOVAs for each population, testing for a possible effect of the experimental 
group that had not been identified in the previous analysis. One-way ANOVA reported a 
weak trend to significance in the percentage of pSTAT5 expression in OXT negative 
neurons (F(2,17)=2.742, p=0.093) (Fig 3.8 C), whereas no effect was found regarding OXT 
positive neurons (F(2,17)=0.018, p=0.982) (Fig 3.8 D). 
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Figure 3.8 Quantification of pSTAT5-ir density and OXT-immunoreactive cell number in 
the AC/ADP of female mice tested for motivated pup retrieval 
Bar histograms including Dams (red), Godmothers (blue) and Virgins (green) show mean + SEM 
values for: (A) number of oxytocin-immunoreactive neurons; (B) density of pSTAT5-
immunoreactive cell nuclei; (C) percentage of pSTAT5 expression on OXT-negative neurons of 
the AC/ADP; and (D) percentage of pSTAT5 expression on OXT-positive neurons of the 
AC/ADP. Statistical analysis in panels A and B was performed using one-way ANOVAs with 
Bonferroni post-hoc comparisons. In panels C and D, differences between experimental groups 
and neuron population were first assessed by a two-way mixed ANOVA model. Then, 
differences between experimental groups were further contrasted by separate one-way ANOVAs. 
(*p<0.05; **p<0.01).  
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Correlational Analysis 
We confronted the latencies to the retrieval of the first and fourth pup of trial 3, as well 
as the total number of retrieved pups, to the number of OXT-expressing neurons, 
pSTAT5-ir density and percentage of pSTAT5 expression over OXT positive and OXT 
negative neurons of the AC/ADP, respectively (Fig. 3.10 D and Table 3.1). In this case, as 
explained before (Section 3.2.5), we explored these correlations within dams and 
godmothers separately, but not virgins, which did not retrieve at all. We found 
significant associations of retrieval with the number of OXT neurons of the AC/ADP, but 
not with pSTAT5-ir density. Both dams (Fig 3.10 B, Table 3.2 B) and godmothers (Fig 3.10 
C, Table 3.2 C) showed substantial negative correlations between the total number of 
retrieved pups and the number of OXT neurons (r=-0.69; p=0.036 for dams and r=-0.73; 
p=0.018 for godmothers, using Spearman’s correlation). This indicates that females with 
greater numbers of OXT-expressing neurons in the AC/ADP retrieve less pups in this test. 
 
Figure 3.9 Significant correlations between motivated pup retrieval and histological 
parameters of the AC/ADP 
Scatterplot showing the distribution of motivated pup retrieval scores (total number of retrieved 
pups across the experiment) and number of OXT neurons in the AC/ADP in dams (red circles), 
godmothers (blue squares) and virgins (green triangles). When experimental females were 
arranged together as a global sample, Spearman’s non-parametric method (r) detected no 
significant correlation between both parameters (black). When analysed separately, however, both 
dams (red) and godmothers (blue), but not virgins, showed significant correlations between these 
parameters. For each of these, correlation coefficients, p-values and regression line are provided. 
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A-DAMS 
OXT cell 
number 
pSTAT5 
density 
% pSTAT5 over 
OXT neurons 
% pSTAT5 over 
OXT-negative 
neurons 
Latency  
T1P1 
r= 0.529 
p= 0.143 
r= - 0.229 
p= 0.553 
r= - 0.028 
p= 0.948 
r= 0.300 
p= 0.470 
Latency  
T1P4 
r= 0.548 
p= 0.127 
r= - 0.550 
p= 0.125 
r= - 0.250 
p= 0.550 
r= 0.577 
p= 0.134 
Latency  
T3P1 
r= 0.150 
p= 0.700 
r= - 0.377 
p= 0.318 
r= 0.084 
p= 0.843 
r= - 0.190 
p= 0.651 
Latency  
T3P4 
R= 0.098 
p= 0.801 
R= - 0.180 
p= 0.642 
R= 0.224 
p= 0.593 
R= - 0.028 
p= 0.947 
Total pups 
retrieved  
r= - 0.699 
p= 0.036* 
r= 0.356 
p= 0.348 
r= - 0.116 
p= 0.784 
r= - 0.358 
p= 0.385 
 
B-GODMOTHERS 
OXT cell 
number 
pSTAT5 
density 
% pSTAT5 over 
OXT neurons 
% pSTAT5 over 
OXT-negative 
neurons 
Latency  
T1P1 
r= 0.407 
p= 0.243 
r= - 0.466 
p= 0.175 
r= - 0.204 
p= 0.661 
r= - 0.618 
p= 0.139 
Latency  
T1P4 
- 
(No retrieval) 
- 
(No retrieval) 
- 
(No retrieval) 
- 
(No retrieval) 
Latency  
T3P1 
r= 0.668 
p= 0.035* 
r= 0 
p= 1.0 
r= - 0.394 
p= 0.382 
r= 0.477 
p= 0.279 
Latency  
T3P4 
R= 0.605 
p= 0.064(*) 
R= - 0.095 
p= 0.793 
R= - 0.605 
p= 0.150 
R= 0.676 
p= 0.095 
Total pups 
retrieved  
r= - 0.726 
p= 0.018* 
r= - 0.013 
p= 0.972 
r= 0.394 
p= 0.382 
r= - 0.477 
p= 0.279 
 
Table 3.1 Correlations between motivated pup retrieval and AC/ADP OXT and pSTAT5 
expression 
Summary of the explored correlations between behavioural variables of motivated pup retrieval 
(latencies to first and fourth pup retrieval on each trial and total number of retrieved pups) and 
histological variables of OXT and pSTAT5 expression measured in the AC/ADP (number of 
OXT neurons, pSTAT5-ir density, percentage of pSTAT5 expression over OXT neurons and 
percentage of pSTAT5 expression over OXT negative neurons). (A) Correlations obtained for 
dams separately. (B) Correlations obtained for godmothers separately.  For each correlation, the 
correlation coefficient (R, r) as well as the statistical significance (p) are listed. Boxes in white 
background represent parametric correlations, performed with Pearson’s method (R), whereas 
grey-shaded boxes indicate non-parametric analyses performed with Spearman’s method (r).  . 
Virgins were not analysed separately because they did not retrieve. Significant correlations and 
non-significant trends are highlighted with a red frame and a pink frame, respectively. *p<0.05; 
(*) p≤0.08. 
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3.3.2. MATERNAL AGGRESSION EXPERIMENT 
Behavioural Analysis 
Results of experimental dams, godmothers and virgins tested in the resident-intruder 
paradigm against intact males can be found in the original publication of our lab (Martín-
Sánchez et al. 2015a). Summarizing, significant differences between experimental 
groups were found in the latency to attack the intact male intruder (χ2(2)=9.8, p=0.008 
on a log-rank test) and the total time spent attacking the intact male intruder (p=0.002 
on a randomisation test). Post-hoc analysis revealed a significantly lower latency to 
attack in dams as compared to godmothers (p=0.045) and virgins (p=0.005), and 
significant higher attack duration in dams with respect to godmothers (p=0.001) and 
virgins (p<0.001). Conversely, godmothers and virgins did not differ significantly in either 
of both measures (p=0.47 and p=0.215, respectively). 
Immunoreactivity for pSTAT5 and oxytocin 
As in the previous experiment (3.3.1), we quantified the number of OXT-
immunoreactive neurons and the density of pSTAT5-ir in a specific anatomical level (Fig 
3.2) of the AC/ADP of female mice tested for maternal aggression. One-way ANOVA 
revealed a slight trend to an effect of experimental group regarding the number of OXT 
immunoreactive neurons sampled (F (2,20)=3.006, p=0.072) (Fig 3.9 A). On the other 
hand, it found significant differences between experimental groups in the density of 
pSTAT5-ir (F(2,17)=15.93, p<0.001) (Fig 3.9 B). Bonferroni post-hoc analysis for pSTAT5-ir 
density indicated that density of pSTAT5 immunoreactive cell nuclei differed significantly 
between dams and virgins (p=0.001) and between dams and godmothers (p<0.001), but 
not between godmothers and virgins (p=1.0).  
Regarding percentages of pSTAT5 expression among OXT-positive and OXT-negative 
neurons (Fig 3.9 C, D) two-way mixed ANOVAs for experimental group and population 
revealed a strong significant effect of population (F(1)=31.171, p<0.001), indicating that 
percentages of pSTAT5 expression significantly differed between OXT positive and OXT 
negative neurons. Conversely, no significant effect of the experimental group 
(F(2)=0.856, p=0.442) or the interaction of both factors (F(2)=2.287, p=0.132) was found. 
Subsequent one-way ANOVA found significant differences between dams, godmothers 
and virgins in the percentage of pSTAT5-ir among OXT negative neurons of the AC/ADP 
(F(2,17)=6.369, p=0.009) (Fig 3.9 C), but not in the percentage among OXT positive 
  
 
116 
 
neurons (F(2,17)=0.097, p=0.908) (Fig 3.9 D). Bonferroni post-hoc comparisons for the 
OXT negative population indicated that the percentage of pSTAT5 in OXT negative 
neurons of dams significantly differed from that of virgins (p=0.008), whereas the 
expression in godmothers did not differ from dams (p=0.198) or from virgins (p=0.332).  
 
Figure 3.10 Quantification of pSTAT5-ir density and OXT-immunoreactive cell number 
in the AC/ADP of female mice tested for maternal aggression 
Bar histograms including dams (red), godmothers (blue) and virgins (green) show mean + SEM 
values for: (A) number of oxytocin-immunoreactive neurons; (B) density of pSTAT5-
immunoreactive cell nuclei; (C) percentage of pSTAT5 expression on OXT-negative neurons of 
the AC/ADP; and (D) percentage of pSTAT5 expression on OXT-positive neurons of the 
AC/ADP. Statistical analysis in panels A and B was performed using one-way ANOVAs with 
Bonferroni post-hoc comparisons. In panels C and D, differences between experimental groups 
and neuron population were first assessed by a two-way mixed ANOVA model. Then, 
differences between experimental groups were further contrasted by separate one-way ANOVAs. 
(*p<0.05; **p<0.01).  
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Figure 3.11 Significant correlations between maternal aggression and histological 
parameters of the AC/ADP 
Scatterplots showing the distribution of behavioural measures of maternal aggression and 
histological variables of OXT and pSTAT5 expression in the AC/ADP, for dams (red circles), 
godmothers (blue squares) and virgins (green triangles). Correlations according to Pearson’s 
parametric method (R) or Spearman’s non-parametric method (r) are listed in each scatterplot, 
with correlation coefficients (R; r), p-values and respective regression lines provided. Correlations 
were performed for the global sample (resulting from arranging all three experimental groups 
together, black) and for Dams (red), the only group showing aggressive behaviour. A) Significant 
negative correlation in dams between the logarithm (base 10) of the latency to the first attack and 
the number of OXT neurons. B) Non-significant trend to positive correlation in dams between 
the logarithm (base 10) of the latency to the first attack and the density of pSTAT5 
immunoreactive cell nuclei in the AC/ADP. C) Non-significant trend to negative correlation in 
dams between the number of attacks and the density of pSTAT5 immunoreactive cell nuclei in 
the AC/ADP. 
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DAMS 
OXT cell 
number 
pSTAT5 density 
% pSTAT5 over 
OXT neurons 
% pSTAT5 over 
OXT-negative 
neurons 
Log10 (latency 
to first attack) 
R= - 0.784 
p=0.021* 
R= 0.684 
P= 0.061(*) 
R= 0.440 
p= 0.275 
R= 0.579 
p= 0.133 
Total attack 
duration 
R= 0.434 
p= 0.282 
R= - 0.614 
p= 0.106 
R= 0.004 
p= 0.993 
R= - 0.503 
p= 0.204 
Number of 
attacks 
R= 0.377 
p= 0.357 
R= - 0.649 
p= 0.081(*) 
R= 0.066 
p= 0.876 
R= - 0.428 
p= 0.290 
 
Table 3.2 Correlations between maternal aggression and AC/ADP OXT and pSTAT5 
expression 
Summary of the explored correlations between behavioural variables of maternal aggression 
(logarithm of the latency to first attack, total attack duration and number of attacks) and 
histological variables of OXT and pSTAT5 expression measured in the AC/ADP (number of 
OXT neurons, pSTAT5-ir density, percentage of pSTAT5 expression over OXT neurons and 
percentage of pSTAT5 expression over OXT-negative neurons) in the dam group. For each 
correlation, the correlation coefficient (R) as well as the statistical significance (p) are listed. All 
the depicted correlations were performed using Pearson’s parametric method. Neither 
godmothers nor virgins were analysed separately, as they did not display any aggressive 
behaviour. Significant correlations and non-significant trends are highlighted with a red frame 
and a pink frame, respectively. *p<0.05; (*) p≤0.081. 
 
Correlational Analysis 
We searched for significant correlations between behavioural parameters of maternal 
aggression (logarithm of the latency to first attacks, total attack duration and number of 
attacks) and pSTAT5 and OXT expression in the AC/ADP. Since dams were the only group 
displaying aggressive behaviour at any rate, we restricted our analysis to this 
experimental group (Fig. 3.10 and Table 3.2). First, using Pearson’s correlation we found 
a robust and significant negative association between OXT-expressing neurons of the 
AC/ADP and the logarithm of the latency to first attack of dams (R=-0.784; p=0.021; Fig 
3.10 A) (but not with number of attacks or total attack time). This finding indicates that 
dams with increasing number of OXT neurons attack quicker. Furthermore, using 
Pearson’s method we found a strong trend to significance between pSTAT5-ir density 
and the logarithm of the latency to first attack (R=0.684; p=0.061; Fig 3.10 B) and a 
weaker trend between pSTAT5-ir density and the number of attacks (R=-0.614; p=0.081; 
Fig 3.10 C). The sign of both correlations indicates that dams with higher pSTAT5-ir 
densities are indeed less prone to attack male intruders. 
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3.4. DISCUSSION 
Maternal behaviours involve both an increased motivation for pups, which acquire 
strong reinforcing properties for dams, as well as the display of aggressive reactions for 
nest defence. Herein, we discuss the implications of our findings on the possible roles 
that PRL might play on the neural substrate of such behaviours, particularly on the 
modulation of AC/ADP neurons of the OXT system. First, we discuss the validity of our 
new test of pup retrieval to assess maternal motivation for pups. Second, we analyse the 
changes in the expression of OXT and in PRL responsiveness in the hypothalamic 
AC/ADP, resulting of prolonged pup exposure as well as pregnancy and lactation. Finally, 
we explore possible associations of different maternal behaviours (maternal aggression 
and motivated pup retrieval) with OXT expression and PRL responsiveness in the 
AC/ADP, in search of hints on the involvement of this nucleus in maternal behaviour 
regulation. 
3.4.1. MOTIVATED PUP RETRIEVAL: A NOVEL BEHAVIOURAL DESIGN FOR THE 
STUDY OF MATERNAL MOTIVATION 
In the classical view of Berridge and Robinson (1998), motivational processes are 
characterized by three main elements: “liking”, “wanting” and “learning”. Liking is an 
affective, hedonic reaction (pleasure or reward) to a reinforcer, in our paradigm pups. 
The first experiences with a given reinforcer elicit learning processes of different kinds 
(conditioned stimulus association, stimulus-response association). Wanting describes 
how attention is directed towards a given stimulus that possesses incentive salience 
(directional aspects of motivation) and how resulting behaviour is energized 
(activational aspects of motivation) to reach (or avoid) the given reinforcer (Salamone et 
al. 2016) . The learning processes associated with the first experiences with a reinforcer, 
in turn, lead to a strong wanting for it and its related stimuli. This wanting represents 
motivation associated to a reward. In line with this paradigm, maternal motivation can 
be defined as a sustained state where pups and all the stimuli associated with them 
acquire incentive salience and elicit proactive maternal responses (i.e. involving 
directional and activational processes) in the female (Olazábal et al. 2013).  
Among the multiple components of maternal behaviour, pup retrieval is commonly 
regarded as the canonical example of a proactive, pup-directed (motivated) maternal 
behaviour (Champagne et al. 2004; Gammie 2005; Numan and Woodside 2010). Hence, 
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conventional pup retrieval tests are usually chosen to assess levels of maternal 
motivation in rodents (Pedersen et al. 2006; Bayerl et al. 2014). Following this rationale, 
there have been several attempts to characterise the acquisition of maternal motivation 
in different models of maternal sensitisation in rodents. In the rat, for instance, virgin 
females that initially avoid pups are able to develop some degree of maternal 
motivation after continuous pup exposure (during 8-13 days), but this level of 
motivation towards pups is low as compared to that of dams (Seip and Morrell 2008). In 
mice, conversely, the lack of an initial pup aversion among virgin females leads to an 
apparently different scenario. As our lab (Martín-Sánchez et al. 2015b) and others 
(Stolzenberg and Rissman 2011) have found, different models of pup-sensitised virgin 
females (including our godmothers) do not differ significantly from dams when facing a 
conventional pup retrieval test, they retrieve pups as quickly as lactating dams. This 
finding might lead to the erroneous impression that pup-sensitised virgins show an 
equivalent motivation for pups to that of dams, since this classical test of pup retrieval 
requires no especial effort, that is, does not regard activational aspects of motivation. 
Motivational processes influence decision making by balancing effort and reward of a 
given incentive stimulus (Salamone et al. 2016). Hence, proactive maternal behaviours 
might be easily expressed under lower levels of maternal motivation if the context is not 
challenging enough for the individual to reach the incentive stimulus. In other words, 
pup retrieval tests performed in the home cage under standard conditions might require 
very low motivation thus not allowing discrimination between dams and virgin female 
mice.  
For this reason, we have developed a novel variant of the pup retrieval paradigm in 
which pup retrieval must be performed under a challenging situation, requiring a high 
motivation given the strong effort of bringing pups back to the nest. Our design, termed 
“motivated pup retrieval”, consists of a pup retrieval assay where experimental animals 
must overcome an obstacle (climb a 10-cm high wire-mesh wall or barrier) and climb it 
back with the pups. The design of this test is adapted from effort-related decision 
making paradigms, which assess motivation by confronting the experimental animals 
with the choice of a high effort/high reward stimulus and a low effort/low reward 
stimulus (Yohn et al. 2016).  
Our results confirm the validity of our novel design for the measurement of motivation 
for pups. Previous designs have employed alternative strategies in which access to pups 
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also posed a challenge, for instance facing a T-maze (a new, anxiogenic environment) 
(Bridges et al. 1972; Stern and Mackinnon 1976; Mackinnon and Stern 1977; Mayer et al. 
1979). These strategies involve not just motivation but fear or anxiety that the female 
has to overcome. Since this emotional responses are also altered in dams, as compared 
to virgin females (Neumann et al. 2000), these tests do not properly separate the 
maternal motivation from fearfulness or anxiety. By contrast, the barriers in our test do 
not elicit any anxiety or even aversive response, as indicated by the number of barrier 
crossings performed by our experimental animals (Fig 3.3A) which is similar in all three 
groups of females. On the other hand, our results support the conclusion by Martín-
Sánchez et al. (2015b) indicating that pups themselves are not anxiogenic or aversive for 
virgin females. In fact, even if the females have to cross the barriers to contact the pups, 
latency to pup contact and total contact time are similar among all of our experimental 
groups (Fig. 3.3B and C). Therefore, differences among the females must pertain to 
motivation.   
As expected, dams displayed significantly higher levels of pup retrieval than pup-naïve or 
sensitized virgins (godmothers; Figs. 3.4 and 3.5), which virtually did not retrieve pups in 
the first tests. This finding evidences that continuous pup-derived sensory stimulation 
alone is not able to induce maternal motivation in comparable levels to dams, in 
contrast to what was previously thought (Stolzenberg and Rissman 2011; Martín-
Sánchez et al. 2015b). Thus, neuroendocrine inputs of pregnancy and lactation (likely 
including PRL) are indispensable for the development of full maternal motivation. Even if 
dams displayed a significant improvement in motivated pup retrieval through the 
experiment (Fig 3.5), this might not reflect an increase in motivation but a procedural 
learning: in the first trial, latency to pup retrieval is longer probably due to the time it 
takes to look for and find a solution to the challenge of carrying pups through the 
barrier. Once they find the solution, dams show no further improvement (trials 2 and 3; 
Fig. 3.5), indicating full maternal motivation. 
Furthermore, although godmothers and pup-naïve virgins initially displayed no pup 
retrieval (Figs 3.4 and 3.5), godmothers improved progressively in subsequent trials and 
by trial 3 displayed consistent pup retrieval, thus significantly differing from pup-naïve 
virgins (Fig. 3.4). This finding has two important implications. First, it indicates that 
prolonged pup exposure is also able to induce certain motivation for pups, although not 
as effectively as its synergistic action with endocrine signals of pregnancy and lactation. 
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Second, this gradual acquisition of motivation for pups reflects a process of maternal 
sensitisation in virgin female mice. Therefore, even if virgins show quasi-spontaneous 
maternal behaviour, they are still subject to a sensitisation process in which pup stimuli 
alone are able to increase motivation for pups.  
Summarizing, we have developed and validated a novel design for the study of maternal 
motivation based on the pup retrieval test and the effort-based decision making 
paradigm. This design has revealed clear differences in maternal motivation between 
dams and pup-sensitised virgin females (godmothers). This group, in turn, experiments a 
progressive increase in maternal motivation as a result of a continuous pup exposure, 
leading to consistent but not fully maternal levels of motivation for pups. Altogether, 
even if both pup stimuli and endocrine signals of motherhood contribute to the onset 
and maintenance of maternal motivation, neuroendocrine adaptations of the maternal 
brain are instrumental for the timely development of full maternal motivation.  
3.4.2. OXYTOCIN EXPRESSION AND PROLACTIN RESPONSIVENESS OF THE 
AC/ADP: CHANGES DURING LACTATION 
Given the prominent role of OXT in maternal physiology and behaviour (Bosch and 
Neumann 2012; Kim and Strathearn 2016), the neural system in charge of the 
production and release of this nonapeptide is a primary target to undergo maternal 
adaptations. Among the different populations integrating the central OXTergic 
pathways, the OXT neuron population of the AC/ADP (Otero-García et al. 2015) is a 
normally underscored but interesting object of study, given its privileged position in the 
BSTv/MPA region of the preoptic hypothalamus (key site in maternal behaviour 
regulation, Terkel et al. 1979; Numan et al. 1998; Consiglio and Bridges 2009). In 
addition, as shown in Study 2, this is one of the regions in which pSTAT5-ir is increased 
during pregnancy and lactation. For the above stated reasons, in the present work we 
conducted an immunohistochemical analysis of OXT and pSTAT5 expression in the 
AC/ADP region of both of our experimental samples (tested for maternal aggression and 
for motivated pup retrieval, respectively). In this section, we will focus on commenting 
changes in AC/ADP OXT neurons and PRL responsiveness in lactating dams, reflecting 
possible hints of maternal adaptations of this brain region. Conversely, the effects of 
pup exposure on OXT and PRL signalling in the AC/ADP of godmothers will be discussed 
below (section 3.4.4). 
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Concerning OXT, we found no significant changes in the number of OXT-expressing 
neurons in the AC/ADP of lactating dams, godmothers or pup-naïve virgins of neither of 
both experimental samples (Fig 3.7B). This replicates previous data of our lab (Martin-
Sanchez 2016) excluding the possibility of new OXT neurons appearing during 
motherhood, or that previously existing neurons of the AC/ADP began to express OXT. 
Rather than changes in the size of the OXT population, it is reasonable to expect more 
subtle changes in the activity of OXT neurons associated to lactation (Sirzen-Zelenskaya 
et al. 2011; Kim and Strathearn 2016). A possible outcome of such changes could be an 
increase in OXT production, but this cannot be properly measured with the methodology 
employed in this work. 
 Regarding PRL signalling in the AC/ADP, our data show a significant increase in pSTAT5 
expression during lactation in both experimental samples (maternal aggression and 
motivated pup retrieval), as compared to pup-naïve virgin females and godmothers (Fig. 
3.7A). This observation is in line with our previous findings (chapter 2 of this work) of 
heightened PRL-derived signalling in the AC/ADP region during lactation, in the context 
of an increased PRL input of the whole BSTv/MPA area during motherhood. However, it 
is worth mentioning that lactating dams of the two experimental samples show 
significant differences in the density of pSTAT5 expression, with dams tested for 
aggression showing significantly greater density (p=0.019 on a t-test for independent 
samples, data not illustrated in Fig 3.7A) than dams tested for motivated pup retrieval 
(Fig. 3.7A). The reason for this difference is unknown, because the observed difference 
appears to be specific of the groups of lactating dams and not shared by all three 
experimental groups. Furthermore, it is worth reminding that experimental females of 
both experiments shared equivalent ages (10-11 weeks), housing conditions, number of 
pups per litter (8) and were sacrificed with only one day difference (PPD5 and 6 for 
motivated pup retrieval and maternal aggression, respectively). However, it should also 
be noted that behavioural testing was carried out by different experimenters at 
different time points. Anyhow, this leads to pose the question of whether behavioural 
testing (i.e. resident-intruder test versus maternal motivation test) had a differential 
influence on PRL signalling in dams. Given the well-known role of PRL in the stress 
response (Neill 1970; Torner et al. 2001), the stressing nature of aggression tests might 
be at the base of the observed differences in pSTAT5-ir levels in dams, coincidentally the 
only group in which testing elicited aggression. Further research is required to address 
this particular issue. 
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In a functional study using c-Fos expression mapping, Tsuneoka and collaborators (2013) 
showed a substantial increase in c-Fos expression in response to pup interaction in a pup 
retrieval test among the OXT neurons of the  AC/ADP in postpartum females, as 
compared to virgin females. This strongly suggests that, because of pregnancy and 
parturition, the AC/ADP OXT neurons increase their responsiveness to pups, implying a 
possible participation in maternal behaviours. There are two possible mechanisms 
mediating this change on AC/ADP OXT cells. On the one hand, pup-sensitive cells that 
did not express OXT at histochemically detectable levels in the brain of virgin mice could 
start expressing OXT after delivery. Our results contradict this possibility, as we found no 
significant differences in AC/ADP OXT cell number between virgins (either pup sensitised 
or not) and lactating dams in neither of both experimental samples (Fig 3.8 A and 3.9 A). 
Alternatively, pup-insensitive, OXT-expressing cells in the brain of virgin females could 
become pup-responsive, which is more likely in the light of our data. In this case, the 
increase in pup responsiveness of these cells could be conveyed either through 
endocrine stimulation (likely including PRL) or, alternatively, through non-endocrine 
mechanisms, where pup-derived sensory stimulation would play a greater role.  
Given these possibility, we tested the hypothesis that PRL might be at the base of the 
maternal increase in pup responsiveness specifically of AC/ADP OXT cells. To explore 
this, we characterised the specific targets of the input of PRL on the AC/ADP by 
analysing the percentage of pSTAT5 expression over total OXT-positive neurons and over 
total OXT-negative neurons in the AC/ADP of virgins, godmothers and lactating dams. 
Even though our analysis revealed an important percentage of OXT-responsive neurons 
in the AC/ADP (roughly a 70% of the total OXT neurons), we found no significant 
changes in this percentage between lactating dams and the remaining groups of virgin 
females. However, PRL input over OXT-negative neurons in the AC/ADP did increase 
significantly during lactation, as compared to virgins (Fig 3.8). This increase was highly 
significant in our maternal aggression sample (p<0.01, Fig 3.8 A), whereas the sample 
tested for motivated pup retrieval showed a weak trend to significance (p=0.093, Fig 3.8 
B). Our data indicate that PRL input over OXT neurons of the AC/ADP is similar in virgin 
and postpartum females, but OXT-negative neurons surrounding this OXT population do 
receive a significantly increased PRL input during postpartum. Therefore, the increased 
sensitivity of OXT neurons to pup stimuli in postpartum, reported by Tsuneoka et al. 
(2013) is likely not due to a direct action of PRL over OXT neurons.  
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This finding leaves an open scenario with multiple, non-mutually exclussive possibilities 
to explain the maternal increase in pup responsiveness of the AC/ADP OXT population 
(shown by Tsuneoka et al. 2013). On the one hand, a modulatory role of PRL at other 
levels of the circuit would still be plausible. In fact, PRL could modulate AC/ADP OXT 
neurons indirectly through adjacent interneurons, which according to our data could 
receive an increased PRL input. Alternatively, PRL could also modulate other nodes of 
the circuit, either upstream or downstream the AC/ADP. Figure 3.12 summarizes some 
of the possible sites of action of PRL to mediate this process. 
In this sense, some afferents from key regions of the SBN that project to the AC/ADP and 
in which we found significant increase of pSTAT5-ir likely contribute substantially to the 
process, too. For instance, neuroanatomical tract-tracing studies indicate an afferent 
connection between the medial amygdala, a classic region receiving and integrating 
chemosensory stimuli, to the AC/ADP region (Pardo-Bellver et al. 2012). The medial 
amygdala can convey inputs of pup-derived chemical stimuli over the AC/ADP which, 
along pup vocalizations (D’Amato et al. 2005), are key for the females to identify their 
pups. Moreover, Scott et al. (2015) identified a sexually-dimorphic dopaminergic neuron 
population in the AVPV region of the preoptic hypothalamus (AVPe) that, according to 
their model, delivers pup-derived stimuli (although it is not specified which and from 
where) to different OXT neurons to promote maternal care. Even though the authors 
focus on analysing the projection of these dopaminergic cells to the Pa, their results 
indicate that these do also project to the AC/ADP region, resulting in another candidate 
to convey pup-derived sensory inputs to the AC/ADP OXT neurons. Remarkably, PRL 
could also have a role modulating these inputs, as supported by our findings in Study 2 
that the MePD and AVPe display a substantial response to PRL during pregnancy and 
lactation. These possibilities are summarized in a speculative model in Fig 3.XX, but, 
anyhow, this issue requires further exploration, of the connectivity and functional 
responses of the AC/ADP during the maternal period. 
3.4.3. PROLACTIN RESPONSIVENESS OF THE AC/ADP REGION: EFFECT OF PUP 
EXPOSURE 
This study is, to our knowledge, the first evaluation of the effect of maternal 
sensitisation on PRL-derived signalling in the female rodent brain.  Our experimental 
design included a group of “godmothers”, virgin females cohabitating with dams and 
pups. As a reminder, godmothers display: (1) pup-directed allomaternal care in virtually 
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equivalent levels to dams (Martín-Sánchez et al. 2015b); (2)  significantly lower 
motivation for pups than dams (our results); (3) no maternal-like aggression towards 
intruders (Martín-Sánchez et al. 2015a). This model constitutes an opportunity to study 
not only the behavioural consequences of prolonged pup exposure, but also possible 
neuroendocrine effects in the female brain underlying maternal sensitisation.   
Two main, not mutually exclusive options stand out when considering the neural 
mechanisms directing the process of maternal sensitisation. First, continuous pup 
exposure could activate endocrine mechanisms (such as the release of PRL in response 
to pup stimulation of the ventral trunk area Cservenák et al. 2013), that would 
contribute to maintenance of lactation and maternal behaviours (Garland and Svare 
1988). As exemplified here, PRL is a major candidate to mediate such mechanisms. 
Alternatively, pup stimulation could also trigger maternal sensitisation through non-
endocrine mechanisms, e.g. the action of pup-derived stimuli exclusively through neural 
sensory pathways. In this regard, our data indicate that, at least in the AC/ADP region, 
five days of continuous pup exposure to pups did not trigger any significant change in 
the level of PRL responsiveness in godmothers (Fig. 3.7). Nevertheless, this does not 
exclude the possibility that other relevant brain regions exhibit different profiles in 
response to persistent pup stimulation. In fact, female mice bearing a deletion of the 
PRLR gene showed significant deficits in pup retrieval as compared to wild-type females 
(Lucas et al. 1998a), suggesting a putative PRL-mediated mechanism intervening in the 
process of maternal sensitisation. In addition, in species with biparental care, paternal 
behaviour is associated with PRL-associated endocrine changes elicited by pup 
interaction and with prior paternal experiences (Brown et al. 1995; Ziegler and 
Snowdown 2000). Therefore, it is feasible to expect a similar mechanism at the base of 
allomaternal care in virgin female mice. Altogether, a systematic analysis of pSTAT5 
expression throughout the brain is warranted to detect possible critical areas of PRL 
action in the process of maternal sensitisation.  
3.4.4. ROLE OF THE AC/ADP IN MATERNAL BEHAVIOUR: CORRELATIONAL 
ANALYSIS 
For the final stage of this study, we confronted our behavioural data on motivated pup 
retrieval and maternal aggression with our histological data on OXT expression and PRL-
derived signalling on the AC/ADP. In doing so, we sought to find associations hinting 
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possible roles of the AC/ADP region in the regulation of maternal behaviours within the 
experimental groups that did express these behaviours.   
Maternal motivation 
According to our findings, the number of AC/ADP OXT-expressing neurons correlated 
negatively with the total number of retrieved pups in both the dam and the godmother 
group. In the first place, these findings lend further support to the effect of maternal 
sensitisation on motivation reported in this study. As illustrated in Figure 3.11, the slope 
of the regression lines is similar for godmothers and dams, with lower levels of retrieval 
in godmothers as compared to dams. In addition, these correlations indicate that the 
greater the OXT neuron population of the AC/ADP, the lower motivated pup retrieval 
performance. This is at first surprising in the view that OXT is well-known to promote 
maternal care rather than hinder it (Bosch and Neumann 2012). Nevertheless, this 
finding can be better understood in the context of anxiety. The release of OXT in 
different brain sites like the Ce or the Pa has been attributed anxiolytic properties 
(Blume et al. 2008; Knobloch et al. 2012). On the other hand, anxiety may exert complex 
and seemingly paradoxical effects on maternal behaviour expression, as reported by the 
observation of female rats selectively bred for high (HAB) or low (LAB) anxiety (Bosch et 
al. 2005). For instance, HAB rats, which show high innate anxiety persisting through the 
maternal period, do also display a highly protective parenting style, including high levels 
of maternal care and comparatively low latencies in pup retrieval tests (Bosch 2011). 
Thus, in the context of our results, if OXT release from the AC/ADP OXT were related to 
the regulation of stress and anxiety, as is the case for OXT released in the Ce and Pa, it is 
feasible that the number of AC/ADP OXT neurons correlate negatively with pup retrieval 
performance. In other words, dams and godmothers with less OXT-expressing neurons 
in the AC/ADP would display higher levels of anxiety and would retrieve pups even more 
eagerly in the motivated pup retrieval test, reflecting a more protective parenting style. 
Anyhow, this result suggests that the AC/ADP OXT neuron population would not be 
directly involved in mediating an increase in maternal motivation, but likely linked to 
maternal care through its effects on anxiety.  
Regarding PRL, we found no direct evidence to link changes in the input of PRL on the 
AC/ADP to the expression of motivated pup retrieval. Neither pSTAT5-ir in the whole 
AC/ADP region nor percentage of pSTAT5 expression in OXT-positive or OXT-negative 
neurons of the AC/ADP correlated significantly with motivated pup retrieval (Table 3.2). 
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This suggests that there is no direct involvement of PRL action on the AC/ADP in the 
regulation of maternal motivation. 
Maternal aggression 
In the present study, we found additional correlations linking OXT and maternal 
aggression. The number of AC/ADP OXT-expressing neurons is negatively correlated with 
the logarithm of attack latency to intruder males in dams. Hence, lactating dams with 
greater number of OXT-expressing cells in the AC/ADP tend to have quicker displays of 
maternal aggression. This evidence is coherent with previous findings of our lab (Martín-
Sánchez et al. 2016) positively correlating maternal aggression with OXT expression in 
the AC/ADP. It is worth noting, nevertheless, that this study found significant 
correlations with other measures of maternal aggression, i.e. number of attacks and 
total attack duration, which we did not replicate directly. This might be due to slight 
differences in the sampling of the AC/ADP in both studies but in any case reveals 
coherent correlations linking higher levels of maternal aggression with bigger AC/ADP 
OXT neuron populations. Importantly, other measures of OXTergic activity have been 
also linked positively to maternal aggression. For instance, it has been reported how, in 
postpartum dams, maternal aggression displays are coincident with increased release of 
OXT in the central amygdala (Ce) and the hypothalamic paraventricular nucleus (Pa) 
(Bosch et al. 2005). The release of OXT in these sites, in turn, has been attributed 
anxiolytic properties, as commented above. In turn, anxiety has been negatively 
correlated to maternal aggression in mice, so that lower levels of anxiety are linked to 
higher maternal aggression (Maestripieri and D’Amato 1991; Maestripieri et al. 1991; 
Parmigiani et al. 1999). Altogether, higher OXT activity and release in the Ce and Pa 
would lead to a decrease in anxiety and to an enhancing effect on maternal aggression. 
Our findings regarding AC/ADP OXT neurons suggest, in turn, that this OXT population 
might also be involved in the release of OXT in the Ce and Pa and its anxiolytic, 
aggression-promoting effect. Further analysis of the OXT terminals of the AC/ADP and 
Pa of our specimens will contribute to test this hypothesis. 
Regarding PRL, we found no direct evidence to consistently link changes in the input of 
PRL on the AC/ADP to the regulation of maternal aggression. However, we did find two 
moderate but non-significant correlations among dams. According to them, pSTAT5-ir in 
the AC/ADP correlated positively with the latency to first attack (on a logarithmic scale) 
and negatively with the number of attacks. These trends indicate a possible negative 
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association between PRL action in the AC/ADP and maternal aggression: the higher 
levels of PRL-derived signalling, the lower aggression. The functional significance for this 
association is unknown, but it could possibly involve the modulation of OXT release by 
AC/ADP neurons to exert a fine-tuned inhibitory control over the expression of maternal 
aggression. More evidence is needed to test this hypothesis. 
 
Figure 3.12 Possible role of AC/ADP oxytocinergic neurons in maternal behaviour 
regulation  
Speculative model integrating evidence from this and previous work on the putative roles of 
AC/ADP OXT neurons in maternal behaviour regulation. According to Tsuneoka et al. (2013), 
AC/ADP OXT neurons (red) become pup responsive during the postpartum period. This 
process could be mediated by the indirect input of PRL (green) on other related neurons of the 
AC/ADP (black), according to our evidence. Alternatively, it could also be mediated by the input 
of PRL or on other nuclei upstream the AC/ADP conveying pup-derived stimuli, or a direct 
action of these nuclei. Putative nuclei relaying pup-derived stimuli to the AC/ADP include the 
MePD (Pardo-Bellver et al. 2012) or the AVPe, which contains a sexually-dimorphic 
dopaminergic pathway (purple) responsible for this particular function (Scott et al. 2015). In turn, 
AC/ADP OXT neurons could possibly project to other nuclei or pathways involved in proactive 
(motivated) maternal behaviour (mesolimbic dopaminergic pathway) or maternal aggression (Ce, 
Pa, LS and/or BST, Davis and Shi 1999; Bosch and Neumann 2012), releasing OXT to exert an 
anxiolytic effect. 
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Role of AC/ADP in the maternal period 
The correlational analysis of both experiments (motivated pup retrieval and maternal 
aggression) does not support a direct role of AC/ADP OXT neurons in maternal 
behaviour. However, they do suggest a direct action on stress and anxiety regulation, as 
discussed above, which in turn would influence both maternal care and aggression. To 
further contrast this hypothesis, it would be advisable to analyse the projections of 
AC/ADP OXT neurons to other brain sites that participate in the control of stress and 
anxiety, for instance the Pa (Blume et al. 2008), the septum (Numan and Insel 2003), the 
anterodorsal BST or the Ce (Davis and Shi 1999). Hence, it would be of interest to 
explore putative functional and/or anatomical connections between the AC/ADP and 
these centres. In this regard, the OXT neurons of the AC/ADP, located just rostral from 
those of the Pa, have been proposed to build an anatomical and functional continuum 
with the latter, based on evidence of common developmental origin (Otero-García et al. 
2015). 
Altogether, our findings and those of others reflect the high complexity of maternal 
behaviour regulation. The different components of maternal behaviour (maternal care 
and aggression) are integrated by different (Fig I.8) but partially overlapping (the SBN, 
Fig I.6) neural substrates. These, in turn, might be differentially modulated by other 
neural responses, e.g. stress and anxiety, as proposed here. 
3.4.5. CONCLUSIONS  
In this chapter, we have analysed the involvement of the OXTergic neuron population of 
the AC/ADP in the regulation of maternal aggression and motivated maternal care. We 
have also tested the interaction of PRL with this OXT population in Dams, Godmothers 
(subject to maternal sensitisation) and naïve Virgins. On the behavioural side, and in 
addition to maternal aggression (discussed here, Martin-Sánchez et al. 2015a), we have 
found that the acquisition of full maternal motivation requires the action of 
neuroendocrine signals of motherhood. However, maternal motivation also increases 
gradually as part of a process of maternal sensitisation driven by continuous pup 
exposure in females not undergoing the hormonal changes associated to pregnancy, 
delivery and lactation.  
Furthermore, we have analysed changes in OXT expression and PRL-derived signalling in 
the AC/ADP during lactation and under continuous pup exposure. According to our 
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findings, both OXT neuron number and PRL input over these OXT neurons remain 
unchanged in postpartum females as compared to virgins, but PRL action onto the 
AC/ADP increases in postpartum females, specifically in OXT-negative neurons. These 
findings do not fit the hypothesis of a direct maternal modulation of the activity of this 
OXT cell population by PRL, but do not rule out the possibility of an indirect regulation 
through other AC/ADP neuron populations. 
Finally, we performed a correlational analysis to link our behavioural and histological 
measures. This analysis revealed a significant positive correlation between the number 
of AC/ADP OXT neurons with maternal aggression and a significant negative correlation 
with motivated pup retrieval. In spite of seeming contradictory at first, these findings fit 
the explanation that AC/ADP OXT neurons are involved in anxiolysis, leading thus to 
increased aggression and preventing the expression of a protective mothering style. 
Moreover, we found a non-significant trend for a negative correlation between pSTAT5-
ir density in the AC/ADP and maternal aggression, suggesting a possible inhibitory 
control of aggressive behaviour through modulation of AC/ADP function. Overall, these 
data reflect complex and multifactorial roles of OXT in the expression of maternal 
behaviour, as well as a complex regulatory interaction of PRL with the OXT neuron 
population of the AC/ADP.  
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Prolactin is a pleiotropic hormone that has in the brain one of its most remarkable 
signalling targets. Despite being a polypeptide, this hormone gains access to the CNS 
bypassing the blood-brain barrier to exert multiple central functions. The present work 
provides a comprehensive analysis of the neuroanatomical distribution of the signalling 
exerted by PRL in the mouse brain, both in males and females. In addition, given the 
close link between PRL, reproductive function and its neuroendocrine control, we have 
evaluated how gonadal steroids (estradiol and progesterone in females, testosterone in 
males) contribute to shape the aforementioned patterns of PRL signalling in the male 
and female brain. The most well studied roles of PRL are related to the period of 
motherhood, where this hormone drives central changes to adapt the female’s 
physiology and behaviour to the particular demands of motherhood. For this reason, we 
have also characterised the distribution and extent of the changes in central PRL-derived 
signalling patterns in the pregnant and lactating female brain. The expression of 
maternal behaviour is one of the most remarkable maternal adaptations, and includes 
maternal care driven by a high motivation for pups, and the territorial defence of the 
pups and nest site, maternal aggression. In this work, we have also analysed the 
involvement of PRL in the onset of these behaviours, specifically maternal motivation 
and maternal aggression, with a particular focus on the action of PRL over a particular 
OXTergic neuron population, located in the AC/ADP.  
The following section will be devoted to discuss the functional implications of the 
findings reported in this work. We will first comment on how PRL might gain access to 
the brain to produce the signalling patterns we have reported. Then, we will analyse the 
possible involvement of PRL in the central regulation of central homeostatical and 
reproductive functions in the brains of males and females (maternal or not). Finally, we 
will focus on revisiting the roles of PRL and other lactogenic signals mediating the 
expression of maternal behaviours.  
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 PROLACTIN CROSSES THE BLOOD BRAIN BARRIER TO 
MODULATE BRAIN FUNCTION 
The first outcome of our findings throughout the present work is the confirmation of the 
sensitivity of the brain to PRL. In fact, the brain is responsive to the hormone in males 
and females in different reproductive stages. It is generally assumed that the central 
patterns of PRL responsiveness examined in this and other works are elicited by 
systemic PRL, mainly, if not entirely, of hypophyseal origin. For PRL signalling to occur in 
the brain, PRL must first gain access to the CNS from the bloodstream. Circulating PRL is 
classically thought to bypass the Blood-Brain Barrier (BBB) into the cerebrospinal fluid 
(CSF) at the level of the choroid plexus, by means of a transportation mechanism 
dependent on the PRLR (Walsh et al. 1987). In addition, circumventricular organs might 
provide an exceptional access point of PRL to the CSF, too (Ganong 2000).  
However, this view has been recently challenged by a study where radiolabelled PRL 
access to the brain was examined in PRLR-knockout female mice (Brown et al. 2015). 
This study concluded that the access of PRL into the brain occurs mostly unabated in the 
absence of the PRLR and, importantly, that the entrance rate through the choroid plexus 
into the CSF is too slow to explain the relatively fast response of the brain that was 
observed (45 minutes after exogenous PRL supplementation, see Section 1.2.4). 
Furthermore, it is important to recall that PRL is a protein of high molecular weight and 
size, resulting in a relatively low passive diffusion capacity through the neural 
parenchyma. Considering the relatively short half-life of the PRL molecule 
(approximately 40 minutes, Yoshida et al. 1991), if the choroid plexus and ventricular 
system were the major access point of the hormone into the brain, PRL would only 
reach and produce its signalling in sites close to the ventricular system, before being 
degraded. This situation could suffice to explain the patterns of PRL-derived signalling 
found among our sample of male mice, where PRL-responsive brain nuclei were mainly 
located in the hypothalamus and distributed around the ventral part of the third 
ventricle. Conversely, it is not coherent with the more extensive patterns reported for 
virgin female mice, much less for pregnant and lactating specimens. In these animals, 
lactogenic signalling was found in locations far away from the choroid plexus and the 
ventricular system, all of which suggests the existence of alternative mechanisms to 
grant a more uniform access of PRL to the brain. Perhaps, the evident dimorphic 
differences in central patterns of PRL responsiveness we report in this work are partially 
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due (in addition to a more restricted PRLR distribution and other conditions) to different 
systems assisting the access of PRL into the brain, with females depending on alternative 
or additional mechanisms that would better fit their more extensive response patterns. 
A possible alternative access of PRL into the brain, albeit not yet properly studied, could 
be through the cerebral microvasculature. As in case of many other molecules, PRL 
could be moved by specific transporters across endothelial cells into the extracellular 
space of the brain (Dutt et al. 1994). An additional mechanism to explain this process 
could involve the production of endogenous PRL in the brain. Evidence in the literature 
points to the existence of PRL circuits in the brain, with PRL-synthetizing neurons located 
mainly in the hypothalamus and immunoreactive fibres widespread throughout the 
brain (Paut-Pagano et al. 1993; Mejía et al. 2003). This system could possibly contribute 
to some degree to elicit the pSTAT5-ir patterns analysed in the present work. In this 
sense, Torner et al. (2004) showed that PRL is released in a paracrine fashion from the 
Pa and MPA of female and male rats under certain physiological circumstances (stress, 
lactation), and that this release can be coupled or not to hypophyseal PRL release and 
subsequent rise in systemic PRL levels. Although this evidence does not demonstrate the 
intracerebral release of PRL in response to the elevation of circulating PRL (elicited in 
our study by exogenous PRL supplementation) it does indeed show that both PRL 
releasing systems (intracerebral and systemic) are not independent from each other, but 
work in an interconnected fashion to provide brain and/or body with PRL when 
required. 
 PROLACTIN REGULATES HOMEOSTATICAL FUNCTIONS 
UNDER DEMANDING SITUATIONS: STRESS AND 
MOTHERHOOD  
In the present work, we have examined and compared the patterns of PRL 
responsiveness of the mouse brain in males and females of different reproductive 
stages. Despite finding an evident sexual dimorphism and substantial differences in 
responsiveness regarding females on different physiological conditions, we have indeed 
identified a number of brain nuclei responsive to PRL common to all the described states 
(males, virgin females, pregnant females and lactating dams). This likely reflects the 
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existence of ubiquitous roles of PRL in the mouse brain, independent of sex or 
reproductive conditions.  
The most apparent and well-documented example of such role of PRL is the feedback 
regulation of its own hypophyseal release (Fig I.3). As introduced before, this negative 
feedback regulation takes place in the TIDA neurons of the Arc and in the PHDA neurons 
of the Pe, and is mediated by STAT5b (Ma et al. 2005b). Therefore, when circulating PRL 
levels are high (due to enhanced hypophyseal PRL release or to exogenous PRL 
supplementation) these dopaminergic neuron populations are increasingly activated by 
PRL through the Jak/STAT pathway and STAT5b phosphorylation, to inhibit the release of 
PRL by hypophyseal lactotroph neurons. It is worth recalling, however, that these brain 
regions also contain other PRL-responsive cell populations not related to PRL feedback 
regulation (e.g. kisspeptin neurons in the Arc, see below), so that measured levels of 
pSTAT5-ir do not necessarily predict directly levels of circulating PRL. For this reason, for 
example, PRL-supplemented male and female mice do show significantly different 
pSTAT5-ir densities in the Arc (Fig 1.3) despite both likely having equivalent, 
supraphysiological circulating PRL levels. 
Studies in lactating rodents ascribe an important role to PRL in the regulation of energy 
balance and food intake (Grattan et al. 2001). This physiological trait is controlled by a 
complex network involving several hypothalamic nuclei, as well as different 
neurochemical signals (Elmquist et al. 1999). According to our findings, some of the 
hypothalamic centres belonging to this network (namely the Arc, the VMH, the DM and 
the Pa) display responsiveness to PRL in the pregnant and lactating brain (Fig 2.1 e-h), 
but also in the brains of virgin female and the male mice (Fig 1.1 e,f and 1.3). 
Remarkably, part of these nuclei (the Arc, the VMH and the DM) are also known to 
express the leptin receptor. Leptin is an endocrine signal secreted by the adipose tissue 
that is presumed a pivotal role in the neuroendocrine control of food intake as an 
adiposity signal (Flier 1998). Taken together, our findings and the evidence mentioned 
above indicate that a similar role to that of PRL in the control of energy balance and 
food intake during motherhood might also take place in the brain of non-lactating 
females and males, under certain physiological circumstances concurrent with high 
levels of circulating PRL. 
Prolactin is also proposed to modulate anxiety and stress. First,  PRL is a neuroendocrine 
agent involved in the stress response, as stress leads both to the acute rise in systemic 
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PRL levels (Fujikawa et al. 2004; Torner 2016), as well as to the paracrine release of PRL 
from the Pa (Torner et al. 2004). The presence of pSTAT5-ir in the Pa of males and virgin 
females (Fig 1.1e and 1.3) suggests a feedback effect of PRL modulating the reactivity of 
the HPA axis, both at a systemic and at a central level (paracrine release form the Pa), an 
effect recently demonstrated in male mice (Kirk et al. 2017). Although the involvement 
of PRL in the stress response has been mainly studied in maternal individuals (Grattan 
2002), the patterns of PRL responsiveness we found show that this is extensive to non-
maternal females and males. This role of PRL would probably be mediated through the 
action on corticotropin-releasing factor (CRF) or vasopressin (AVP) cells (Mejía et al. 
2003; Aguilera et al. 2008). In fact, PRL is a well-documented regulator of the function of 
magno- and parvocellular vasopressinergic neurosecretory cells at the level of the 
hypothalamic Pa (Donner and Neumann 2009; Blume et al. 2009; Vega et al. 2010). 
Although the effect of PRL on these parvocellular AVP cells has been proven to be 
mediated by ERK/MAPK pathway (Blume et al. 2009), our data in males and females 
suggest that the Jak/STAT5 signalling cascade can also be involved. This would imply a 
non-dimorphic regulatory role of PRL on the stress response.  Further experiments are 
needed to evaluate where PRL acts directly onto AVP expressing parvocellular cells in 
the Pa.   
 In addition to its effect on the HPA axis and stress response, studies in female rats 
indicate that PRL has anxiolytic properties when acutely administered i.c.v. or i.v., 
whereas chronic i.c.v. antisense targeting of the PRLR results in increased anxiety and of 
the associated HPA axis response (Torner et al. 2001).  In contrast to females, PRL has a 
weak anxiolytic effect in males (Torner et al. 2001). This intersexual difference might be 
related to our findings of a sexually dimorphic responsiveness to PRL in the central 
structures directly involved in the regulation of anxiety and emotionality, the Ce and the 
anterodorsal BST (Davis and Shi 1999). In these nuclei, females show apparent pSTAT5 
immunolabelling, especially during pregnancy and lactation (Fig 2.6), whereas males are 
devoid of pSTAT5-ir in these structures (Fig 1.1c and d).  
In both males and females, pSTAT5-ir appears in locations of the Pa where oxytocin 
(OXT) is present, which suggests a possible action of PRL modulating OXT cells in the Pa. 
In fact, there is solid evidence demonstrating such an effect in the brain of female rats, 
both virgin (Blume et al. 2009; Sirzen-Zelenskaya et al. 2011) and lactating (Parker et al. 
1991; Ghosh and Sladek 1995). Our data indicate that this role of PRL might be 
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translatable to males, too. In addition to its conspicuous roles in maternal behaviour 
regulation, OXT subserves multiple roles in the regulation of social cognition and 
emotionality, not only in rodents, but also in other mammals, including humans (Kirsch 
2015). Hence, the notion that PRL might regulate central OXTergic pathways not only 
during the postpartum period, but also in non-maternal females and males, might be 
useful in the neuropsychiatric field. 
The essential requisite for PRL to exert the central functions discussed above is the 
presence of sufficient levels of circulating hormone to allow it to reach the respective 
brain sites. As our findings reflect, this condition is easily met in the pregnant and 
lactating female. During pregnancy (Fig I.4), systemic levels of either hypophyseal PRL 
(early pregnancy) or placental lactogens (late pregnancy) are high, whereas in the 
postpartum period, circulating PRL levels are permanently increased due to lactation 
(Anderson et al. 2006). The functional significance of the action of PRL during this 
periods is to prepare the organism to the highly demanding period of motherhood. 
Conversely, in the virgin female and male, circulating PRL levels are lower than in 
pregnant and lactating females (Guillou et al. 2015), especially in males, where the lack 
of exogenous PRL supplementation suppresses virtually all PRL-derived signal 
transduction in the brain (Fig 1.2). Consequently, our findings indicate that proper 
central responses to PRL in these animals would be facilitated only after a given PRL 
surge, when circulating PRL levels increase abruptly. Although plasma levels of PRL are 
subject to circadian rhythmicity in females and males (Guillou et al. 2015), the most 
prominent elevations of this parameter occur mostly in stressful situations, as the stress 
response and HPA axis activation lead to the release of both systemic (Fujikawa et al. 
2004; Torner 2016) and intracerebral (Torner et al. 2004) PRL (see above). In addition, 
females experiment an upregulation of the central PRL system during the estrous cycle, 
promoted by the rise in gonadal steroid levels, granting increased hypophyseal PRL 
release (Neill 1972) and increased PRLR expression within the brain (Sugiyama et al. 
1994). This leads ultimately to the increase of PRL signalling under higher gonadal 
steroid levels (Fig 1.6). Consequently, it is possible that some of the previously discussed 
roles of PRL in the brain are also facilitated during the proestrous and estrous phases of 
the estrous cycle, as gonadal steroid levels are increased. 
Summarizing, although PRL-derived signalling in the brain is clearly sexually dimorphic 
and female biased, our findings indicate that this hormone is able to access and signal in 
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the brain of both males and virgin females. This signalling would mediate homeostatical 
responses, mostly geared to adapt the brain to situations of high-energy demand and 
stress. 
 THE MATERNAL HORMONE IN THE MALE BRAIN: ROLE 
OF PRL ON MALE SEXUAL BEHAVIOUR 
A prominent function of PRL in males is the regulation of sexual behaviour (Freeman et 
al. 2000). The specific role of PRL in this context is complex and not completely 
understood. The classical view is that acute systemic PRL rises during mating mediate 
the postcopulatory refractory period of male sexual behaviour, through both peripheral 
and central actions (Krüger et al. 2002). This effect is in accordance with evidence on 
male models of chronic hyperprolactinaemia in certain species like the human and the 
rat, where sexual behaviour (as well as gonadotrophin secretion) is impaired due to this 
condition (Drago and Lissandrello 2000; Hernandez et al. 2006; Saito et al. 2013). 
However, the role of PRL seems to be opposite in other species such as the mouse, 
where males subject to chronic hyperprolactinaemia display increased rather than 
suppressed copulatory behaviour and circulating gonadotrophin (FSH, LH) levels (Bartke 
et al. 1987). 
The action of PRL on male copulatory behaviour, either stimulatory or inhibitory, most 
likely requires the hormone to directly modulate the neural pathways involved in the 
expression of male sexual behaviour. Importantly, PRL has been proposed to influence  
attentional, appetitive and consummatory motor processes related to sexual behaviour, 
integrated by three major central dopaminergic circuits: the incertohypothalamic, 
mesocorticolimbic and nigrostriatal dopaminergic pathways (Krüger et al. 2002). This 
hypothesis is based on evidence that peripheral PRL administration alters dopaminergic 
activity in the main target sites of these pathways (Lookingland and Moore 1984; Chen 
and Ramirez 1988; Hernández et al. 1994). However, it is important to remark that none 
of the brain nuclei integrating these dopaminergic pathways (nucleus incertus, ventral 
tegmental area and substantia nigra) are responsive to PRL in males (according to our 
evidence, Fig 1.1) and they do not express either form of the PRLR (Bakowska and 
Morrell 1997; Bakowska and Morrell 2003). Hence, this lactogenic modulation of 
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dopaminergic tone should be necessarily mediated by an indirect input of PRL on these 
dopaminergic populations.  
An additional candidate nucleus in which PRL might exert its actions related to sexual 
behaviour is the VMH. This nucleus is sexually dimorphic (Dugger et al. 2007), is known 
to promote the expression of copulatory behaviour in females (Kow and Pfaff 1998) and 
to inhibit mounting in male rats (Christensen et al. 1977). According to our results, the 
VMH is substantially responsive to PRL in males, showing in fact similar levels of pSTAT5-
ir as in females (Fig 1.3). In addition, our data on castrated male mice suggest that this 
responsiveness is also dependent on testosterone (Fig 1.4). Hence, PRL could be able to 
control male reproductive behaviour also through the VMH in an androgen-dependent 
fashion. The nature of this control would be species-specific, thus explaining the 
interspecies differences in the effects of PRL on male sexual behaviour.  
In addition to the VMH, evidence has been found during the last decades of the 
involvement of OXT in the regulation of reproductive behaviour. Research conducted 
fundamentally in male rats has established that the magno- and parvocellular OXTergic 
systems in the Pa are responsible for the facilitation of genital reflexes, erection and 
copulatory behaviour in response to sexual cues. For instance, significant increases in 
Fos expression (Nishitani et al. 2004; Caquineau et al. 2006) and local OXT release 
(Waldherr and Neumann 2007) have been found in the OXTergic neurons in the Pa in 
response to sexual cues or sexual interaction. In addition, paraventricular OXT neurons 
project (through the spinal cord) to several penile tissues and associated glands, thus 
facilitating genital reflexes (Veening et al. 2015). As described before, our findings reveal 
considerable levels of pSTAT5-ir in the Pa of male mice, comprising the magno- and 
specially the parvocellular division of the nucleus. This responsiveness to PRL is also 
dependent on testosterone, since castrated males display significantly lower levels of 
pSTAT5-ir in this nucleus (Fig 1.6). Therefore, PRL is likely able to control copulatory 
behaviour through the influence of OXTergic cells in the regulation of genital reflexes. 
Aside from the control of genital reflexes, OXTergic cells can also exert a high-level 
control of sexual behaviour through their action onto key centres of the hypothalamic 
circuits for sexual behaviour, such as MPO and VMH. In females, it has been shown that 
OXT can control the activity of estrogen receptor-expressing VMHvl neurons to regulate 
lordosis (Numan 2014). The existence of Pa projections to the MPO (Simerly and 
Swanson 1986; Wang and Swann 2014) and the demonstrated effects of OXT in the 
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MPO on male copulatory behaviour (Gil et al. 2011), suggest a similar regulatory action 
of paraventricular OXTergic cells on MPO populations regulating male sexual behaviour, 
which could in turn be modulated by PRL. Therefore, the presence of abundant pSTAT5-
ir in the Pa might constitute the anatomical substrate of an additional mechanism for 
the influence of PRL on male copulatory behaviour. 
 TUNING THE BRAIN FOR MOTHERHOOD: REVISITING 
THE ROLE OF LACTOGENIC AGENTS IN THE EXPRESSION 
OF MATERNAL BEHAVIOURS 
The results of the present work show that several brain nuclei belonging to the so-called 
maternal brain (Lonstein and Gammie 2002; Gammie 2005) display a substantial 
increase in lactogenic signalling during pregnancy and/or lactation, as compared to the 
basal condition in virgin females. This indicates that PRL is involved in the endocrine 
modulation of the neural centres of maternal behaviours, suggesting a possible role of 
the hormone regulating the onset and/or maintenance of maternal behaviour. 
Nevertheless, maternal behaviour is a complex behavioural phenomenon with multiple, 
differentially-regulated components and with remarkable interspecies differences. In 
this section, we will review the current evidence, provided by our work and that of 
others, on the involvement of PRL, as a major endocrine signal of pregnancy, in the 
onset and regulation of different components of maternal behaviour. 
Proactive maternal responses 
Evidence on the role of endocrine signals of pregnancy and lactation in the control of 
pup-directed maternal care in mice might seem conflicting, since, opposite to rats, virgin 
females quickly engage in allomaternal care (Martín-Sánchez et al. 2015b). Herein we 
will argue, however, that these signals are instrumental for the immediate onset of 
essential aspects of maternal care and that they might play a key role in the expression 
of these behaviours in non-maternal individuals. 
In this respect, the major finding reported in the present work is the demonstration that 
high maternal motivation towards pups is dependent on the endocrine input of 
pregnancy. Even if virgin females engage almost spontaneously in allomaternal care in 
standard, home-cage and undisturbed conditions, full motivation for pups is not 
spontaneously expressed even after pup exposure. As shown in Study 3, when faced to a 
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pup retrieval task in an effort-related decision making paradigm (Yohn et al. 2016; 
Salamone et al. 2016), where retrieving pups is challenging, only dams will complete the 
task from the first moment.  
This strongly suggests that endocrine signals (including PRL) are responsible for the 
increase in motivation for pups, by acting pre- and peripartum onto the neural pathways 
of maternal care. In this sense, the mesocorticolimbic dopaminergic pathway has been 
proposed as a key element to assign incentive value to pups and their stimuli and to 
mediate proactive maternal responses (Figs I.7 and I.8). Remarkably, our analysis of 
lactogenic signalling patterns in pregnant and lactating female mice (chapter 2) found no 
hint at all of PRL or other lactogens acting directly on this circuit (neither in the VTA 
originating the projection, nor on the targets of the projection in the striatum, Fig 2.2). 
Furthermore, neither form of the PRLR is expressed in none of these nuclei in the female 
rat (Bakowska and Morrell 1997; Bakowska and Morrell 2003), suggesting the same to 
be true in mice. Nevertheless, the BST-MPA continuum, regarded in this model as the 
master control directing the activation of the pathway for maternal responses (Fig I.7) 
does express the PRLR and is increasingly responsive to lactogenic signals during 
pregnancy and lactation, as indicated by our findings (Fig 2.2 C-E and 2.6). Consequently, 
as in rats (Bridges et al. 1990b; Bridges and Freemark 1995), the onset of fully-developed 
maternal care in the mouse might be dependent on the action of PRL in the medial 
preoptic area during late-pregnancy and the peripartum period, although partial 
increases can be achieved through pup sensitisation (Fig 3.4 and 3.5, Seip and Morrell 
2008). 
In line with this, a further point of discussion is the involvement of PRL in the expression 
of allomaternal behaviour. Even though we have advanced above that virgin female 
mice easily express allomaternal care (in the absence of the endocrine inputs of 
pregnancy), evidence stemming from gene deletion studies suggest that PRL might, at 
some point, play a greater role than expected in mediating this effect. The behavioural 
characterisation of mouse models with a targeted deletion on the PRLR gene reveals 
that both pup retrieval (proactive response) and the performance of nursing postures 
(consumatory response) are severely impaired in both heterozygous knockout dams and 
homozygous knockout virgins (Bole-feysot et al. 1998; Lucas et al. 1998b). This indicates 
that the expression of allomaternal care in mice is also dependent on PRL action.  
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There are at least three hypothesis to fit a role of PRL in alomaternal behaviour 
facilitation. In the first place, PRL could exert a rapid endocrine action on the brain in 
response to interaction with pups. In this regard, this work provides an analysis of the 
effect of continuous pup exposure (the godmother model) in the responsiveness to PRL. 
This analysis is for now limited to a single nucleus, the hypothalamic AC/ADP. In this 
region, no significant effect of prolonged pup exposure was found in the levels of PRL-
derived signalling (Figs 3.8 B and 3.9 B). Nevertheless, as discussed before, we cannot 
dismiss the possibility that pup exposure conveys a significant effect on PRL-derived 
signalling in other brain regions, thereby supporting the hypothesis here discussed. The 
analysis of the effect of prolonged pup exposure on PRL-derived signalling is going to be 
extended in the near future to the major sites of the brain involved in maternal 
behaviour expression. 
A second putative mechanism of PRL to mediate allomaternal responsiveness would 
involve a continuous facilitating input of the hormone. Even if we have found quite 
extensive patterns of PRL-derived signalling among virgin female mice, with substantial 
PRL-derived signalling in critical areas like the MPA (Fig 1.1), a continuous input of PRL is 
difficult to compromise with the general variability we have observed among virgins in 
our analysis. This adds to the fact that brain PRL responsiveness is subject to gonadal 
steroid regulation (Fig 1.6) and thus to the variance with the estrous cycle. Hence, our 
findings do not fit this hypothesis. 
Finally, PRL could also exert a sort of “preparatory effect”, hard-wiring the 
responsiveness to pups permanently in the female’s brain through an acute action at 
some point during the postnatal development of the female mouse. In support of this 
hypothesis, it has been shown that prepubertal female mice react with neophobia 
towards pups, even performing infanticide (Gandelman 1973). However, as puberty 
advances, the proportion of aversive reactions diminishes as the proportion of 
allomaternal behaviour-expressing females increases. In addition, Gandelman reports 
that prepubertal ovariectomy disrupted this increasing allomaternal predisposition. This 
lies in stark contrast with the situation in rats, which become neophobic to pups with 
puberty. In sum, the aforementioned evidence on pup-elicited reactions and on PRLR 
knockout female mice, suggests an interaction of PRL and gonadal steroids during the 
puberty of the female mouse to permanently facilitate maternal care. 
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Altogether, female mice display maternal care easily in the absence of endocrine signals 
of pregnancy, but these signals are crucial for the complete onset of maternal behaviour 
(including maternal motivation). Consequently, fully-developed maternal behaviour is 
only elicited during motherhood. In a comparative point of view, mice and rats do not 
differ as much as it appears at first glance in the relative contribution of endocrine and 
sensory factors to the regulation of maternal care (Fig I.9). In Numan and Woodside’s 
model for proactive maternal responses (Fig I.7), both species require hormones of 
pregnancy for the full development and immediate onset of proactive (motivated) 
maternal care. This endocrine input, in turn, would most likely lead to the priming of the 
MPA to facilitate the activation of the mesolimbic dopaminergic pathway. Conversely, 
continuous pup exposure elicits only a slow, progressive and partial increase in pup 
caregiving, which might also be mediated by endocrine mechanisms involving PRL. 
Hence, the major difference between rats and mice resides in the fact that adult female 
laboratory mice lack an active neural pathway mediating avoidance responses to pups. 
This neural pathway for avoidance responses might be active at some point in the 
female’s life, but appears to be inhibited during puberty (Gandelman 1973), possibly by 
PRL in interaction with gonadal steroids. Interestingly, the suppression of this aversive 
pathway seems to be a consequence of artificial selection in mouse housing colonies, 
since only laboratory mice engage so easily in allomaternal behaviour, whereas feral 
female mice tend to commit infanticide on unfamiliar pups (D’Amato 1993; Numan and 
Insel 2003). In sum, PRL might play a greater role than previously thought in the 
regulation of maternal- and allomaternal responses in the female mouse.  
Maternal aggression 
In contrast to maternal care, maternal aggression in mice is observed exclusively in 
dams. Gonadally-intact virgin females, even after prolonged intimate contact with pups, 
do not attack intruders approaching the nest (Martín-Sánchez et al. 2015a). Therefore, 
the induction of maternal aggression in mice is most likely dependent on endocrine 
factors involved in pregnancy and/or lactation, which, like in rats or hamsters (Wise and 
Pryor 1977; Mayer et al. 1990), would include PRL and placental lactogens. Consistent 
with this possibility, we found pSTAT5-ir in the nodes of the circuit for maternal 
aggression in our pregnant-lactating females (Lonstein and Gammie 2002; Gammie 
2005), illustrated on Figure I.8 . This network comprises the lateral septum (Brady and 
Nauta 1953), the BST (Klampfl et al. 2014), the medial and central amygdala (Bosch and 
Neumann 2010; Unger et al. 2015), the MPA and MPO in the preoptic hypothalamus, 
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the Pa in the anterior hypothalamus and the VMH in the tuberomammilar hypothalamus 
(Toth et al. 2010; Lin et al. 2011; Yang et al. 2013), the paraventricular thalamus (PV) and 
the caudal PAG (Lonstein and Stern 1997), the peripeduncular region (Factor et al. 1993) 
and the locus coeruleus (LC) in the midbrain. Indeed, virtually every site in this network 
included in our quantitative evaluation experiments a significant increase in lactogenic 
signalling during pregnancy and/or lactation (Fig. I.6).  
Despite this evidence, the role of PRL in the expression of maternal aggression has been 
dismissed according to observations that hypophysectomy (Erskine et al. 1980) or 
bromocriptine treatment (Mann et al. 1980) conducted postpartum, do not disrupt 
maternal aggression. In addition, Broida et al. (1981) observed no correlation between 
serum PRL levels and maternal aggression in lactating dams. Instead, pup-derived 
sensory stimulation of the dams has been proposed as the pivotal factor promoting 
maternal aggression (Garland and Svare 1988). In this work we show, however, that the 
lactogenic modulation of brain function leading to a maternal state occurs mainly during 
late pregnancy (see above). Therefore, prolonged action of lactogenic agents during 
pregnancy, and not its acute action after parturition, could promote the onset of 
maternal aggression. Consistent with this, PRL-induced maternal sensitisation in virgin 
rats is also dependent on prolonged PRL priming, e.g. continuous administration of 
exogenous PRL (Loundes and Bridges 1986) or prolonged exposure to estradiol eliciting 
hypophyseal PRL release (Bridges and Ronsheim 1990), rather than acute PRL action. If 
this were also the case for maternal aggression in mice, the aforementioned lactogenic 
suppression strategies (hypophysectomy or bromocriptine treatment) applied 
postpartum would have a minor effect on maternal defence, since these are approaches 
aimed at testing not the onset but rather the maintenance of this behaviour.  
In further support of this hypothesis, Mann et al. (1984) reported aggression in pregnant 
female mice against conspecific intruders already during gestation day 14, when neither 
pup stimuli nor hypophyseal PRL can play a role, but lactogens are already acting on the 
brain, according to our results. Nonetheless, contact with pups and the correct 
processing of pup-derived stimuli, such as suckling stimulation conveyed by the PIL 
(Cservenák et al. 2010; Cservenák et al. 2013) or chemosignal stimuli processed by the 
MePD (Pardo-Bellver et al. 2012), may be major factors in the maintenance (rather than 
the onset) of maternal aggression. In fact, information derived from pup chemosignals 
and from suckling stimulation may converge in the medial amygdala, since it receives 
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projections from the main and accessory olfactory bulbs and the PIL (Cadiz-Moretti et al. 
2016). To sum up, evidence in the present work lends further support to the hypothesis 
that in the mouse, lactogens operating during late pregnancy fulfil an instrumental role 
in the onset of maternal aggression, through the extensive modulation of the neural 
pathways integrating this behaviour.  
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1. Both male and female brains are responsive to PRL, provided sufficient circulating 
levels of the hormone (e.g. after exogenous administration). However, brain PRL-
derived signalling patterns are sexually dimorphic and female biased, in both 
qualitative and quantitative terms. Signalling in the female brain is most abundant 
in the hypothalamus, but extensive to the amygdala, BST, septum and to discrete 
thalamic and midbrain areas. In the male brain, PRL-derived signalling is restricted 
to circumventricular hypothalamic sites, with the exception of the 
septofimbrial/triangular septal area and the subfornical organ. 
2. Lactogenic signalling in the female brain is regulated by estradiol and 
progesterone. In the analysed nuclei, estradiol has a general promoting effect of 
lactogenic signalling, whereas progesterone acting on top of estradiol exerts 
variable, region-dependent effects, either synergistic or antagonizing. 
3. Lactogenic signalling in the male brain is dependent on testosterone. 
Orchidectomy decreases the density of PRL-derived signalling in the 
paraventricular and ventromedial hypothalamic nuclei. 
4. Lactogenic signalling in the female brain is markedly increased during late 
pregnancy and the postpartum period, in terms of extension and intensity, as 
compared to patterns of virgin females. This increase is likely related to the role of 
lactogenic hormones in physiological and behavioural adaptations to 
motherhood. 
5. This increase in lactogenic signalling during late pregnancy and lactation is 
observed in all the nodes of the socio-sexual brain, likely driving this network to a 
maternal state, thus promoting the onset of maternal behaviours.  
6. In the maternal period, lactogenic signalling peaks during late pregnancy in most 
of the analysed nuclei. This indicates that late pregnancy instead of postpartum, is 
the critical timing for lactogenic hormones to exert maternal adaptations in the 
brain.  
7. Pharmacological suppression of hypophyseal PRL release by means of 
bromocriptine has no significant effects on the levels of lactogenic signalling in the 
analysed nuclei of the pregnant brain. This indicates that other lactogenic sources, 
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likely placental lactogens but also possibly brain PRL, are responsible for the 
observed signalling patterns. 
8. The behavioural assessment of maternal motivation requires the evaluation of 
proactive maternal responses under challenging conditions. We have validated a 
novel pup retrieval test, based on reward-based decision making paradigms, for 
the analysis of maternal motivation in rodents. 
9. At first, only dams show pup retrieval in challenging conditions, thus indicating 
that motivational aspects of maternal behaviours require the action of the 
endocrine signals of pregnancy/lactation (which include lactogenic hormones). 
10. Alternatively, virgin females undergoing prolonged interaction with pups (the so-
called godmothers) display a moderate increase in motivation for pups, as part of 
a maternal sensitisation process. 
11. The AC/ADP, a cell group located in a critical region for maternal behaviour, 
undergoes a significant increase in lactogenic signalling during motherhood (late 
pregnancy and postpartum period). This increase is not centred on its population 
of oxytocin-expressing cells, but on adjacent, non-oxytocinergic neurons. 
12. Godmothers show no significant increase in lactogenic signalling in the AC/ADP 
region as compared to pup-naïve virgins. This suggests that prolonged interaction 
with pups has no direct effects on central prolactin action, at least in this nucleus.   
13. The AC/ADP undergoes no changes in number of oxytocin-expressing neurons, 
either during the postpartum period or because of prolonged pup exposure. This 
suggests that, in mice, endocrine- or pup-induced brain changes associated with 
motherhood are not directly focused on the expression of oxytocin in the preoptic 
region.  
14. Nevertheless, the number of oxytocin neurons in the AC/ADP correlates 
negatively with measures of motivated pup retrieval in dams and godmothers, 
and positively with measures of maternal aggression in dams. This suggests a role 
of the AC/ADP oxytocin population in the reduction of stress and anxiety during 
motherhood, which would indirectly affect maternal care and aggression. 
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El correcto funcionamiento del organismo depende en gran medida de la interacción 
recíproca de los sistemas nervioso y endocrino. En este diálogo, el sistema nervioso 
regula la secreción hormonal sistémica a través del hipotálamo y la hipófisis, pero las 
hormonas también son capaces de entrar en el encéfalo y regular la función nerviosa. La 
regulación endocrina del sistema nervioso excluye generalmente la acción directa de 
hormonas peptídicas, que dada su naturaleza polar no atraviesan libremente la barrera 
hematoencefálica. La prolactina (PRL) constituye una excepción destacada a esta regla. 
Esta hormona peptídica parece ser transportada a través de los plexos coroideos (Walsh 
et al. 1987; Mangurian et al. 1992) al líquido cefalorraquídeo del interior del SNC para 
regular una multitud de procesos fisiológicos y comportamentales (Freeman et al. 2000). 
En este sentido, la función más prominente de la PRL es quizás la regulación de la 
maternidad, no limitada únicamente al desarrollo de la glándula mamaria y la 
producción de leche (Riddle et al. 1933b), sino consistente en la minuciosa coordinación 
de la homeostasis y conducta maternal. 
Este trabajo se centrará en la caracterización de las acciones de la PRL en el encéfalo del 
ratón, con particular énfasis en su papel en la neuroendocrinología de la reproducción y 
la maternidad. En primer lugar, introduciremos la biología molecular de esta hormona, 
incluyendo su receptor, vías de señalización y regulación, y su interacción con esteroides 
sexuales. Después, introduciremos los aspectos funcionales de esta hormona, 
especialmente en aquellos vinculados a la maternidad. Finalmente, nos centraremos en 
el papel de la PRL en la regulación del comportamiento maternal, que constituye una de 
las líneas principales de nuestro laboratorio. 
A. PROLACTINA – CARACTERÍSTICAS GENERALES 
La prolactina es una hormona polipeptídica con una masa molecular de 23 kDa (Shome 
and Parlow 1977), perteneciente a la familia de citoquinas de tipo I (Rand-Weaver et al. 
1991). Su proteína está codificada por un solo gen en el humano y otros primates y por 
varios genes parálogos en roedores y otros mamíferos (Soares 2004), y a su vez consta 
de diversas variantes estructurales generadas por ensamblaje alternativo y otras 
modificaciones posttraduccionales (Freeman et al. 2000). La PRL tuvo su origen 
evolutivo aparentemente en peces teleósteos o condrictios (Breves et al. 2014; 
Yamaguchi et al. 2015) asumiendo originalmente funciones relativas a la 
osmorregulación y/o a reproducción. Eventualmente, intervino en el desarrollo de 
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glándulas integumentarias (mamarias) y la regulación de sus secreciones (leche) 
(Horseman and Gregerson 2013). 
En mamíferos, la secreción sistémica de PRL se da principalmente en las células 
lactotróficas de la adenohipófisis ventrolateral (Nakane 1970), aunque otros muchos 
órganos producen también esta hormona o alguna forma homóloga (Freeman et al. 
2000), entre los que destaca el encéfalo. Las principales poblaciones neuronales 
productoras de PRL se encuentran en el hipotálamo (núcleos paraventricular y 
supraóptico, Mejía et al. 1997)  y accesoriamente en otros centros hipotalámicos y 
extrahipotalámicos (Roselli et al. 2008), mientras que las proyecciones nerviosas de 
éstas se distribuyen ampliamente en el encéfalo  (Freeman et al. 2000). A su vez, la PRL 
tiene una gran variedad de tejidos diana, incluyendo los sistemas reproductivos 
femenino y masculino, la hipófisis, el corazón, los pulmones o los riñones (Freeman et al. 
2000). El encéfalo es también un importante órgano diana de la PRL.  
B. EL RECEPTOR DE LA PROLACTINA Y SUS VÍAS DE SEÑALIZACIÓN 
La PRL ejerce sus acciones biológicas a través del receptor de la PRL (PRLR), un receptor 
de membrana perteneciente a la superfamilia de receptores de citoquinas de tipo I 
(Bazan 1990). Éste cuenta con múltiples variantes estructurales (variables entre 
especies) que difieren únicamente en la longitud de sus dominios intracelulares y se 
clasifican generalmente como receptores largos o cortos (Bole-feysot et al. 1998). Las 
formas largas del PRLR son plenamente funcionales, no así las isoformas cortas, cuyo 
dominio intracelular es incapaz de iniciar las respectivas vías de señalización del 
receptor (Berlanga et al. 1997).  
La figura I.2 esquematiza la variabilidad estructural y las vías de señalización del PRLR. La 
principal vía de señalización del receptor recibe el nombre de Jak/STAT y está integrada 
por la kinasa Janus (Jak2) y por las moléculas STAT (Signal Transducers and Activators of 
Transcription) (Ihle et al. 1994). Esta vía culmina con la fosforilación de STAT5 (a 
pSTAT5). Una vez fosforilada, pSTAT5 dimeriza y se transloca al núcleo celular, donde 
mediará las acciones biológicas de la PRL (Bole-feysot et al. 1998). Además, existen otras 
vías documentadas del PRLR, dependientes por ejemplo de la kinasa MAP u otra kinasas, 
o de cambios en concentraciones iónicas de potasio (K+) o calcio (Ca2+) (Buckley et al. 
1994; Prevarskaya et al. 1995; Berlanga et al. 1995; al-Sakkaf et al. 1997; 
Ratovondrahona et al. 1998). 
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C. REGULACIÓN DE LA SEÑALIZACIÓN POR PROLACTINA EN EL ENCÉFALO 
Las acciones pleiotrópicas de la PRL sobre el encéfalo están sujetas a una regulación 
compleja a diferentes niveles. El primero es la propia secreción sistémica de PRL, que 
determina los niveles circulantes de la hormona y la cantidad accesible al SNC. Los 
lactótrofos hipofisarios son células con una elevada actividad espontánea y bajo un 
control tónico inhibitorio mediado por dopamina (Ben-Jonathan and Hnasko 2001a). 
Esta dopamina es liberada por neuronas hipotalámicas específicas (neuronas TIDA y 
PHDA) e inhibe a los lactótrofos hipofisarios vía receptores dopaminérgicos D2 (Caron et 
al. 1978). A su vez, la PRL activa a las poblaciones neuronales TIDA y PHDA para inhibir 
su propia secreción (DeMaria et al. 1999), cerrando el bucle de retroinhibición. Este 
sistema de regulación queda ilustrado en la Figura I.3. 
El segundo nivel en la regulación de la acción central de la PRL corresponde al acceso de 
la hormona al encéfalo. Como se ha detallado antes, este acceso se produce a través de 
un mecanismo de transporte activo a nivel de los plexos coroideos que parece depender 
del PRLR (Walsh et al. 1987; Mangurian et al. 1992), y que, por tanto, puede ser 
regulado a través de la expresión o afinidad de los receptores coroideos de PRL 
(Mangurian et al. 1992; Tabata et al. 2012) Cabe destacar que, además de este 
mecanismo, ciertas evidencias sugieren la existencia de mecanismos adicionales 
independientes del receptor (Brown et al. 2015). 
Las acciones centrales de PRL dependen también de la expresión de los PRLR en el 
encéfalo. La distribución del PRLR ha sido cartografiada en el cerebro de la rata hembra 
(Bakowska and Morrell 1997), pero la evidencia indica que esta distribución es 
relativamente variable en función de diferentes situaciones fisiológicas o condicionantes 
externos, por ejemplo el parto y la presencia de crías (Ma et al. 2005a), la lactancia y el 
amamantamiento (Pi and Grattan 1999; Pi and Voogt 2001) o el estrés crónico (Faron-
Górecka et al. 2014). Como se ha descrito antes con respecto a los plexos coroideos, la 
actividad del PRLR puede ser regulada a través de modificaciones postraduccionales del 
receptor, por ejemplo mediante la variación del balance entre isoformas cortas y largas 
del PRLR. De hecho, la forma corta del PRLR no sólo no es funcional, sino que parece ser 
capaz de secuestrar isoformas largas formando heterodímeros inactivos (Lesueur et al. 
1991; Berlanga et al. 1997).  Por último, la acción central de la PRL puede ser regulada a 
través de las vías de señalización del PRLR. La vía Jak/STAT, por ejemplo, está sujeta a 
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inhibición por las proteínas SOCS (Suppressors of Cytokine Signalling) (Pezet et al. 1999) 
o CIS (Cytokine-Inducible SH2-containing proteins) (Masuhara et al. 1997). 
Los esteroides sexuales son hormonas estrechamente ligadas a la regulación de la 
señalización central de PRL. El estradiol y, en menor medida, la progesterona, son 
promotores de la secreción de PRL o de la expresión de PRLR en el encéfalo y plexos 
coroideos durante, por ejemplo, el ciclo estral de la rata, la gestación o la lactancia 
(Sugiyama et al. 1994). Por otro lado, los andrógenos parecen ejercer un efecto 
inhibitorio sobre la secreción hipofisaria de PRL (O’Hara et al. 2015). Uno de los 
objetivos principales de este trabajo consistirá en la caracterización del dimorfismo 
sexual en los patrones encefálicos de señalización por PRL en el ratón, así como su 
regulación por los respectivos esteroides sexuales. 
D. ACCIONES CENTRALES DE LA PROLACTINA Y EL DESARROLLO DEL CEREBRO 
MATERNAL 
Además de su bien conocido papel en la función mamaria (Riddle et al. 1933b), la PRL 
cuenta actualmente con más de 300 funciones documentadas (Bennett and Morris 
1989), muchas de ellas en el sistema nervioso central. Por ejemplo, está implicada en la 
regulación de diversos circuitos neuropeptidérgicos centrales (oxitocina, vasopresina u 
hormona liberadora de corticotropinas, entre otros, Aguilera et al. 2008; Blume et al. 
2009), del eje hipotálamo-hipofisario-adrenal (HPA, Fujikawa et al. 1995; Torner et al. 
2002),del sueño y vigilia (Roky et al. 1995), o en la regulación sexualmente dimórfica del 
comportamiento sexual (Krüger et al. 2002; Egli et al. 2010), entre otros. 
En los mamíferos, la reproducción resulta un desafío importante para el organismo, que 
requiere una serie de adaptaciones homeostáticas y conductuales para sobrellevar  la 
condición maternal. Gran parte de estas adaptaciones maternales se inician y mantienen 
por señales endocrinas específicas de la gestación y postparto, entre las que destaca la 
PRL. Durante el periodo postparto, los niveles elevados de PRL están asegurados por la 
lactancia, que favorece un estado sostenido de hiperprolactinemia (Andrews et al. 
2001b; Cservenák et al. 2010). Durante la gestación, sin embargo, los niveles de PRL 
circulante disminuyen drásticamente por la inhibición de la secreción hipofisaria de PRL 
(Fig I.4). Pese a esto, esta supresión queda compensada por los lactógenos placentarios, 
homólogos estructurales y funcionales de la PRL (Soares et al. 1998a; Linzer and Fisher 
1999) secretados por la placenta (Yamaguchi et al. 1992). Uno de los objetivos de este 
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trabajo consistirá en la caracterización de los patrones encefálicos de señalización por la 
PRL en la hembra gestante y de su dependencia de PRL hipofisaria o fuentes alternativas 
como los lactógenos placentarios. 
La PRL y sus homólogos lactogénicos son las hormonas maternales por antonomasia, 
responsables del desarrollo de las principales adaptaciones del cerebro maternal. Entre 
éstas destacan, por ejemplo, la activación de la ingesta y el anabolismo para asegurar el 
desarrollo embrionario (Augustine et al. 2008), la estimulación de la neurogénesis en 
centros olfativos para asegurar el correcto reconocimiento de la descendencia en 
roedores (Shingo et al. 2003), la regulación del anestro de la lactancia (Araujo-Lopes et 
al. 2014), la facilitación de la secreción de oxitocina y vasopresina (Van Tol et al. 1988) o 
la atenuación del eje HPA y la respuesta al estrés (Torner et al. 2001). Una de las 
adaptaciones maternales más prominentes y que centrará una parte importante del 
presente trabajo, es la regulación del comportamiento maternal. 
E. PROLACTINA Y COMPORTAMIENTO MATERNAL 
Introducción al comportamiento maternal 
El comportamiento parental se define como una colección de conductas dirigidas a 
incrementar la supervivencia de la descendencia (Numan & Insel 2003). En mamíferos, 
es la madre, como responsable última de la lactancia (Kleiman & Malcolm), quien asume 
la práctica totalidad de éstas conductas, pasando a denominarse comportamientos 
maternales. Los comportamientos maternales pueden dividirse en aquéllos dirigidos a 
crías (su búsqueda, su recolección, aseo, termorregulación y amamantamiento) y 
aquéllos no dirigidos (la construcción del nido y la agresión maternal) (Gammie 2005) 
(Fig I.5). La importancia del comportamiento maternal va más allá de la supervivencia de 
la prole, también tiene un impacto positivo sobre su desarrollo cognitivo y emocional, 
normalmente transmitido a través de mecanismos epigenéticos (Zhang et al. 2013). 
Sustrato neural del comportamiento maternal  
Como variante especial de conducta social, el comportamiento maternal está controlado 
por una red altamente interconectada de núcleos telencefálicos, hipotalámicos y 
mesencefálicos denominada el “Cerebro sociosexual” (Newman 1999) (Fig I.6). Esta red 
supone el núcleo para la integración de la totalidad de conductas sociales y 
reproductivas expresadas por cada especie. El comportamiento maternal surgirá 
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exclusivamente durante la gestación, parto y postparto como resultado de la 
modificación de los patrones de actividad del Cerebro sociosexual, modificado hacia un 
estado maternal (el “Cerebro Maternal”). 
El comportamiento maternal dirigido a crías tiene componentes reflexivos y proactivos. 
Los componentes proactivos, como la búsqueda de las crías y su recolección en el nido, 
están motivados por las crías y sus estímulos, que adquieren un carácter reforzante para 
la madre (Lee et al. 2000; Pereira & Morrell 2011). Esto implica que los circuitos neurales 
que regulan la recompensa y la motivación (vía dopaminérgica mesocorticolímbica) han 
de estar integrados, junto al cerebro sociosexual, en la gestión de comportamientos 
maternales proactivos. Numan y Woodside (2010) desarrollaron un modelo funcional, 
basado en evidencia en la rata, que integra la acción conjunta del cerebro maternal y los 
circuitos de recompensa. La rata tiene reacciones peculiares a las crías. Ratas hembra 
vírgenes sentirán aversión hacia éstas y, sólo tras una exposición continuada de varios 
días, iniciarán un acercamiento y eventualmente expresarán comportamientos 
alomaternales. En cambio, las ratas madres primíparas expresarán atracción hacia las 
crías y el repertorio completo de conductas maternales desde la primera interacción. 
Este modelo (Fig I.7) detalla cómo ambas respuestas antagónicas (aversión en hembras 
vírgenes y atracción en madres) están controladas por dos circuitos independientes (ver 
detalles en Figs I.7 e I.8) que responden a estímulos de crías. Éstos, a su vez, están 
supeditados a un centro maestro, el área medial preóptica del hipotálamo (MPA) (parte 
del cerero sociosexual), que dirige la conversión de una a otra conducta inhibiendo una 
u otra vía. El mediador de la inhibición de respuestas aversivas de vírgenes y la 
activación de la vía maternal son las hormonas de la gestación, particularmente la acción 
de la PRL (junto con esteroides sexuales) sobre el MPA. La figura I.8 A resume los centros 
y conexiones implicados en la gestión del comportamiento maternal proactivo. 
Respecto a la agresión maternal, el número de centros nerviosos implicados en su 
expresión es elevado y sus interconexiones, complejas (Fig I.8 B). Entre los centros 
implicados, destacan la amígdala medial (MeA, como centro integrador de estímulos 
quimiosensoriales), el septum lateral (LS) o los núcleos hipotalámicos paraventricular 
(Pa) o ventromedial (VMH), todos ellos nodos principales del Cerebro sociosexual (Fig 
I.6). Quizás el centro más relevante implicado en este sistema es la región conformada 
por el núcleo BST y MPA, entendido como región maternal clave (Numan 1996). Dentro 
de la fenomenología de la agresión maternal, destaca la atenuación del estrés y 
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ansiedad que experimentan las madres y que facilita sus reacciones agresivas hacia 
amenazas peligrosas. Los centros implicados en este fenómeno incluyen el Pa, el BST o 
la amígdala central (Ce), ente otros. 
El nonapéptido oxitocina (OXT) es moduladores bien documentados de la expresión de 
conductas sociales y reproductivas a lo largo de la evolución de vertebrados (Insel & 
Young 2000), incluyendo las conductas maternales. Además de su funciones sistémicas 
como neurohormona (estimulación de la contracción uterina durante el parto y de la 
eyección de leche en la lactancia, Nishimori et al. 1996; Blanks & Thornton 2003), la OXT 
también es producida y liberada como neuromodulador en circuitos encefálicos internos 
(Otero-García et al. 2015). Las principales poblaciones de neuronas oxitocinérgicas 
cerebrales se ubican en: (1) el BST medial posterior (BSTMP) ventral, (2) el área anterior 
comisural/anterodorsal preóptica (AC/ADP) del hipotálamo, (3) el Pa, (4) el núcleo 
supraóptico (SO) del hipotálamo, y (5) la amígdala medial (Otero-García et al. 2015). La 
OXT tiene un papel demostradp como modulador del comportamiento maternal, 
estimulando, por ejemplo, el cuidado maternal a crías en hembras vírgenes de ratón 
(Pedersen & Prange 1979; Pedersen et al. 1982), o la agresión maternal a través de su 
liberación en ciertos núcleos cerebrales como la Ce (Bosch et al. 2004; Bosch et al. 
2005). La OXT juega también un papel fundamental en la modulación del MPA 
(Champagne et al. 2004) y la vía para conductas maternales proactivas (Pedersen et al. 
1994)  durante la gestación en la rata (Fig I.7). Sin embargo, el origen concreto de estas 
proyecciones OXTérgicas moduladoras no es del todo conocido aún. Si bien una parte 
procede del Pa (Knobloch et al. 2012), no se ha examinado todavía la contribución de 
otras poblaciones OXTérgicas. Uno de los objetivos del presente trabajo  consistirá en 
analizar la posible relación entre las neuronas OXTérgicas del AC/ADP (localizadas en 
una posición privilegiada junto al contínuo BST-MPA) y la modulación del 
comportamiento maternal. 
La prolactina y la regulación del comportamiento maternal: análisis comparativo 
La maternización del Cerebro Sociosexual que media la expresión de comportamientos 
maternales depende principalmente de dos tipos de señales: estímulos sensoriales de 
crías y estímulos endocrinos de la gestación y lactancia (incluyendo la PRL). La acción 
específica y la contribución relativa de cada componente sobre el Cerebro sociosexual 
permiten la estabilización de diferencias interespecíficas en la expresión de 
comportamientos maternales. 
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Como antes se ha descrito, en ratas, las hembras vírgenes inicialmente neofóbicas hacia 
crías pasan a ser completamente maternales al experimentar la gestación. Esta 
conversión la produce la modulación del MPA por las señaes hormonales de la 
gestación, específicamente por los lactógenos (PRL y/o lactógenos placentarios), 
actuando de forma sinérgica con el estradiol (E) y la progesterona (P) (Bridges et al. 
1985; Bridges & Ronsheim 1990; Bridges & Freemark 1995; Bridges et al. 1996). Los 
estímulos sensoriales derivados de crías, en cambio, tendrían un mayor protagonismo 
en la rata en el mantenimiento del comportamiento maternal durante el periodo 
postparto (Numan & Insel 2003). 
 En contraste con la rata, los ratones hembra vírgenes exhiben conductas alomaternales 
de cuidado de crías muy fácilmente (Stolzenberg & Rissman 2011; Martín-Sánchez et al. 
2015b). Esto llevaría a suponer que la PRL y otras señales endocrinas de la gestación 
tienen una importancia secundaria en la inducción del comportamiento maternal (las 
vírgenes no las han experimentado). Sin embargo, este fenómeno se da exclusivamente 
respecto al cuidado maternal, no frente a la agresión maternal (expresada 
exclusivamente por hembras maternales). Además, mutantes KO para el PRLR exhiben 
déficits significativos en la expresión de conductas maternales. Todo esto apunta a una 
mayor relevancia de la PRL en el control de estos comportamientos en el ratón. Este 
trabajo pretende, entre otros, contextualizar mejor la acción de PRL sobre las vías de 
control del comportamiento maternal (proactivo y agresión) y sobre sistemas 
moduladores accesorios como el oxitocinérgico.  
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F. OBJETIVOS DE ESTE TRABAJO 
I. Describir los patrones básicos de señalización por PRL en el encéfalo de ratones 
hembra y macho y su posible dimorfismo sexual. 
II. Analizar la regulación específica de estos patrones por testosterona (machos) y 
estradiol y progesterona (hembras). 
III. Examinar los cambios en los patrones basales de señalización cerebral por PRL de 
hembras producidos durante la gestación y lactancia. 
IV. Evaluar la contribución de PRL hipofisaria frente a otras fuentes (lactógenos 
placentarios) a la conformación de los mencionados patrones de señalización por 
PRL durante la gestación. 
V. Investigar la acción lactogénica sobre la población oxitocinérgica específica del 
AC/ADP en vírgenes y madres lactantes. 
VI. Desarrollar un nuevo modelo comportamental para el estudio de la motivación 
maternal en hembras de ratón lactantes, hembras vírgenes expuestas a crías y 
vírgenes no expuestas a crías. 
VII. Analizar la influencia de PRL y la acción de OXT en la expresión de dos conductas 
maternales: la recogida de crías y la agresión maternal. 
  
166 
 
  
6. Resumen en castellano 
167 
 
DIMORFISMO SEXUAL E INFLUENCIA DE 
HORMONAS ESTEROIDEAS EN LA 
REACTIVIDAD CEREBRAL A PROLACTINA 
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1.1. OBJETIVOS 
El primer objetivo de este estudio es la descripción exhaustiva de los patrones de 
distribución de células sensibles a PRL en el encéfalo de ratones hembra y macho y la 
identificación de diferencias sexualmente dimórficas. Además, pretendimos explorar la 
contribución de hormonas esteroideas sexuales femeninos (estradiol y progesterona) y 
masculinos (testosterona) a la modulación de dichos patrones en hembras y machos, 
respectivamente. Como estrategia para la obtención de los citados patrones de 
sensibilidad central a PRL, empleamos la detección inmunohistoquímica de la formas 
fosforilada de STAT5 (pSTAT5, ver sección II de la Introducción). 
1.2. METODOLOGÍA 
1.2.1. Animales y diseño experimental 
Para este estudio se empleó un total de 30 ratones adultos de la cepa CD1, 18 hembras 
y 12 machos, con edades comprendidas entre 10 y 24 semanas.   
Las hembras experimentales fueron ovarectomizadas (sección 1.2.2) y posteriormente 
sometidas a un tratamiento de sustitución hormonal, consistente en la administración 
de estradiol (mediante implantes de liberación lenta), progesterona (mediante inyección 
i.p.) o vehículo (aceite) (sección 1.2.3). Estas hembras fueron divididas aleatoriamente 
en 3 grupos experimentales según el tratamiento recibido: (1) grupo EP (estradiol y 
progesterona), (2) grupo EO (estradiol y vehículo), y (3) grupo OO (vehículo, control). 
Tras 7 días de tratamiento hormonal, las hembras recibieron una suplementación de PRL 
ovina (sección 1.2.3) y fueron perfundidas 45 minutos después (Brown et al. 2010) para 
la detección inmunohistoquímica de pSTAT5. 
Los machos experimentales fueron asignados aleatoriamente a dos grupos 
experimentales: (1) Intactos y (2) Castrados (que fueron esterilizados, ver sección 1.2.2). 
Imitando el procedimiento al que las hembras fueron sometidas, los machos de ambos 
grupos recibieron implantes e inyecciones de vehículo. Siete días después, recibieron 
una suplementación equivalente de PRL y fueron perfundidos 45 minutos la 
suplementación. 
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1.2.2. Ovarectomía y orquidectomía 
Las hembras y machos experimentales fueron sometidos a esterilización a las 10 
semanas (hembras) y 12 semanas (machos) de edad. Para ambos procedimientos 
quirúrgicos se empleó ketamina i.p. (Imalgene 500, 75mg/kg) y medetomidina (Domtor, 
1 mg/kg) para la anestesia, tartrate de butorfanol 1% (Torbugesic, 20 µl s.c.) como 
analgésico  sedante y hidrocloruro de atipamezol (Antisedan, 1 mg/kg) para revertir los 
efectos de la anestesia tras la cirugía. Los animals tuvieron como mínimo 7 días de 
recuperación después de la cirugía. 
1.2.3. Tratamiento hormonal 
En función de su grupo experimental, las hembras ovarectomizadas recibieron estradiol, 
progesterona y/o vehículo. El estradiol fue administrado mediante implantes 
subcutáneos de liberación lenta, rellenos con una solución de 20 µg/ml de β-estradiol 
(Sigma) en aceite de girasol. En cambio, la progesterone fue administrada de forma 
aguda mediante una inyección subcutánea de 500 µg, disuelta también en aceite de 
girasol. Este protocol de sustitución hormonal está diseñado para emular la dinámica 
hormonal del estro (Rissman 1997). 
Tres horas después de la administración de progesterone (o vehículo), machos y 
hembras recibieron una dosis i.p. de 5 mg/kg de PRL ovina (25 UI/mg) para asegurar 
niveles elevados y equivalents de PRL circulante en ambos sexos y, 45 minutos después, 
fueron perfundidos.  
1.2.4. Perfusión y procesado histológico 
Los animales experimentales fueron perfundidos usando paraformaldehido 4% en 
tampón fosfato 0,1M a pH 7,4 (PB) como fijador. El tejido cerebral fue extraído y 
postfijado por inmersión en el mismo fijador durante la noche y después crioprotegido 
en una solución de sacarosa 30% en PB. Finalmente, el tejido fue cortado al micrótomo 
de congelación (Microm HM-450) en 5 series paralelas de secciones coronales de 40 µm 
y las series almacenadas a -20 ºC. 
1.2.5. Detección inmunohistoquímica de pSTAT5 
La inmunohistoquímica se realizó siguiendo un protocolo adaptado de Brown y 
colaboradores (2010). Éste comprende: (1) un proceso inicial de exposición antigénica 
6. Resumen en castellano 
171 
 
(incubaciones secuenciales en tampón TRIS pH 10 a 85ºC); (2) inhibición de peroxidasas 
endógenas; (3) bloqueo de uniones inespecíficas; (4) incubación en anticuerpo primario 
anti pSTAT5 (Rabbit-anti-pSTAT5 Tyr694; Cell Signalling Technology) diluido 1:500 
durante 72 horas; (5) incubación en anticuerpo secundario biotinilado (goat anti-rabbit 
IgG biotinilado, Vector) diluido 1:200 durante 90 minutos y (6) amplificación de la señal 
mediante incubación en complejo ABC (ABC Elite kit; Vector). Por último, se sometió al 
tejido a un revelado permanente con 3-3’-, diaminobenzidina 0,005%  (Sigma) y H2O2 
0,01%. Finalmente, el tejido revelado fue montado y cubierto. 
1.2.6. Análisis de inmunorreactividad pSTAT5 
Para el análisis microscópico de las preparaciones histológicas obtenidas se empleó un 
microscopio óptico Leitz DMRB (Leica). Para el mapeo de los patrones de 
inmunorreactividad pSTAT5 (pSTAT5-ir) se registró la presencia o ausencia de pSTAT5-ir 
en todo núcleo cerebral en todos los especímenes analizados. Además, se llevó a cabo 
un muestreo cuantitativo de la densidad de células pSTAT5-positivas en una selección de 
núcleos cerebrales con pSTAT5-ir tanto en machos como en hembras. Para este 
muestreo, se tomó fotomicrografías de los núcleos de interés de ambos hemisferios 
cerebrales usando una cámara Leica DFC495 asociada al microscopio y siguiendo 
“frames” determinados para cada núcleo (Fig 1.5). Después, se analizó las imágenes 
obtenidas usando el software ImageJ y se cuantificó automáticamente la densidad 
media interhemisférica de células pSTAT5 positivas para cada núcleo muestreado. 
1.2.7. Análisis estadístico 
Los datos resultantes fueron sometidos a análisis estadístico con el software SPSS. En 
primer lugar, se comparó la densidad de pSTAT5-ir en los núcleos analizados entre 
machos (intactos) y hembras (grupo EP), aplicando un test-t para muestras 
independientes o, como alternativa no paramétrica cuando los datos no se distribuían 
normalmente, un ANOVA de Kruska-Wallis. Para la comparación entre los tres grupos de 
hembras (OO; EO; EP) se empleó un ANOVA de Kruskal Wallis (datos no distribuidos 
normalmente) con análisis post-hoc de Dunnett. Finalmente, para la comparación de 
machos intactos y castrados, se empleó también un test-t o un ANOVA de Kruskal Wallis 
(en ausencia de normalidad). 
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1.3. DISCUSIÓN 
En este estudio se ha examinado los patrones de señalización central mediada por PRL 
en hembras y macho de ratón de la cepa CD1. Para este propósito, hemos empleado 
machos y hembras suplementados con una dosis de PRL exógena que aseguró niveles 
circulantes suprafisiológicos de la hormona, evitando así el sesgo debido a la diferencia 
sustancial en niveles de PRL circulante en machos y hembras. En este análisis, hemos 
hallado un dimorfismo sexual evidente en favor de hembras, que presentan patrones de 
señalización mediada por PRL más extensos y abundantes que machos. Los patrones 
descritos en machos quedan restringidos al hipotálamo, a núcleos cercanos al sistema 
ventricular. En hembras, además de los anteriores, pSTAT5 se observa también en 
núcleos amigdalinos, en el BST, septum y, en menor mediad, en núcleos talámicos y 
mesencefálicos.  
Aun así,  los machos presentan una respuesta encefálica clara a PRL tras la 
suplementación hormonal, lo que indica que esta hormona ejerce funciones centrales 
también en machos. Éstas se darían siempre y cuando los niveles circulantes y/o 
intracerebrales de PRL sean lo suficientemente altos, lo que en machos puede ocurrir 
durante la cópula (Kamel et al. 1977) o durante la respuesta al estrés (Torner et al. 
2004), entre otros.  
Por otro lado, hemos evaluado también cómo los esteroides sexuales femeninos 
(estradiol y progesterona) contribuyen a modular la sensibilidad central a PRL. Para ello, 
hemos analizado la expresión de los patrones centrales de señalización mediada por PRL 
en hembras ovarectomizadas y tratadas con vehículo, estradiol, o estradiol más 
progesterona. El tratamiento de estradiol produjo una tendencia generalizada al 
incremento de la inmunorreactividad de pSTAT5, que llevó a aumenos significativos 
respecto a los controles (tratados con vehículo) en MePD, LSV, AC/ADP, PIL y VLPAG. 
Con respecto a la acción del estradiol, la progesterona produjo efectos variables según 
región: o bien sinérgicos (MePD, PIL), neutros (LSV, VLPAG) o incluso antagónicos 
(AC/ADP) respecto al estradiol. En suma, la señalizaión lactogénica central se halla bajo 
la influencia de los niveles circulantes de estradiol y progesterona, de forma compleja y 
neuroanatómicamente heterogénea. 
Del mismo modo, hemos evaluado también el papel de la testosterona en la modulación 
de la sensibilidad central a PRL en ratones macho. En este caso, la supresión de la 
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testosterona sistémica mediante castración produjo una disminución significativa de la 
densidad de señalización mediada por PRL específicamente en el SFi del septum y el Pa y 
VMH en el hipotálamo. Esto indica que la testosterona contribuye a mantener la 
sensibilidad a PRL en estas regiones cerebrales. 
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CARACTERIZACIÓN DE LA SENSIBILIDAD 
ENCEFÁLICA A PROLACTINA A LO LARGO DEL 
CICLO REPRODUCTIVO DE LA HEMBRA DEL 
RATÓN 
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2.1. OBJETIVOS 
Durante la gestación y la lactancia, el encéfalo experimenta una serie de adaptaciones 
maternales, cambios en la regulación fisiológica y conductual encaminados a afrontar la 
maternidad (Grattan 2001). Éstas están mediadas entre otros por la PRL. El objetivo 
principal de este estudio es caracterizar  la variación de la sensibilidad central a PRL en el 
cerebro de la hembra del ratón durante los periodos críticos de la gestación y la 
lactancia, para lo que se caracterizará los patrones cerebrales de pSTAT5-ir en hembras 
gestantes tardías, lactantes y vírgenes (controles). Existe evidencia de que durante la 
segunda mitad de la gestación, la secreción hipofisaria de PRL queda inhibida en favor 
de otras hormonas lactogénicas como los lactógenos placentarios (PLs) (Soares 1998; 
Soares 2004). Este estudio pretende también explorar la contribución de agentes 
lactogénicos hipofisarios y no hipofisarios a la modulación lactogénica del encéfalo 
durante la gestación. Para este cometido, se incluirá un grupo adicional de hembra 
gestantes donde la secreción hipofisaria de PRL fue inhibida farmacológicamente 
mediante bromocriptina (sección 2.2.2). 
2.2. METODOLOGÍA 
2.2.1. Animales y diseño experimental 
En este estudio se empleó 32 hembras de ratón adultas de la cepa CD1, de entre 8 y 12 
semanas de edad. De éstas, 27 fueron asignadas aleatoriamente a 4 grupos 
experimentales diferentes: (1) Vírgenes (n=7); (2) Gestantes (n=6); Gestantes + 
bromocriptina (n=8); y (4) Lactantes (n=6). Las hembras del grupo Vírgenes fueron 
perfundidas directamente. Las hembras del resto de grupos fueron cruzadas con machos 
reproductores durante 4 días y posteriormente estabuladas en parejas hasta el día de su 
perfusión. Las hembras de los Grupos Gestante y Gestante + bromocriptina fueron 
perfundidas 18 días después de comenzar su cruzamiento, evaluando el día exacto de 
gestación a posteriori a través del grado de desarrollo de sus fetos. Las hembras del 
grupo Lactante fueron perfundidas en el día 6 postparto.  
2.2.2. Inhibición farmacológica de la secreción hipofisaria de prolactina 
Para este procedimiento se empleó la bromocriptina, agonista D2 dopaminérgico que 
inhibe a los lactótrofos hipofisarios emulado la acción de las neuronas TIDA y PHDA (Fig 
I.3). Se administró dos inyecciones s.c. consecutivas de una solución de 100 µg de 
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bromocriptina (2-Bromo-α-ergocriptina, Sigma-Aldrich) en etanol 10%, 19 y 2 horas 
antes de su perfusión, respectivamente.  
2.2.3. Perfusión, procesado histológico e inmunohistoquímica para pSTAT5 
Ver secciones 1.2.4 y 1.2.5. 
2.2.4. Análisis de inmunorreactividad pSTAT5 
Tanto el análisis cualitativo como el cuantitativo se realizaron siguiendo la metodología 
descrita en la sección XX. Los “frames” de muestreo empleados están recogidos en la 
figura 2.5.  
2.2.5. Análisis estadístico 
Se aplicó un contraste ANOVA de 1 vía en cada núcleo muestreado para analizar las 
diferencias en densidad de pSTAT5-ir en los grupos de Vírgenes, Gestantes y Lactantes. 
Se empleó el mismo contraste estadístico para evaluar el efecto de la inhibición 
hipofisaria de PRL, comparando las densidades de pSTAT5-ir en cada núcleo muestreado 
entre los grupos de Gestantes y Gestantes + bromocriptina. 
2.3. DISCUSIÓN 
En este capítulo, se ha caracterizado cómo varían los patrones de señalización mediada 
por PRL en el encéfalo del ratón a lo largo del ciclo reproductivo femenino (en hembras 
vírgenes, gestantes y lactantes). Hemos hallado patrones aumentados (en términos de 
extensión y de densidad de marcaje) en hembras gestantes y lactantes respecto a 
vírgenes. Además, nuestros resultados sugieren que estos patrones son generados por 
lactógenos alternativos a la PRL hipofisaria. 
Con respecto a los patrones de señalización de PRL obtenidos en hembras vírgenes, cabe 
destacar que éstos son relativamente similares pero también más variables que los 
patrones analizados en vírgenes ovarectomizadas y tratadas con estradiol y 
progesterona (capítulo 1). Esta comparación apunta a que la PRL puede ejercer un rango 
muy variable de actividad central, oscilando entre prácticamente nula y moderadamente 
elevada. El factor causal más probable para esta variabilidad son los esteroides sexuales, 
como apunta nuestra evidencia (capítulo 1) y la de otros (Sugiyama et al. 1994). 
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El hallazgo más significativo de este estudio es el marcado incremento en señalización 
lactogénica producido en el encéfalo gestante y lactante. Este incremento es patente en 
términos de extensión (implicando que muchas regiones cerebrales se vuelven sensibles 
a la PRL durante estos periodos) y de densidad (en la mayoría de centros basalmente 
sensibles a PRL se produce un aumento significativo de la misma). Es importante 
destacar que, al menos en términos cuantitativos, este aumento no se produce en todas 
las regiones analizadas de forma homogénea a lo largo de estos periodos. Así pues, los 
picos de señalización lactogénica aparecen generalmente durante la gestación (en CeM, 
MePD, LSV, BSTMPM, Pa, SO, VMHvl y VLPAG). De estos, en la mayoría de casos los 
niveles elevados persisten durante postparto (mantenidos probablemente por los 
elevados niveles de PRL circulante derivados de la lactancia), pero en algunos centros 
disminuyen de nuevo hasta niveles basales. Esta evidencia tiene la importante 
implicación de que la actividad lactogénica que media las principales adaptaciones 
maternales centrales se da preparto, de forma que la madre primípara estaría ya 
completamente adaptada a las necesidades del periodo maternal desde el parto y el 
primer contacto con sus crías. Excepcionalmente, dos de las regiones estudiadas 
(AC/ADP y MPO) presentaron un aumento moderado de señalización lactogénica 
durante la gestación, que sin embargo alcanza su máximo durante la lactancia, lo que 
sugiere un papel de la PRL en estos núcleos en el mantenimiento de ciertas 
adaptaciones maternales. 
Los núcleos encefálicos integrados en los patrones obtenidos en hembras gestantes y 
lactantes en este trabajo reflejan la participación de PRL en la inducción de las 
adaptaciones maternales más destacadas (Grattan 2001), que incluyen: la modulación 
de circuitos oxitocinérgicos y vasopresinérgicos (Ghosh & Sladek 1995; Sirzen-Zelenskaya 
et al. 2011), la atenuación de la respuesta al estrés (Torner et al. 2002), la activación de 
ingesta y anabolismo (Sauvé & Woodside 2000), o, notablemente, la inducción del 
comportamiento maternal (Slotnick et al. 1973; Lonstein & Gammie 2002; Gammie 
2005; Brunton & Russell 2008). 
Finalmente, en relación al origen de la actividad lactogénica central descrita en este 
estudio, la inhibición de la secreción hipofisaria de PRL en hembras gestantes mediante 
la administración de bromocriptina tuvo un efecto virtualmente nulo sobre la extensión 
y densidad de sus respectivos patrones de señalización lactogénica. Esto demuestra que 
el agente causal de estos patrones es un lactógeno alternativo. Esta actividad tendrá, 
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pues, su origen probable en  los lactógenos placentarios, sustitutos funcionales de la PRL 
(Bridges and Freemark 1995) producidos por la placenta durante la segunda mitad de la 
gestación. Sin embargo, un posible origen alternativo y no excluyente es la PRL 
intracerebral  (Paut-Pagano et al. 1993; Grattan and Kokay 2008). 
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COMPORTAMIENTO MATERNAL, 
PROLACTINA Y OXITOCINA – ANÁLISIS DE 
COMPORTAMIENTOS MATERNALES 
ESPECÍFICOS Y EXPRESIÓN DE  
pSTAT5 Y OXITOCINA EN EL AC/ADP 
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3.1. OBJETIVOS 
Durante la maternidad, las hembras adquieren una motivación incrementada por las 
crías y sus estímulos, que facilitan la ejecución de comportamientos maternales 
proactivos. En el ratón, este tipo de conductas maternales parecen expresarse sin la 
necesidad de cambios endocrinos asociados a la gestación y lactancia, ya que las 
hembras vírgenes emprenden el cuidado de crías ajenas con facilidad. Sin embargo, se 
desconoce todavía si la expresión de estas conductas maternales va acompañada de un 
incremento de motivación maternal inducido por la interacción con crías, o si, por el 
contrario, la motivación maternal sólo puede incrementarse con la acción apropiada de 
agentes endocrinos maternales. Este estudio pretende, en primer lugar, caracterizar la 
contribución relativa de los agentes endocrinos maternales (que incluyen a la PRL) y el 
contacto con crías y sus estímulos al incremento de motivación maternal. Para este 
cometido, se ha desarrollado un nuevo test comportamental que permite analizar la 
motivación maternal de forma más específica (ver sección 3.2.1). 
El nonapéptido oxitocina (OXT) cumple una función clave como neuromodulador del 
comportamiento maternal proactivo (Numan & Woodside 2010; Bosch & Neumann 
2012). El segundo objetivo de este estudio consiste en analizar la interacción de la 
exposición prolongada a crías, por un lado, y la PRL (como hormona principal en la 
gestación y lactancia), por otro, sobre los circuitos OXTérgicos centrales y sobre la 
expresión de conductas maternales proactivas. Este análisis se centrará concretamente 
en la población OXTérgica específica del área anterior comisural/anterodorsal preóptica 
del hipotálamo (AC/ADP), que ocupa un lugar privilegiado en la región preóptica medial, 
crítica para la regulación del comportamiento maternal (Numan et al. 1988; Tsuneoka 
2013). El análisis consistirá en la cuantificación de la expresión y coexpresión de OXT y 
pSTAT5 (como marcador de señalización mediada por PRL) en este núcleo y en la 
búsqueda de correlaciones significativas entre estos parámetros histológicos y las 
medidas conductuales de comportamiento maternal motivado obtenidas previamente. 
Por último,  emprenderemos un análisis histológico y correlacional equivalente con una 
muestra adicional de hembras de ratón que ha sido testada en agresión maternal, otro 
componente clave del comportamiento maternal con una dependencia clara de señales 
endocrinas. 
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3.2. METODOLOGÍA 
3.2.1. Animales, diseño experimental y análisis conductual 
Motivación maternal 
En este experimentó se empleó un total de 66 hembras adultas de ratón de la cepa CD1, 
de 11 semanas de edad. De éstas, 30 fueron asignadas aleatoriamente a 3 grupos 
experimentales: (1) Vírgenes (n=10); (2) Comadres (vírgenes expuestas de forma 
prolongada a crías, n=10) y Madres (en día postparto 6, n=9). Las hembras restantes 
fueron empleadas como acompañantes o como donantes de crías. Estas hembras fueron 
sometidas a una versión modificada del test de recogida de crías, en la que 4 crías se 
encuentran separadas del nido por una barrera de 10 cm de altura que la hembra debe 
superar para efectuar la recogida (Fig 3.1). Se sometió a las hembras experimentales a 
una sesión diaria del test, de 10 minutos de duración, comenzando en el día postparto 2 
y durante 3 días. En la mañana del día postparto 5, las hembras experimentales fueron 
perfundidas. Las sesiones fueron grabadas en vídeo y las grabaciones analizadas por un 
observador ciego a las condiciones experimentales, que registró los siguientes 
parámetros: latencia al primer contacto con crías, latencia a la recogida de cada cría (4 
en total), tiempo total de contacto con crías y número de cruces de barrera. 
Agresión maternal 
La muestra en la que se evaluó la agresión maternal consta de 27 hembras de ratón CD1 
adultas, divididas en los mismos grupos experimentales: Vírgenes (n=9); Comadres (n=9) 
y Madres (n=9). La metodología del análisis conductual queda recogida en un trabajo 
previo de nuestro grupo de investigación (Martín-Sánchez et al. 2015a). 
3.2.2. Perfusión y procesado histológico 
Ver sección 1.2.4. 
3.2.3. Inmunofluorescencia doble para pSTAT5 y oxitocina 
Este protocolo comprendió las siguientes fases: (1) un proceso doble de exposición 
antigénica (incubación en solución de H2O2 y NaOH a pH > 13; incubación en solución de 
glicina y dodecilsulfato de sodio); (2) un bloqueo de autofluorescencia (incubación en 
borhidruro sódico); (3) un bloqueo de uniones inespecíficas; (4) incubación conjunta de 
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72 horas en anticuerpos primarios, rabbit-anti-pSTAT5 Tyr694 1:500 (ver 1.2.3) y mouse-
anti-oxitocina monoclonal 1:200 (Dr. Harold Gainer, NIH Cat#PS38); (5) incubación 
conjunta en anticuerpos secundarios fluorescentes, goat anti rabbit IgG conjugado con 
Alexa Fluor 488 (1:200) y goat-anti-mouse IgG conjugado con Rhodamine Red (1:250); y 
(6) tinción nnuclear con DAPI (600 nM). Finalmente, se montó y cubrió los cortes 
histológicos con medio de montaje fluorescente (Fluorsave). 
3.2.4. Análisis histológico 
El marcaje fluorescente se analizó con un microscopio confocal Leica TCS SP8. Se realizó 
escaneos secuenciales triples de un “frame” determinado del AC/ADP (Fig 3.2) en los 
canales para DAPI, Alexa Fluor 488 (AVP) y Rodamina (OT). Las longitudes de onda de 
excitación fueron 405 nm para DAPI, 488 nm para Alexa Fluor 488 y 559 nm para 
Rodamina Red-X. Las longitudes de onda de emisión fueron 461, 520 y 591 
respectivamente. Las secciones del plano Z se tomaron con 4 µm de separación y a un 
aumento de 20x.  
Tras el muestreo, un observador ciego a las condiciones experimentales del mismo 
analizó los stacks (pilas de imágenes) obtenidos para cuantificar: (1) el número medio 
(interhemisférico) de neuronas OXTérgicas; (2) la densidad media (interhemisférica) de 
pSTAT5-ir; (3) el porcentaje de inmunorreactividad pSTAT5 sobre neuronas OXT-
positivas; y (4) el porcentaje de inmunorreactividad pSTAT5 sobre neuronas OXT-
negativas. Este análisis se realizó con el software Image J, de forma manual usando la 
herramienta contador de células en todos los casos salvo en la cuantificación de pSTAT5-
ir, donde se plicó un protocolo automatizado similar al empleado en los estudios 
anteriores. 
3.2.5. Análisis estadístico 
Datos conductuales 
El análisis de motivación maternal mediante recogida de crías comprendió, en primer 
lugar, la comparación entre grupos experimentales de la latencia a contacto con crías, 
tiempo total de contacto y número de cruces de barreras. Ante la falta de normalidad de 
estos datos, se empleó un test ANOVA de Kruskal Wallis para cada variable y cada sesión 
de conducta. Después, para evaluar la recogida de crías en cada grupo experimental, se 
aplicó un análisis de supervivencia log Rank (Kaplan Meier) a las latencias de recogida de 
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la primera y cuarta cría en cada sesión. Finalmente, para obtener una medida del 
aprendizaje o mejora de cada grupo en la tarea en cuestión, se comparó las latencias a 
la recogida de la primera cría dentro de cada grupo entre cada sesión, mediante un test 
Wilcoxon de muestras emparejadas. 
Datos histológicos 
Para analizar la expresión de pSTAT5 y OXT en el AC/ADP en ambas muestras (recogida 
de crías y agresión maternal), se aplicó ANOVAs de una vía discretos, con comparaciones 
post-hoc según Bonferroni. Para comparar los pocentajes relativos de expresión pSTAT5 
sobre neuronas OXT-positivas y –negativas, se aplicó en primer lugar un ANOVA de dos 
vías mixto (con población neuronal y grupo experimental como factores independiente y 
de medidas repetidas, respectivamente), seguidos de ANOVAs de una vía discretos para 
cada muestra y cada población neuronal, en busca de diferencias entre grupos 
experimentales. 
Análisis correlacional 
Finalmente, se comprobó la asociación de las variables histológicas obtenidas con las 
variables conductuales de recogida de crías y de agresión maternal (en sus respectivas 
muestras experimentales). Cuando se cumplía el requisito de normalidad en los datos, 
se empleó el método paramétrico de Pearson. Cuando no se cumplía la normalidad, se 
transformó logarítmicamente los datos. En caso de que aún tras esto no se cumpliera 
normalidad, se aplicó el método no paramétrico de correlación de Spearman. 
3.3. DISCUSIÓN 
En este capítulo, hemos desarrollado y validado un nuevo test conductual para la 
evaluación de la motivación maternal. También hemos analizado los cambios en la 
expresión de OXT y en el input de PRL en la región AC/ADP del hipotálamo, tanto 
durante el periodo maternal como resultando de la exposición prolongada a crías. 
Finalmente, hemos explorado correlaciones existentes entre los datos conductuales e 
histológicos recogidos. 
La motivación maternal se define como un estado sostenido en el que las crías 
adquieren propiedades reforzantes para la madre, desencadenando conductas 
maternales proactivas (Olazabal et al. 2013). La recogida de crías supone la conducta 
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maternal proactiva por excelencia, por lo que habitualmente se emplea como 
aproximación para la evaluación de la motivación maternal. Sin embargo, en ratones 
hembra vírgenes, dada su facilidad para expresar conductas alomaternales, el test 
clásico de recogida de crías (en condiciones estándar) puede llevar a conclusiones 
erróneas o poco precisas. Por esta razón, hemos desarrollado un nuevo test que 
pretende evaluar la recogida de crías en un contexto adverso (acceso a crías limitado 
por barreras), que enfrente al animal a la decisión de ejercer un esfuerzo significativo 
para realizar la conducta y así obtener la recompensa. 
Nuestros resultados confirman la validez de este test. Hemos hallado diferencias 
significativas y previamente obviadas en la motivación por crías en el grupo de madres 
respecto a vírgenes (Figs 3.4 y 3.5). Esto confirma que los eventos endocrinos de la 
gestación y postparto son esenciales para el completo desarrollo de la motivación 
maternal. Por otro lado, hemos determinado que las hembras vírgenes pueden también 
adquirir una cierta motivación incrementada por crías, si bien de forma gradual, si éstas 
se encuentran expuestas de forma continua a crías (grupo comadres, Figs 3.4 y 3.5). 
El sistema OXTérgico cerebral es un candidato clave para experimentar adaptaciones 
maternales. Dentro de este sistema, hemos estudiado en profundidad los cambios en el 
input de PRL (como mediadora de adaptaciones maternales) sobre la población 
OXTérgica del AC/ADP asociados tanto a la maternidad como a la exposición a crías. 
Respecto a OXT, no hemos encontrado cambios en el número de neuronas OXTérgicas 
en ningún caso (Figs 3.8 y 3.10). Respecto a PRL, hemos hallado un aumento significativo 
en la densidad de células pSTAT5-positivas asociado al periodo postparto, pero no a la 
exposición a crías (Figs 3.8 y 3.10). Sin embargo, el incremento asociado al periodo 
maternal parece centrarse en  neuronas no OXTérgicas del AC/ADP, mientras que la 
expresión de pSTAT5 sobre la población OXTérgica permance constante. Esto sugiere 
que, pese a que esta población se hace sensible a estímulos de crías durante el periodo 
maternal (Tsuneoka et al. 2013), este cambio probablemente no se da en virtud de una 
acción directa de la PRL (si bien no queda excluída la posibilidad de una acción de PRL 
sobre otros centros dentro de las vías que procesan los estímulos de crías). Además, la 
ausencia de cambios en la expresión de pSTAT5 sobre el AC/ADP en comadres indica 
que, en el AC/ADP, no se produce ninguna acción o cambio mediado por PRL en 
respuesta a la exposición continuada a crías. 
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Por último, hemos explorado posibles correlaciones entre nuestras medidas 
conductuales (motivación maternal y agresión maternal) y nuestras medidas histológicas 
en el AC/ADP. Respecto a motivación maternal, hemos hallado correlaciones negativas 
en madres y comadres entre el número de neuronas OXTérgicas en el AC/ADP y el 
número total de crías recogidas (Fig 3.9). Con relación a la agresión maternal, hemos 
hallado una correlación positiva en madres entre el número de neuronas OXtérgicas del 
AC/ADP y la latencia a la primera agresión (Fig 3.11). Aunque aparentemente 
contradictorias, las correlaciones halladas podrían indicar un papel de la población 
OXTérgica del AC/ADP en la liberación de OXT asociada a la respuesta al estrés. Por un 
lado, la respuesta al estrés conlleva la liberación de OXT en ciertas regiones, con un 
efecto anxiolítico (Blume et al. 2008). Por otro, mayores niveles de estrés se vinculan a 
menor expresión de agresión maternal y a mayor atención y cuidado a las crías (Bosch 
2011). De estar la población OXTérgica del AC/ADP implicada en la respuesta al estrés, 
pues, la liberación de OXT desde ésta tendría un efecto anxiolítico, promoviendo la 
agresión maternal y una atención a crías menos acusada.  
 
 
6. Resumen en castellano 
189 
 
 
 
CONCLUSIONES 
  
  
190 
 
  
6. Resumen en castellano 
191 
 
 
1. En el ratón, tanto el encéfalo masculino como el femenino muestran reactividad 
evidente a la prolactina, siempre y cuando los niveles circulantes de la hormona 
sean suficientemente altos (p.e. tras administración exógena). Sin embargo, estos 
patrones son sexualmente dimórficos en favor de hembras. La señalización mediada 
por prolactina en el encéfalo femenino está presente en el hipotálamo, amígdala, 
BST, septum y en áreas talámicas y mesencefálicas discretas, mientras que en el 
macho está restringida a regiones hipotalámicas circunventriculares, con la 
excepción del núcleo septofimbrial y el órgano subfornical. 
2. La señalización lactogénica en el encéfalo femenino está regulada por estradiol y 
progesterona. En los núcleos analizados, el estradiol tiene un efecto general 
promotor, mientras que la interacción de la progesterona con el estradiol tiene 
efectos regionales variables, o bien sinérgicos, o antagónicos. 
3. La señalización lactogénica en el encéfalo masculino es dependiente de 
testosterona. La castración provoca una disminución de la densidad de señalización 
lactogénica en los núcleos hipotalámicos paraventricular y ventromedial. 
4. La señalización lactogénica en el cerebro femenino aumenta considerablemente 
durante la gestación tardía y postparto, tanto en extensión como en intensidad. Este 
aumento está probablemente relacionado con el papel de las hormonas 
lactogénicas en la inducción de adaptaciones fisiológicas y conductuales a la 
maternidad. 
5. Este aumento en la señalización lactogénica durante la gestación tardía y postparto 
se observa en todos los nodos del cerebro sociosexual. Esto sugiere que las 
hormonas lactogénicas están probablemente modulando esta red neural hacia un 
estado maternal, promoviendo así la expresión de comportamientos maternales.   
6. Durante el periodo maternal, en la mayoría de los núcleos analizados, la señalización 
lactogénica alcanza su máximo durante la gestación tardía. Esto indica que es la 
gestación tardía y no el postparto el periodo crítico para la inducción de las 
adaptaciones cerebrales a la maternidad.  
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7. La supresión farmacológica de la secreción hipofisaria de prolactina mediante 
bromocriptina no atenúa significativamente los niveles de señalización lactogénica 
medidos en el encéfalo gestante. Esto indica que las hormonas responsables de la 
señalización lactogénica observada son de origen no hipofisario, probablemente 
lactógenos placentarios y/o prolactina intracerebral. 
8. La correcta evaluación de la motivación por las crías requiere la medición de 
respuestas maternales proactivas bajo condiciones adversas para la madre. Con este 
fin, hemos diseñado y validado un nuevo test de recogida de crías para la que se 
requiere un elevado esfuerzo. 
9. En estas condiciones sólo las madres realizan la recogida de crías desde el primer 
test, lo que indica que el desarrollo de los aspectos motivacionales de la conducta 
maternal requiere de la acción de señales endocrinas de la gestación y lactancia 
(incluyendo hormonas lactogénicas). 
10. Alternativamente, las hembras vírgenes sujetas a una interacción prolongada con 
crías (comadres) experimentan un incremento moderado de motivación por las 
crías, como parte del proceso de sensibilización maternal. 
11. El AC/ADP, núcleo localizado en una región crítica para el comportamiento maternal, 
experimenta un incremento significativo de señalización lactogénica durante el 
periodo maternal (gestación tardía y postparto). Este incremento no ocurre en su 
población de neuronas oxitocinérgicas, sino en neuronas no oxitocinérgicas 
adyacentes. 
12. Las comadres no muestran ningún incremento en señalización lactogénica en la 
región del AC/ADP en comparación con vírgenes sin contacto con crías. Esto sugiere 
que la interacción prolongada con crías no tiene efectos directos sobre la acción 
central de prolactina, al menos en este núcleo. 
13. El AC/ADP no sufre ninguna variación en el número de neuronas oxitocinérgicas 
asociada al periodo postparto ni a la exposición prolongada a crías en comadres. 
Esto sugiere que, en el ratón, los cambios neurales inducidos por agentes 
endocrinos o estímulos de crías durante el periodo maternal no afectan 
directamente a la expresión de oxitocina. 
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14. Aún así, el número de neuronas oxitocinérgicas del AC/ADP correlaciona 
negativamente con las medidas de recogida (motivada) de crías en madres y 
comadres, y positivamente con las medidas de agresión maternal en madres. Esto 
sugiere un papel de estas neuronas oxitocinérgicas en la reducción de estrés y 
ansiedad durante la maternidad, que a su vez afectaría indirectamente al cuidado y 
agresión maternales. 
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